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Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited 
kidney disease. Mutations in PKD1 (85%) or PKD2 (15%) account for almost all cases of 
ADPKD. The ADPKD proteins, termed polycystin-1 (PC1) and polycystin-2 (PC2) form a 
receptor-ion channel complex and in part, co-localise to the primary cilia. Since primary cilia 
are reported to be structurally normal in ADPKD unlike other ciliopathies, this project sought 
to test the hypothesis that changes in ciliary dynamics in relation to extracellular or 
intracellular stimuli might be an unrecognised feature of ADPKD.  
 
Primary cilia assembly and disassembly was assessed in several established cellular models 
and shown to be synchronised to the cell cycle. In both control and ADPKD cell models, 
changes in intracellular Ca
2+
 and cAMP were found to similarly regulate ciliary length. 
Unexpectedly, primary cilia in ADPKD cell models were consistently shorter compared to 
normal controls; this was confirmed in diseased kidney tissue. Disease cells showed evidence 
of increased actin and microtubule polymerisation and disorganisation compared to controls. 
Of significance, the defect in cilia length could be fully restored by cytochalasin D, an 
inhibitor of actin polymerisation. This effect was independent of cAMP/PKA signalling. 
Inhibition of Rho GTPases showed differential effects on cilia length between control and 
disease cells with the most specific difference observed with a Rho inhibitor. Disease cells 
were less able to reorient cilia towards the migratory axis in wounding assays. Finally, several 
cystoproteins were shown to bind to either polycystin-1 or polycystin-2 and regulated cilia 
length (INPP5E) or polycystin-2 localisation to cilia (INVS). 
 
These results indicate that a primary defect in actin organisation may result from polycystin-1 
deficiency. Restoring actin dynamics in ADPKD may restore the structure and function of the 
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1.1 Autosomal Dominant Polycystic Kidney Disease 
 
 
Hereditary cystic kidney diseases comprise a number of monogenic disorders (Bisceglia et al, 
2006), which are characterized by the clinical manifestation of multiple bilateral fluid-filled 
cysts in the kidney (Gabow 1993). For ADPKD, up to date studies show a prevalence of 
almost 1/2500 people with ADPKD in the European Union, a number which just categorizes 
it under the threshold for a rare disease according to EU definitions (Willey et al, 2016). 
However, the prevalence numbers might still be underestimated with a majority of affected 





Figure 1.1  Artistic representation of a normal and ADPKD kidney. With disease progression, 
ADPKD kidneys expand due to the formation of multiple fluid-filled cavities (or cysts) increasing in 





Children of a parent with ADPKD have a 50 percent chance of inheriting the disease, 
reflecting dominant transmission. In general, the disease is of late onset and the clinical 
manifestations can be variable. Kidney dysfunction is not clinically apparent until the age of 
30 to 40 due to compensatory mechanisms from healthy tissue (Grantham 2008; Ong et al, 
2015). In cases where the family history is not known, the first diagnosis of ADPKD and the 
presence of early cysts can be diagnosed incidentally. In the advanced stages, disease 
progression is more rapid leading to a measurable decline in kidney function. These cysts 
increase in diameter and number throughout the afflicted person’s life and lead to progressive 
impairment of normal kidney function. At the cellular level, the cystic kidney is characterized 
by increased proliferation, apoptosis, altered fluid secretion and extracellular matrix 
deposition. Some of the first symptoms include elevated blood pressure which when left 
untreated can further damage kidney function and increase the risk of heart disease (Ong et 
al, 2015).  
 
As a systemic disorder ADPKD is also the cause for other symptoms, including 
cardiovascular abnormalities and cyst formation in the liver and other organs (Gabow 1993). 
However the kidney is always affected and becomes enlarged as the direct result of cyst 
formation and expansion. Common symptoms include urinary tract infections, hypertension, 
hematuria, nephrolithiasis, acute or chronic flank and abdominal pain (Gabow 1993; Rizk and 
Chapman 2003). The diagnosis is most commonly made by ultrasound imaging using defined 
criteria; total kidney volume (TKV) measured by MRI or CT can give an accurate measure of 
disease burden and has prognostic value (Ong et al, 2015). Currently, symptomatic treatment 
of symptoms and complications such as the management of high blood pressure, pain or 
urinary tract, bladder or kidney infections is the main management strategy. Patients with 
end-stage disease commonly undergo dialysis or renal transplantation (Patel et al, 2009). 
Recently, a promising new treatment- Tovalptan, a vasopressin V2 receptor antagonist, 
showed some effect in slowing kidney growth and the associated decline in function (Torres 






1.2 Genetics of ADPKD 
 
ADPKD is caused in 85% of cases by mutations in PKD1 which is located on the short arm 
of the chromosome 16. Mutations in PKD2, mapped on the long arm of chromosome 4, are 
responsible for the remaining 15% of cases. In both genotypes, the phenotype is clinically 
indistinguishable, although PKD2 patients generally have a later onset of end stage renal 
disease (ESRD) than PKD1 patients (Gabow 1993; Patel et al, 2009). This overlapping 
phenotype suggests that both proteins function in the same complex or biochemical pathway, 
a hypothesis that has been shown experimentally for the ADPKD proteins, polycystin-1 
(PC1) and polycystin-2 (PC2) (Grimm et al, 2003; Ong et al, 2005; Torres et al, 2007). 
 
However, regardless of genotype, the onset and progression of ADPKD is more variable than 
the simplified scheme presented above, making accurate prognostic prediction difficult even 
within the same family. It is likely that environmental, epigenetic and other genetic factors 
play a role in modifying disease severity. Somatic mutations have been detected in cystic 
cells at low frequency but are now not considered necessary for cysts to form through a ‘two 
hit’ model.  
 
Genetic screening for PKD1 or PKD2 is becoming widely available and is advisable in the 
absence of family history or where the diagnosis is in doubt. In future, mutation analysis will 
be an important factor as part of the general assessment of prognosis of disease onset, 










Figure 1.2 Membrane topology of the polycystin-1/polycystin-2 complex 
The PKD1 gene encodes Polycystin-1, a glycoprotein of 4304 amino acid size widely expressed in 
epithelial cells. The PLAT (Polycystin-1, Lipoxygenase, Alpha-Toxin) domain is located between 
transmembrane segments 1 and 2 of polycystin-1. The PKD2 gene encodes polycystin-2, a smaller 
protein of 968 amino acids expressed in the endoplasmic reticulum and in the cell plasma membrane. 
The Ca
2+
 channel pore is positioned within transmembrane segments 5 and 6 of polycystin-2. 









Polycystin-1 is an 11 trans-membrane protein with an extracellular N-terminal domain and a 
short cytoplasmic C-terminal domain (Tsiokas et al, 1997; Newby et al, 2002). It is a large 
glycosylated protein with a molecular weight of approximately 460 kDa. The majority of the 
protein is expressed in the eleven transmembrane domains which share some homology to 
polycystin-2 and the large N-terminal extracellular domain. These includes various motifs 
involved in protein to protein interactions and a proteolytic cleavage domain typical of other 
G protein-coupled cell-receptors (GPCR) regulated by cell/matrix adhesion (Delmas et al, 
2002; Parnell et al, 1998; Parnell et al, 2002; Sandford et al, 1999). The C-terminal 
intracellular domain is characterized by a coiled-coil domain (mediating interaction with 
polycystin-2), a G-protein binding domain and various predicted phosphorylation sites. 
One of the first observations made was its ability to interact with polycystin-2, and its 
function in tubular morphogenesis (Qian et al, 1997). In addition, studies showed that this 
interaction upregulated the expression of polycystin-1 (Tsiokas et al, 1997) and induced 
calcium-permeable whole cell currents (Hanaoka et al, 2000). 
 
1.3.2 Polycystin-1 and cell adhesion  
Early studies found that polycystin-1 co-localized and co-precipitated with the cell adhesion 
molecules E-cadherin and alpha-, beta-, and gamma-catenin (Huan and van Adelsberg 
1999), suggesting a role in regulating E-cadherin mediated adhesion and signalling.  
Other groups showed that polycystin-1 co-localized with another type of junctional 
complexes termed desmosomes and to cell-cell contacts in MDCK cells (Scheffers et al, 
2000; Bukanov et al, 2002) and that the Ig-like repeats of polycystin-1 might be directly 
involved in mediating cell adhesion (Ibraghimov-Beskrovnaya et al, 2000; Streets et al, 
2003).  
Within the cell, the C-terminus of polycystin-1 was shown to interact with cytoskeletal 
structures such as the intermediate filaments vimentin and cytokeratins (Xu et al, 2001), actin 





1.3.3 Polycystin-1 Localization and expression 
 
The subcellular localization of polycystin-1 has been an area of controversy and complexity 
(Ong 2000). Multiple locations have been attributed to polycystin-1 including the plasma 
membrane, endoplasmic reticulum, primary cilium and the nucleus (following C-terminal 
cleavage) (Grimm et al, 2003; Nauli et al, 2003; Chauvet et al, 2004). These studies hinted 
that polycystin-1 could have multiple functions and regulate a number of different signalling 
pathways in different cellular compartments. Some of the earliest localization studies of 
Polycystin-1 showed localization to sites of interaction between adjacent cells, which 
enhanced the role for polycystin-1 in cell-cell interactions. Kidneys and liver cells represent 
the main pathogenic tissues, where polycystin-1 expression has been reported (Peters et al, 
1999). However, polycystin-1 expression was also found expressed in tissues such as 
epithelia and endocrine cells, not directly reported to be involved in ADPKD. Some examples 
include pancreatic cells in islets, Leydig cells in the testis or myocardium and myocytes of 
cardiac valves, cerebral arteries and skeletal muscles (Peters et al, 1999).  
 
1.3.4 Polycystin-1 regulation of different signalling pathways 
 
Despite many studies, the physiological function/s of polycystin-1 and the major signalling 
pathways regulated by polycystin-1 remain elusive. The C-terminal tail of polycystin-1 has 
been shown to interact with STAT3 (Talbot et al, 2014) and STAT6 (Low et al, 2006). 
Furthermore, polycystin-1 was suggested to be involved in the mTOR pathway. It was found 
that following the mTOR and STAT signalling cascade, a protein named tuberin interacted 
with the cytoplasmic tail of polycystin-1. Tuberin is an essential inhibitor of the mammalian 
target of rapamycin (mTOR) kinase, a key mediator in cell proliferation which can be 
modulated with specific drugs (Shillingford et al, 2006) and whose activation has also been 
linked to primary cilia (Boehlke et al, 2010). Interestingly, tuberin is also known for its 
ability to regulate specific GTPases and mTOR FRAP1 kinase activity, thus establishing a 
potential link between cystoproteins and proliferation or apoptosis mechanisms (Shillingford 
et al, 2006). In addition to that, potential roles in intermediate filament network regulation, by 
interaction with vimentin and cytokeratins with the C-terminus and coiled-coil region of 
polycystin-1 (Xu et al, 2001) further suggested a role of polycystin-1 in regulating cell 




protein complex consisting of Arf4, Rab6, Rab11 and GTPase-activating proteins, possibly 
involved in vesicle budding and Golgi exocytosis (Ward et al, 2011). 
Furthermore, it is theorized that polycystin-1 undergoes proteolytic cleavage at different 
positions, with different possible functions (Lal et al, 2011; Bertuccio et al, 2013). Studies 
suggested that polycystin-1 was able to transmit messages directly to the nucleus by cleaving 
and releasing its C-terminal tail, which subsequently activated different signalling process 
through transport into the nucleus (Chauvet et al, 2004). Other studies suggested a possible 
cleavage at the GPS domain in synchrony with the REJ domain at the beginning of large N-
terminal region of the polycystin-1 protein, and studies showed that mutations preventing this 
cleavage resulted in an impaired ability to transduce signals and induced tubulogenesis in 




Polycystin-2, is characterised by six transmembrane domains with cytoplasmic N and C 
termini. It is approximately 110 kDa in size and shows significant homology to the transient 
receptor potential (TRP) channel superfamily: it is also known as TRPP2. 
 
1.3.6 Polycystin-2 localization 
Precise localization studies of this protein showed that only a minority (approximately 8%) 
co-localized with polycystin-1 to the plasma membrane of human and mouse kidney cells, 
where it could function as a calcium permeable channel (Koulen et al, 2002). In addition, this 
surface localization was dependent on the co-expression of polycystin-1 (Hanaoka et al, 
2000; Newby et al, 2002). Other groups have shown that polycystin-2 can act as a calcium 
release channel at the endoplasmic reticulum (ER) (Koulen, et al 2002) where it has been 
shown to interact with other resident ER channel proteins such as TRPC1, IP3R and RyR 
(Anyatonwu et al, 2007; Sammels et al, 2010). In support of a ciliary role, a later study found 
endogenous polycystin-2 expression in the primary cilium of IMCD3 and MDCK cells (Luo 
et al, 2003). Expression in tissue of polycystin-2 has been shown in ovary, fetal and adult 





1.3.7 Polycystin-2 functions 
The main proposed function of polycystin-2 encompasses its role as a calcium cation-channel 
and although the main mechanisms underlying polycystin-2 gating are currently not clear, 
some evidence suggests gating mechanisms dependent on phosphatidylinositol 4,5-
bisphosphate (PIP 2 ) or the actin organizing diaphanous-related formin 1 (mDia1) interaction 
(Bai et al, 2008). 
An early study showed that polycystin-2 interacted with HAX1, an actin-associated protein 
through its ability to bind to the F-actin-binding protein cortactin (Gallagher et al, 
2000). Other studies suggested that both intracellular domains could associate with alpha-
actinins, actin-bundling and actin-binding proteins (Li et al, 2005). In addition, it was shown 
that polycystin-2 was able to bind indirectly to the actin microfilaments (Li et al, 2003) and 
that microtubule dynamics were able to regulate polycystin-2 channel functions in renal 
epithelial cells (Li et al, 2006). Furthermore, polycystin-2 has been shown to directly regulate 
the cell cycle via modulation of the ID2-CDKN1A-CDK2 pathway, a channel independent 
function (Li et al, 2005). More recent studies have shown that polycystin-2 was able to 
interact with different integral membrane receptor proteins including TRPC1, IP3R and RyR 
and that in the ER, association with these receptors elevated intracellular calcium levels 
(Anyatonwu et al, 2007; Sammels et al, 2010), while others showed involvement in the 
regulation of correct left-right patterning (Yoshiba et al, 2012).  
 
1.3.8 The Polycystin-1/Polycystin-2 complex 
Since both proteins are expressed on primary cilia of renal tubular epithelial cells, one of the 
most debated functions of a cilia-localized polycystin-1 and 2 (PC1-PC2) complex is in the 
flow-activation of polycystin-1 regulating the influx of extracellular calcium through 
polycystin-2 (Nauli et al, 2003; Mangolini et al, 2016). Recent studies have disputed this 
finding leaving the physiological ciliary function of the polycystins unclear (Delling et al, 
2016). Calcium influx is one of the factors besides growth factors and cAMP which through 
the extracellular signal-regulated kinase (ERK) pathway governs the proliferative state of 
renal tubular cells (Yamaguchi et al, 2004). Other important signals include the mammalian 
target of rapamycin (mTOR) kinase, which was found increased in activity in cysts found in 




effectors (Distefano et al, 2009). However, some evidence points to a homeostatic action of 
the polycystin-1/2 complex, involving the regulation and balance of cAMP and calcium 
signalling, which in turn activate intracellular pathways that oppose proliferation signals such 
as the mTOR and mitogen-activated protein kinase (MAPK) pathways (Franco et al, 2015). 
Other pathways such as JAK2/STAT1/p21, have also been shown to be regulated by the 




1.4 Primary Cilia 
 
Primary cilia have been shown to act as an important sensory organ, able to detect 
extracellular chemical and mechanical signals and transducing them via intracellar signalling 
pathways to specific coordinated responses which affect proliferation and differentiation 
(Marshall and Nonaka 2006). The primary cilium is a solitary microtubule-based cytoskeletal 
organelle that emanates from the surface of most mammalian cell types during growth arrest. 
The reported length of these organelles is very variable, ranging from 1 1 μm up to 30 μm 
reported in some kidney epithelial cells (Saggese et al, 2012). 
Within the kidney, one of the main roles attributed to primary cilia is as a sensor of 
extracellular stimuli, including mechanosensation and receptor signalling, and transmitting 
these signals through intracellular pathways which regulate proliferation and differentiation 
(Irigoín & Badano 2011). Other roles of primary cilia can be found during embryonic 
development in cell orientation and differentiation (Goetz and Anderson 2010), in contact 
inhibition, cancer and directional migration during wound healing (Michaud and Yoder 2006; 
Schneider et al, 2010).  
Changes in the structure or function of the cilium are likely to underlie the development of 
many cystic diseases such as ADPKD, Nephronophthisis (NPHP) and Bardet-Biedl syndrome 
(BBS). The structure of a cilium is highly evolutionarily conserved and is formed by a 
cytoskeletal scaffold arrayed by microtubule triplets termed the axoneme (Plotnikova et al, 
2009) (Figure 1.3). The ciliary axoneme is composed of nine doublet microtubules. It arises 
out of the mother centriole (forming the basal body) and is enveloped by the ciliary 
membrane, a specialised compartment distinct from the apical membrane (Plotnikova et al, 
2009). Motile (9+2) cilia are distinguished from the non-motile cilia (9+0) by the presence or 
absence of a central pair of microtubule doublets, which confer cilia motility (Satir and 
Christensen 2007). The length of the primary cilium, which is influenced by the assembly and 
disassembly of ciliary building blocks such as tubulins and other axonemal proteins, has been 
suggested to critically modulate cilia function by attenuating chemokine and other responses 
(Wann and Knight 2012). Additional evidence supporting the importance of the role of ciliary 
organelles has come from the cancer field, where cilia are proposed to function in a 
surveillance role of proliferation (Seeley et al, 2009; Rocha et al, 2014); thus loss of primary 
cilium is associated with uncontrolled proliferation, a feature of cyst formation. Interestingly, 
studies performed on a variety of tumour cells revealed in the majority of cases no cilia 




restrictive signals mediated through cilia or that the inability of malignant cells to enter 
quiescence results in defective cilium development (Seeley et al, 2009; Wheatley 1995). 
Interestingly, it was found that that loss of intact cilia was able to suppresses cyst growth 
following inactivation of polycystins, suggesting a still unknown intricate co-regulatory 
mechanism between the cilia polycystin system (Ma et al, 2013).  
 
 
1.5 Cell cycle and primary cilium modulation 
 
Most of our current knowledge on primary cilium has been based on structural studies using 
electron and immunofluorescence microscopy (Jensen et al, 1987; Plotnikova et al, 2009). 
The processes by which primary cilia are assembled and disassembled during the various 
stages of the cell cycle remain poorly understood. However, it is broadly accepted that 
ciliation is a characteristic of cell cycle exit and quiescence, while disassembly of cilia takes 
place when cells actively re-enter the cell cycle, resulting in their complete absence in mitotic 
cells (Archer and Wheatley 1971; Paridaen et al, 2013). This is closely linked to other 
observations that at a specific stage during cell cycle progression, ciliated centrioles i.e. the 
basal body (which derives from the mother centriole) have to be released to function as a 
microtubule-organizing centre (MTOC) responsible for the organization of the mitotic 
spindle apparatus (Plotnikova et al,  2009; Paridaen et al, 2013). Studies in vertebrate cells 
have shown that the inter-conversion between basal body and MTOC conformations are 
directly associated to an elongation of primary cilia in quiescent cells or cilium disassembly 
prior to mitotic entry (Archer and Wheatley 1971; Plotnikova et al, 2009).  
 
In the majority of cells, the assembly of primary cilium occurs in G1 after cytokinesis. 
During the formation of the primary cilium, the mother centriole that acts as a template for 
the assembly of the second daughter centriole during S phase of the previous cycle, migrates 
near the plasma membrane and differentiates into a basal body. From there, the axoneme 
starts to elongate, still connected to the basal body. The established connection is known as 
the transition zone where later proteins will traffic in and out from the cilium (Zalli et al, 
2012). Thus, in each G1 phase, cells possess both a daughter centriole and a mother centriole 
where the latter plays a unique role in basal body development via the specific ability to 




During interphase, both centrioles are located at the centrosomes. In S- phase, both centrioles 
and DNA undergo replication and towards the end of G2 at the M transition, cilia 
disassembly begins. Immediately after mitosis, cilia reassemble in G0-G1. The observed 








Figure 1.3 Primary Cilia and the Cell cycle. As cells exit mitosis (M), the cell enters the first stage 
of the interphase. Assembly of primary cilia occurs by an increase of anterograde IFT molecules from 
the basal body into the cilia tip of the primary cilium, with maximal cilia length during G1-G0 phase. 
The next stage is represented by the S phase where centrioles and DNA replication initiates. At this 
point, for some cells an increase of retrograde IFT transport thus cilia disassembly begins, whereas for 
other cells cilium disassembly begins at the end of the G2 phase with complete disassembly at 





1.6 Molecular control of the cilia assembly and disassembly 
 
Studies of cilia development in mammalian cells have uncovered numerous mechanisms 
involved in the regulation of the primary cilia growth cycle. Besides phosphorylation of 
different protein kinases -which have been shown to be involved in cilium regulation- 
including aurora kinases (AurA), mitogen-activated protein (MAP) and never in mitosis A 
(NIMA) kinases or more novel cyclin-dependent protein kinases (Mahjoub et al, 2005; Cao et 
al, 2009; Majeed et al, 2012), it has been reported that flagellar length can be influenced by 
intracellular calcium concentrations and cyclic AMP (cAMP) acting through protein kinase A 
(PKA) activation (Besschetnova et al, 2010). Cilia elongation is believed to take place via a 
PKA dependent rise in the amount of anterograde IFT particles involved in the intraflagellar 
transport (IFT) process (Besschetnova et al, 2010). The IFT process is an essential 
component for cilia development and maintenance. IFT particles are formed by non-
membrane bound protein complexes, which are transported along the axonemal doublet 
microtubules along the entire cilia length from the base to the tip (Plotnikova et al, 2009).  
IFT defines an active process where ciliary building blocks can be transported in both 
directions by IFT particles. These associate with ciliary proteins and represent the executers 
of anterograde and retrograde ciliary protein transport.  
 
Differences between the velocity of anterograde and retrograde movement can define cilia 
resorption or extension. This has been shown in studies performed in Chlamydomonas where 
cilium disassembly was augmented when cargo-less IFT particles entered the primary cilium 
(Pan and Snell 2005; Rosenbaum and Witman 2002). The two-way protein transport is 
accomplished by two different IFT macromolecular complexes. Complex A, associated with 
the motor protein dynein, is responsible for retrograde transport from the tip while complex 
B, connected to kinesin 2, is responsible for anterograde transport from the cell body towards 
the tip (Plotnikova et al, 2009; Williamson et al, 2012; Huet et al, 2014). The balance 
between the rate of anterograde and retrograde delivery through these two complexes 
ultimately influences ciliary assembly and resorption during different stages of the cell cycle 
(Rosenbaum and Witman 2002). The process initially observed in Chlamydomonas is a 
highly conserved process through evolution as shown by studies performed on mammalian 
cilia in RPE cells (Pan and Snell 2005; Pugacheva et al, 2007). Mutations in IFT particles or 




from the recognition that the intraflagellar transport 88 protein (also known as Tg737, polaris, 
or OSM-5), a component of the IFT-B complex resulted in abnormally short flagellar and 
cilia in Chlamydomonas, C. elegans, mice and in cyst development and abnormal cell-cycle 
progression (Haycraft et al, 2001, Taulman et al, 2001, Yoder et al, 2002).  
However, a number of mechanisms independent of IFT are also known to influence ciliary 
dynamics in mammalian cells as indicated in studies on Ptk1 cells, where cilia resorption 
during mitosis associated this organelle as a component of the cytoplasmic microtubule 
complex (CMTC) and spindle pole formation regulate cilia dynamics (Rieder et al, 1979). 
Comparative genomics and proteomic analysis on eukaryotic cilia have identified a variety of 
proteins localized to the cilium or the basal body which have been shown to negatively affect 
ciliogenesis and result in cystic diseases including the large families of Bardet-Biedl, Joubert 
or Meckel-Gruber syndrome genes, (Li et al, 2004; Pazour et al, 2005 Badano et al, 2006), 
and others, including the primary ciliary dyskinesia and the nephronophthisis genes.  
A potential link to ADPKD has been the reported by the association of nephrocystin-1 
encoded by the NPHP1 gene, with polycystin-1 (Wodarczyk et al, 2010). Other links between 
proteins involved in cilia development and the polycystin proteins are therefore promising 
candidates to study in the pathogenesis of ADPKD. Recent examples include a variety newly 
identified CP centrosomal proteins (CEP) that are involved in suppression of cilium protusion 
(Graser et al, 2007, Spektor et al, 2007, Tsang et al, 2008, Chaki et al, 2012) or the “Never-
In-Mitosis” NIMA-related kinases (NRK or NEK) which have been shown to localize to the 
cilium and shown involvement in cell cycle and primary cilium regulation (Otto et al, 2008; 
Trapp et al, 2008; White and Quarmby 2008; Hoff et al, 2013). In the latter case, it was 
specifically shown that mutations in two of the kinases, Nek1 and NPHP9 (Nek8) resulted in 
the development of cysts in kidneys of mice and humans (Liu et al, 2002; Upadhya et al, 
2000; Zalli et al, 2012).  
At least two large recent functional genomics screens aimed at the identification of novel 
modulators of ciliogenesis and cilium length and have highlighted a variety of new candidate 
genes involved in ciliogenesis and cilia length regulation (Kim et al, 2010; Wheway et al, 
2015). Some of the new ciliogenesis regulators hint to mitotic cell cycle regulators such as 
Cdc27 or Cdc77 or novel centrosome proteins such as CEP120 (Wheway et al, 2015),  
components of the ubiquitin-proteasome system, G-protein-coupled receptors, pre-mRNA 




mechanisms involved in ciliogenesis are also involved in early steps of the autophagic 
process, with partial inhibition of  autophagy and cell-volume regulation in primary cilia 
ablated models (Pampliega et al, 2013; Orhon et al, 2016). In addition, there is evidence to 
suggest that endocytic recycling proteins such as EHD1 might also represent an important 
factor in primary cilia modulation and SHH signalling as shown by studies in Ehd1 gene 
knockout in mice (Bhattacharyya et al, 2016). 
Interesting are recent ciliary modulating molecules involved in microtubule organization 
(Miyamoto et al, 2015), vesicle trafficking and actin dynamics (Kim et al, 2010), the latter 
gaining importance later in our study, were it was shown that actin organization is an 
important ciliary length regulator possibly disturbed in ADPKD. 
Although the clear mechanisms and exact pathways of actin control over ciliogenic processes 
is still poorly understood and only recently gaining increased importance, some studies 
suggest that the transcriptional regulators Yes-associated protein (YAP) and transcriptional 
coactivator with PDZ-binding motif (TAZ), which are the main effectors of Hippo signalling 













Figure 1.4  Primary cilium regulation. Summary figure of the currently major identified pathways 
involved in primary cilium dynamics and regulation. ADPKD, and other diseases characterized by the 
formation of renal cysts are commonly classified into the family ciliopathies. Ciliary proteins or 
building blocks are transported in both directions by IFT particles, which are the executers of the 
anterograde and retrograde machinery. The primary cilium formation machinery is influenced by 
different pathways which are known to affect to various degrees cilia formation and development. 
Primary cilia are found on the apical surface of the epithelial cells of the renal tubules and collecting 
ducts. Ciliary IFT Anterograde activating signalling and pathways such as cAMP and PGE2 (Green 
arrows). Ciliary IFT Retrograde activating or stabilizing signalling and pathways such as PDGF and 






1.7 The role of primary cilia in the pathogenesis of ADPKD 
 
From its structural conformation it is safe to assume that the main function of primary cilia 
revolves around cell signalling. Some of the most well-known are summarized in (Figure 
1.4). The primary cilium is packed with a large amount of different receptors, ion channels 
and transporter proteins. The formation of a structure such as the cilium, extends these 
sensing organs far out from the cell similarly to an antenna. This allows for flexibility and an 
increased overall reach of signal detection in regions accessible to diffusing biological 
molecules, mechanical forces or other extracellular regulators, without the possible 
limitations posed by the physical organization of the whole cell. The localization of 
polycystin-1 and polycystin-2 to the primary cilium was the first link to primary cilia function 
as potentially relevant to ADPKD pathogenesis. Since cilia have been reported to be 
structurally normal, it was postulated that a defect in function was the main abnormality. The 
ability of polycystin-1 to act as a flow-sensor has been supported by studies showing that its 
extracellular region is endowed with high mechanical strength (Forman et al, 2005). 
Although studies have shown that an increase of intracellular calcium was specifically 
mediated by the deflection of the cilia axoneme (Praetorius & Spring 2003) and possibly 
mediated by the ciliary resident polycystins (Nauli et al, 2003), recent studies have disputed 
the ability of polycytin-1/2 or primary cilium bending in transducing a flow-sensitive cilia 
Ca
2+
 current (Delling et al, 2016). In multiple different cell lines including kidney epithelial 
cells, they showed that intracellular Ca
2+
 was not altered upon mechanical bending of the 
primary cilia as previously suggested, from which they concluded that a possible ciliary 
mechanosensation role, if present, was not mediated by Ca
2+
 entry in cilia (Delling et al, 
2016). 
 
Alternatively, primary cilia are speculated to be involved in a surveillance task of cell 
regenerative potential against extensive proliferation, via sequestration of the in cell division 
required centrioles (Seeley et al, 2009; Rocha et al, 2014). Studies on a PKD mouse model 
support these findings, showing that wound healing following acute kidney injury modulated 
cilia length and activates cell cycle processes. Without the normal cilium surveillance, this 
promoted the uncontrolled proliferation of cells, increasing the overall cystogenic potential 




Impaired cilium cell cycle surveillance mechanisms could then lead to unopposed 
proliferation. 
 
Recent studies have also implicated STAT6 (Low et al, 2006) and mTOR in cilia signalling, 
the latter through the action of LKB1 (Boehlke et al, 2010); both pathways have also been 
linked to polycystin-1. Primary cilia have also been associated with growth factor signalling 
such as the platelet-derived growth factor (PDGF) and thus involved in cell migration and 
proliferation (Hoch and Soriano 2003). The PDGFRα receptor is upregulated and localizes to 
primary cilia in growth arrested cultured fibroblasts and is activated through ligand PDGF-
AA binding leading to downstream activation of the Akt, ERK1/2- and MEK1/2-pathway 
(Schneider et al, 2005), thus primary cilia defects are likely to impair these mechanisms.  
Interestingly, recent studies hypothesize a possible role of primary cilia as a sensor, which 
regulates directional cell movement in migrating fibroblasts through the PDGFRα receptor 
(Christensen et al, 2013). Beside the PDGF receptor, other tyrosine kinases (RTK) are shown 
to be regulated and mediated via the primary cilia in different cell models, such as the 
insulin-like growth factor (IGF1R), the epidermal growth factor receptor (EGFR) and the 
angiopoietin receptor (Tie-2) (Christensen et al, 2012) all of which influence basic cellular 
functions which might converge in ADPKD pathogenesis. 
 
The primary cilium is also found involved in the Hedgehog (Hh) pathway, activation of the 
latter being mainly depends on cilia integrity (Fliegauf et al, 2007). The Hh-signaling 
pathway is involved in many developmental mechanisms and cell differentiation and recent 
studies showed that downregulation of this pathway reduced the renal cystogenic potential of 
mouse models (Tran et al, 2014), suggesting that enhanced or uncontrolled hedgehog activity 
may be a feature related to common ADPKD development. In this context, a defect in cilia 
integrity is able to critically influence Hh-signaling, which depending on defect type either 
increase or decrease Hh-signaling (Goetz et al, 2010) resulting in according developmental 
defects for example in neural tube patterning.  
 
Primary cilia seem also to be important in restraining canonical Wnt signalling, important in 
developmental and homeostatic processes (Gerdes et al, 2007). Downregulation of different 
genes important in ciliogenesis such as BBS1, BBS4, MKKS or KIF3A in different models 




accumulation of nuclear β-catenin (Corbit et al, 2008). Interestingly, in context to the β-
catenin involvement is that the ciliary resident nephronophthisis protein NPHP2/INVS is able 
to deactivate β-catenin by a Dishevelled (Dvl) protein mediated transport to the destruction 
complex, thus INVS impairment results in an abnormal augmentation of nuclear β-catenin 
accumulation (Otto et al, 2003; Simons et al, 2005), which is a common hallmark of renal 
cysts (Kheddouci et al, 2001). 
 
New studies have uncovered additional potential roles of primary cilia that could have an 
implication in the pathogenesis of ADPKD such as Notch-signalling (Ezratty et al, 2012), 
which is important during renal development and has been shown to be involved in renal 
cysts formation in mouse cells (Surendran et al, 2010), or the disruption of signalling via the 
alterations in the composition of the specific and unique primary cilia membrane proteins 
itself, such as the inositol polyphosphate-5-phosphatase E (INPP5E) (Bielas et al, 2009; 












The major hypothesis of this project was that altered primary cilia formation or regulation 





 Assess the effect of polycystin-1 and /or polycystin-2 deficiency on ciliogenesis 
 
 Investigate molecular mechanisms underlying the observed defects in ciliogenesis in 
ADPKD  
 
 Identify novel polycystin-1 or polycystin-2 binding proteins involved in primary 









































2.1 Materials and Reagents 
2.1.1  Compounds 
 
BSA A7906 Sigma 
Blasticidin Invitrogen 
BM Chemiluminescence Blotting kit  Roche 
BSA A7906 Sigma 
Cytochalasin-D Sigma 
DAPI Vector Laboratories 
dbc cAMP Tocris Biosciences 
Dimethyl Sulfoxide Sigma 
Dual Colour Precision Plus  Bio-Rad 
Dynabeads Protein G Life Technologies AS 
EGF Sigma 
EP-1-4 agonists Ono 
Ep-2, Ep-4 antagonists Ono 
FBS Biosera 
Forskolin  Tocris Biosciences 
Glycine VWR Chemicals 
H89 (PKA inhibitor) LKT laboratories 
InCellect AKAP St-Ht31 inhibitor peptide Promega 
Ionomycyn calcium salt Sigma 
ITS Sigma 
L-Glutamine BioWhittaker® Lonza 
LY 294002 Tocris 
ML 141 Tocris 
Mounting medium  VectaShield®  
Nocodazole Sigma 
NSC23766 Tocris 
Nu Serum BD Biosciences 





PBS (10X) BioWhittaker® Lonza 
Penicillin and streptomycin BioWhittaker® Lonza 
Phalloidin Tocris 
PKA inhibitor 14-22 amide Calbiochem 
Propidium Iodide P-4864 Sigma 
Prostaglandin E2 (PGE2) Tocris Biosciences 
Protein Assay Standards II Bio Rad 
Rapamycin Sigma 
Skim Milk Powder Oxoid 
Taxol Tocris 
Thapsigargin T7458 Invitrogen 
Tris Base Fisher Scientific 
Triton X-100 Sigma 
TWEEN 20 Sigma 
y-27632 Sigma 
 




SDS-PAGE Separating Gel (5%) 
1.35 ml 30% acrylamide (Biorad®) 
2 ml 1.5 M Tris (pH8.8) 
4.5 ml dH2O 
80 μl 10 % SDS 
80 μl 10 % APS 
8 μl TEMED 
 
SDS-PAGE Stacking Gel  
0.67 ml 30% acrylamide (Biorad ®) 1.25 ml 0.5 M Tris 
(pH6.8) 
3.05 ml dH2O 
50 μl 10 % SDS 
50 μl 10 % APS 
10 μl TEMED 
 
Immunoprecipitation (IP) lysis 
buffer 
150 mM NaCl 
25 mM NaPO4 pH 7.0 
1 % Triton X-100 
0.5 % Nonidet-P40 
Complete protease inhibitor cocktail (Roche, Burgess Hill, 
UK) 
50 mM NaF 




Phosphate buffered saline (PBS) 16 mM Na2HPO4 
4.6 mM NaH2PO4 
0.15 M NaCl 
Tris buffered saline with tween 
(TBST) 
8 g NaCl 
10 ml 2M Tris pH 7.6 
2 ml Tween 20 
H2O to 1 litre 
Western blot transfer buffer 14.4 g Glycine 
3 g Tris 
200 ml Methanol 
H2O to 1 litre 
SDS-PAGE Running Buffer 14.4 g Glycine 
3 g Tris 
1 g SDS 
H2O to 1 litre 
 
2.1.3  Cell lines 
 
Name Description Source 
NIH-3T3 Mouse embryonic fibroblast cell line A.Evans  
(Sheffield, UK) 
IMCD3 Murine Inner Medullary Collecting Duct cells Lorraine Eley (Newcastle, 
UK) 
hTERT-RPE1 Human Retinal Pigment Epithelial cells A.Fry 
(Leicester, UK) 




Proximal Tubule Epithelial cells 
DS RED control/PC1 KO cells 
De Smedt H 
(Leuven, Belgium) 
MEK 
PC1+/+ / PC1 -/- 
Mouse Embryonic Kidney cells 
PC positive contol/PC1 null cells 
S.M.Nauli 
(Toledo, USA) 
MDCKII Madin-Darby canine kidney N. Simmons (University 
of Newcastle 
 
Primary cultures of cystic tubular cells derived from ADPKD human kidneys 
(Described in detail in (Parker, et al 2007). 
OX161 (8+13) Germline Mutation exon 15 (E1537X)  
The generation of 
these cell lines has been 
previously reported 
(Parker et al, 2007) 
OX938 Germline exon 16, 7000dup7 
SKI001 Germline Mutation 3904-4001aaIVS43-2A>G 
SKI002 Germline Mutation 2983-3067aaIVS25-3C>G 
UCL93 Normal cell line 
RFH Normal cell line 
 
M7 PKD1 transgenic mouse kidney cells (M7) The generation of 
these cell lines has been 
previously reported 




non-transgenic mouse kidney cells 








2.1.4  Plasmids  
Name Description 
CT2  (GST) C-terminus polycystin-2 GST 
FLAG PC1 HA  HA and FLAG tagged polycystin-1 
GFP INVS plasmid GFP tagged Inversin (NPHP2) 
HA-INPP5E Phosphatidylinositol-4,5-bisphosphate 5-phosphatase with an N-terminal 
HA tag 
INPP5E-GFP Phosphatidylinositol-4,5-bisphosphate 5-phosphatase with an N-terminal 
GFP tag 
INVS-GFP GFP tagged Inversin (NPHP2) 
N PC 2  (GST) N-terminus polycystin-2 GST 
NPHP3-FLAG FLAG tagged NPHP3 
NPHP3-PKTAG PKTAG tagged NPHP3 
NPHP9-FLAG FLAG tagged NPHP9 
NPHP9-PKTAG PKTAG tagged NPHP9 
PCDNA3 Control Vector 
PEBG Control Vector 




PLAT domain with an C-terminal YFP Tag 
Patient Mutation which prevents phosphorylation by PKA at this site 
YFP-PLAT (S3164A) 
Mutant 
PLAT domain with an C-terminal YFP Tag 




PLAT domain with an C-terminal YFP Tag 
Mutation created in our lab, phosphomimetic mutation is always 
phosphorylated and is the control of the S3164A Mutant 
 
  






Directed against Type  Application/ 
Dilution 
Source  
HA Rat WB/1:1000 Roche Diagnostics Limited, Burgess 
Hill  
HA Rabbit WB/1:1000 Abcam 
GFP Rabbit WB/1:1000 Santa Cruz Biotechnology, Santa Cruz 
FLAG Mouse WB/1:1000 Sigma 
GFP Mouse  WB/1:1000 Santa Cruz Biotechnology, Santa Cruz  







WB/1:1000 Santa Cruz Biotechnology, Santa Cruz 





WB/1:1000 Santa Cruz Biotechnology, Santa Cruz 
Myc Rabbit WB/1:1000 Santa Cruz Biotechnology, Santa Cruz 
PkTAG Mouse WB/1:1000  
FLAG Rabbit WB/1:1000 Sigma 
INPP5E polyclonal Rabbit IS/1:1000 Proteintech 
α-Tubulin T7451 IS/1:1000 Sigma 
γ-Tubulin T5192 IS/1:1000 Sigma 
ARL13b polyclonal 
antibody (rabbit) 
Rabbit IS/1:500 Proteintech 
Ki67 mouse IS/1:500 Sigma 
Aurora A Sheep IS/1:1000 LifeSpan BioSciences 
    




Goat anti Rat WB/1:5000 Santa Cruz Biotechnology, Santa Cruz 
Goat anti Mouse 
IgG1 
WB/1:1000 Santa Cruz Biotechnology, Santa Cruz 
Goat anti mouse 
IgG2b 
WB/1:5000 Dako 
Goat anti Rabbit 
HRP  
WB/1:5000 Santa Cruz Biotechnology, Santa Cruz  
Goat anti Rabbit 
FITC 
IS/1:1000 Santa Cruz Biotechnology, Santa Cruz 











2.2.1 Mammalian cell culture 
 
Different cell lines were cultured in DMEM-F12 media supplemented with 10% fetal bovine 
serum and 2mM L-Glutamine or in cell dependent modified media. 
All media was provided with a streptomycin and penicillin solution. Cell growth was induced 
in T25 flasks until confluence and subsequently passaged at higher volumes in T75 flasks in 
cell dependent temperatures (33 and 37 °C) in 5 % CO2 incubators.  
Growth media was replaced every 2 days and cell passaging was performed once cells 
reached 90% confluency to ensure the healthy viability of cells. Cells were passaged by 
removing media, washing with PBS and incubation with Trypsin/EDTA at 37 ºC until cells 
detached from the flask surface. Trypsin was then neutralized by addition of FBS 
supplemented media. Cells were spun down and re-suspended in fresh media. The number of 
cells per volume of the new cell suspension was counted using a haemocytometer and 
subsequently inoculated at the desired density. 
 
2.2.2  Freezing and thawing of cultured cells 
Cryogenic preservation was routinely used for the maintenance of mammalian cells.  
Prior to storage in liquid nitrogen at -196°C, cells were grown until confluence in a 75mm 
flask and subsequently harvested, resuspended in freezing media (DMEM, 20% (v/v) FBS, 
and 10% (v/v) DMSO). The suspension was then aliquoted into cryogenic vials and gradually 
frozen to a temperature of -85°C for 24-72 h before transfer to a liquid nitrogen freezer for 
long term storage. 
The process of gentle cell thawing which provides a best recovery rate of cells was initiated 
by the removal of the vial from liquid nitrogen which was placed in a 37°C water bath for 60-
90sec with gentle swirling. Next, the cryoprotective agents were removed by transferring the 
suspension to a sterile 15ml tube with fresh media, followed by centrifugation at 1000×rpm 
and removal of the old media. The pellet was resuspended in 10ml fresh medium and then 
transferred to a suitable flask for normal incubation. 





2.2.3 Specific growth media protocols 
 
Culture media of a control non Knock down PTEC cell line (PTEC DS RED) and a 
Polycistin-1 Knock down PTEC line (PTEC PC1 KD) which was generated using lentiviral 
vectors (Mekahli et al, 2012). Culture of this cell lines was modified according (Mekahli et 
al, 2012) and was set up as follows: Growing conditions at 33C°and 5%CO2 with full 
supplemented DMEM-F12 with addition of insulin (5 g/ml), transferrin (5 g/ml), selenium (5 
ng/ml), hydrocortisone (36 ng/ml), epithelial growth factor (10 ng/ml), and tri-iodothyronine 
(40 pg/ml). Stable selection pressure towards the PC1 KD and DS RED vector is achieved by 
addition of 10 g/ml Blasticidin previous to each inoculation or cell passage. Starving 
conditions are set with serum free media at 37 C° and 5% CO2. 
The different PKD mutant used in this study are listed in Materials section and were mainly 
isolated from cysts of PKD patients. As our control, I used the non-cystic epithelial cell line 
(UCL93-3-6) which was derived from a normal human kidney for clinical indications and 
was used routinely as our control model for normal kidney cells (Parker et al, 2007). 
Growing conditions for these cell lines were at 33C°and 5%CO2 while starving condition 
were set with serum free media at 37 C° and 5% CO2. Growth medium was DMEM-F12 




2.2.4 Primary cilium study 
 
The beginning of our study was initiated by the inoculation in serum supplemented media of 
an experimental cell line capable of primary cilium formation. The first phase is characterized 
by a mitotic cell expansion with low levels of ciliated cells. The subsequent phase begins 
when cell expansion reached approximately 70-80% confluence. At this point the media was 
replaced with serum free media for 48 h to allow serum deprivation induced cell cycle exit, 
thus primary cilia formation. The last phase is induced by reintroduction of serum for a 
determined amount of time until primary cilia number returns to a comparable level before 
starvation. During each stage of the analysis, cells were collected, fixed and stained for 





2.2.5 Cell fixation and Immunofluorescence 
 
For immuno-fluorescence studies, different cells were grown on coverslip until reaching 
confluence. Next, at room temperature growth media was removed and the coverslips are 
rinsed with PBS prior to an incubation step for 15 min in 4 % paraformaldehyde to achieve 
cell fixation. Subsequently, cells were briefly permeabilized in a 0.1 % Triton X-100 solution 
for 2 min. Next, cells were washed three times with a PBS solution and then blocked in a 5% 
bovine serum albumin (BSA) in the PBS solution for 1 h. The BSA was then removed and 
after a repeated washing step with PBS, cells were incubated with the primary antibody for 1 
h at room temperature or over-night at 4 C°. Finally, after another 3X PBS washing step, cells 
were incubated with the secondary antibody for 1 h and then the coverslips mounted with 
Vecta-Shield mounting medium and DAPI on a microscope slide and the edge sealed with 
DPX resin. A wide variety of poly- and monoclonal antibodies can be used to specifically 
stain the primary for immunofluorescence microscopy. For the scope of a high quality of 
primary cilium detection, antibody combinations were adapted and changed according to the 
cell lines used or the scope of the assay. Antibodies for primary cilium detection included 
Acetylated tubulin, which is known to stain alpha tubulins present in the primary cilium 
(Alieva et al, 1999) or ARL13b which was later kept as a standard for its ability to 
exclusively stain the primary cilium while the Acetylated tubulin in some instances stained 
also microtubules of the mid-body and some cytoplasmic microtubules. In some instances I 
also used γ-tubulin, which in interphase marks the position of the centrioles and basal bodies 
found as two dots at the base of the cilium (Liang et al, 1996). DAPI was used by default to 
stain for the cell nuclei and enhance cell detection. I was able to detect primary cilia 
formation after a starvation step which peaked between 48 h and 72 h after induced 
starvation. I decided to choose the 48 h starvation step for our study, since prolonged periods 
of starvation in some cases resulted in a general decrease of cell number on the coverslip 









2.2.6 Primary cilia treatments 
 
Different compounds including cAMP or Thapsigargin were tested for their ability to regulate 
ciliary length. The design of the experiment based on the study of (Besschetnova et al, 2010), 
were the cilium status was evaluated within 3 h after addition of the bioactive compounds. 
Treatment with these compounds was carried out with a range of different concentrations and 
cilium length was measured via immunofluorescence microscopy on Olympus IX71 and 
length assisted detecting software package, SimplePCI (Hammamatsu).  
 
Initial concentration and optimization studies of new tested compounds used in our 
experiments ranged above and below concentrations previously used in other studies 
(Besschetnova et al, 2010). All treatments with inhibitors of ciliary regulators e.g. PKA 
inhibitors, agents like H89 (50 µM) and 14-22 Amide (20µM) (Farrow et al, 2003) were used 
for 1 h prior to incubation with ciliary regulating compounds + inhibitors at the same 
concentration as the pre incubation step. DMSO and dH2O were used to dilute the bioactive 




2.2.7 Nocodazole resistance assay 
 
Nocodazole resistance assays were performed to test the ability of cells to withstand tubulin 
depolymerizing agents i.e. nocodazole. The assay consisted of a short treatment (30 min) of 
normal and ADPKD models with a high concentration of nocodazole (5 µM) followed by 
consecutive washes with 1% Triton to remove destabilized tubulin. Cells were then stained 
for α-tubulin and analysis of residual microtubule levels was performed via microscopy 
imaging. Cells with residual tubulin were counted as resistant and counted against cells 







2.2.8 Measurement of primary cilium number and length 
 
Primary cilia number and primary cilia length was measured with Hamamatsu SimplePCI 
image analysis software provided with the Olympus fluorescent microscope.  
 
Primary cilia number was measured in 3 individual experiments with an independent 
coverslip and time point. For each coverslip triplicate, a number of > 100 cells were analyzed. 
Images were taken at 60x magnification from random coverslip fields. Number of ciliated 
cells was counted via SimplePCI and correlated to the number of non-ciliated cells.  
 
Primary cilia length was measured in 3 individual experiments as described above. Images 
were taken at 60x magnification from random coverslip fields. The length of primary cilia 
was measured with tools provided by SimplePCI software. Functions provided in the 
SimplePCI software, included precise length analysis tools for straight or curved cilia.  
 
 
2.2.9 Wound healing protocol and cilia orientation measurement 
 
Cells were plated on coverslips and incubated until reaching confluence. A 200ml sterile 
pipette tip was used to mark straight scratch from the top to the bottom side of the coverslips. 
Multiple coverslips were scratched marking different time points ranging from 0h (start time 
point) to 24h (end time point). Coverslips were collected between this ranges and after 
paraformaldehyde fixation and antibody staining, prepared for fluorescent microscopy 
analysis for the visualization of cilia orientation. Antibodies used where DAPI for cell nuclei, 
acetylated tubulin for primary cilia and gamma tubulin for basal bodies. 
 
Measurement of cilia orientation was achieved via analysing software (Image J). Primary 
cilia orientation was measured by analysis of the orientation angle after different time points 
of the migration assay. Using Image J, a leading line was marked on the primary cilium 
starting from its tip in direction to its base (basal bodies were used as orientation markers). 
From the base of the cilium, a subsequent line was marked which pointed orthogonally in the 
direction of the scratch. The angle between the two lines of each cilium was recorded and 







Staining of paraffin sections: Slides were dewaxed with xylene for 3x for 5 min each. 
Rehydration was achieved through alcohol incubation: 
100% alcohol for 5 min for 2x each, 95% alcohol 5 min, 70% alcohol 5 min. 
Sections were immersed in 500ml trisodium citrate (1.47g pH 6.0) and transferred to a 
microwave for 10 min at 500W. Subsequently, the slides were cooled in ddH2O. 
Slides were blocked for 30 min wirh X0909 protein block (Dako), then primary antibody at 
1/100 concentration were added and incubated for 1 h at room temperature. 
Slides were washed 2x with PBS for 5 min, then secondary antibody at 1/200 concentration 
were added for 1 h at room temperature. Slides were washed 2x with PBS for 5 min and then 
left to dry prior to addition of vectorshield hard set mounting medium with DAPI. Slides 
were wrapped in foil and incubated O/N 
 
2.2.11 Mammalian cell transfection 
 
24h before transfection, 1-3×10
5
 cells were plated in standard growth medium + antibiotics 
per 35-mm dish (6-well plate) and incubated at 37°C (5% CO2) overnight. Optimal 




Lipofectamine® (Invitrogen) is a transfection reagent based on the propriety of its lipid 
subunits to form artificial vesicles in an aqueous environment composed of a lipid bilayer 
called liposomes. These liposomes are able to entrap transfection materials and overcome the 
electrostatic repulsion of the cell membranes. Cell Transfection was usually performed in 12 
well plates with a 70% confluent HEK cell monolayer. Before transfection culture media was 
replaced with Antibiotic/Antimycotic free media to prevent cell death during transfection 
procedure. 
Lipofectamine and 0.5 μg DNA were first added to separate Eppendorf containing 100 μl 
Optimem each, and gently mixed and incubated at room temperature for 5 min. Subsequently, 
the DNA/Optimem was added to the Lipofectamine/Optimem solution, gently mixed by 




the solution was added dropwise across the surface of the inoculated plate and gently rocked 
to allow an even distribution on the cells. Plates with transfected cells were incubated at 37 




Transfections with GeneJuice® Transfection Reagent (Novagen, USA) were performed 
according to the manufacturer’s instructions. The mechanism of action of this compound is 
similar to lipofectamine. In a sterile Eppendorf, 100µl of serum-free media (Opti-MEM) was 
mixed with 3µl of the provided GeneJuice® Transfection Reagent followed by an incubation 
step of 5 min. As with lipofectamine, 1μg of DNA is then added to the mix and gently mixed 
by resuspending followed by another incubation step of 15 min. The GeneJuice/DNA 
solution is then added to the cells and gently rocked to ensure an even distribution. 





Co-immunoprecipitation (Co-IP) is a standard method routinely used to analyze putative 
protein-protein interactions in mammalian cells. As a brief overview: Specific antibodies 
selected for their ability to target a protein of interest or target protein A are immobilized to a 
solid support, such as sepharose G beads or magnetic beads. These beads are the inserted in a 
total cell lysate, were they specifically bind and capture the target protein, leaving all other 
proteins not specific to the antibody unbound in the solution. When then the protein is 
precipitated, any other proteins which are able to bind to target protein will co-precipitate and 
accumulate on the pelleted beads. Any other proteins not precipitated or not able to strongly 
bind by the immobilized Protein are washed away leaving a pool of potential interacting 
partners. The bound protein complex is then eluted from the solid support for further analysis 
by SDS-PAGE and western blotting. 
A more detailed description of this method will be described with the example of the 
INPP5E/PLAT interaction experiment described in result chapter 5.2 
A YFP tagged PLAT construct (YFP-PLAT) was co-transfected with an HA tagged INPP5E 
construct in HEK293 cells in a 12 well plate. 1600 ng DNA of each of the two constructs was 
transfected per well. A positive control of YFP tagged PLAT (YFP-PLAT) and HA-tagged 




constructs with pcDNA3 were also done. Transfected cells were lysed 24h/48h after 
transfection with 500μl lysis buffer which was added to each tube and incubated at 4°C for 
30min in a rotator. The samples were then centrifuged at maximum speed 13,000 rpm for 5 
min to pellet the cell debris and subsequently the supernatant was transferred to a new tube 
for further analysis, i.e. protein concentration measurement as described in (methods section 
2.7). All following steps were performed at 4°C on ice and using cooled centrifugation. From 
the resulting protein lysates 20 µl were removed as a lysate control and stored in ice. Samples 
(250 µg) were subsequently incubated with GFP or HA tagged primary antibody and 
incubated at 4°C for 1h in a rotator. PLAT-GFP was precipitated with rabbit-GFP while 
INPP5E-HA was precipitated with rabbit HA (2.5 µg antibody per immunoprecipitation).   
Simultaneously, a bead equilibration step on Dynabeads® beads was performed by 
resuspension of 30 µl per sample of beads in 1 ml IP lysis buffer and removal of the 
supernatant after each centrifugation step. This was repeated for 3X to complete the washing 
step. After the incubation step the cell lysates were cleared to remove endogenous antibodies. 
For the immunoprecipitation the protein/antibody sample was incubated at 4 °C for 15 min 
with 30 µl equilibrated magnetic beads on a rotator. To remove unspecific bindings, samples 
were subsequently washed 3X by resuspension of samples in 500 µl IP lysis buffer following 
separation step on a magnet.  Next, bead conjugated samples were re-suspended in 20 µl 2X 
Loading Buffer + ß-Mercaptoethanol and denatured together with total lysate samples in 
heating block at 37 °C for 30 min.  Finally, samples were placed in the magnet separating the 
beads from the in the supernatant residing protein of interest which was subsequently 
transferred into a clean microfuge tubes and analysed by SDS-PAGE (methods section 2.8) 
and western blot (methods section 2.9). The Western blot membranes were probed 
accordingly with antibodies raised in different species compared to the antibodies used for 
immunoprecipitation. 
 
2.4.13 GST pull-down assay 
 
The GST pull-down assay is a standard in vitro method routinely used to test for direct 
physical interactions between a GST (Glutathione S-transferase) fusion protein and another 
protein.  For this technique the protein of interest is incubated with the GST fusion protein 
(for a total amount of 1-2μg each) for 1h with gentle rotation to allow binding. Glutathione 




incubation on the rotator at 4°C. Next, centrifugation at 6000rpm for 2min is applied to 
sediment the beads and the supernatant is discarded. A washing procedure is applied by with 
1ml of cold 1×PBS (pH7.3) for 4-6 times to remove unbound proteins. To elute the protein 
from beads a heating step was performed in reducing sample buffer for 5-10min at 70°C or 
1h at 37°C depending on the protein of interest. Then, the samples were spun at 13,000rpm 
for 1min to pellet the beads and the supernatant transferred to a fresh tube. The sample is 
mixed with an equal amount of 2× gel loading buffer for further analysis by SDS PAGE and 
Western blotting.  
 
 
2.4.14 Protein concentration assay 
 
The assessment of the protein concentration of cell lysates was performed using a Bio-Rad 
DC protein assay kit according to the manufacturers protocol. A standard curve was first 
created using a BSA (bovine serum albumin) solution of known concentration and generating 
dilutions in IP lysis buffer ranging from 0 to 1.4 mg/ml in (protein standards). For the 
measurement of our proteins of interest, a cell lysate of a transfected cell line had to be 
produced. To ensure adequate cell yield cells from a PBS pre-washed inoculated 12 well 
plates were inoculated with  IP lysis buffer and then scraped and transferred into relevant 
labelled microfuge tubes and  incubated on a rotator at 4 ºC for 30 min. Subsequently, the 
tubes were centrifuged at maximum speed to separate the cell debris and then supernatant cell 
lysates were transferred to new labelled microfuge tubes and either prepared for western blot 
analysis or further diluted for a protein concentration assay. To measure protein concentration 
5 μl of each of the BSA standard dilution and protein samples were carefully pipetted in 
triplicate in a 96 well elisa plate. Next 25 μl reagent S was added followed by 200 μl reagent 
B and incubated at 37°C for 15 min. Absorbance was measured at 750 nm and protein 




SDS-PAGE is widely used as a tool to separate proteins according to their size. The running 
gel was prepared according the recipe (Table below) and cast in a Mini-Protean II
™
 apparatus 
and subsequently covered with 100 % ethanol, and allowed to polymerize. After 




wells prior to solidification. Next, the prepared gels were placed in the tank and the inner and 
outer chambers were filled with 1x running buffer. Before loading on the gel, protein samples 
were incubated for 30 min at 37°C in 2 × SDS-PAGE sample buffer and ß-mercaptoethanol 
to allow protein denaturation and subsequently loaded alongside Dual Colour Precision Plus 
molecular weight markers via micropipette. The gel was then run at 100 V for 15 min and the 
voltage subsequently increased to 200 V until the sample buffer dye had run off the gel. Once 
electrophoresis is complete, the gel was removed and transferred to PVDF membranes for 
western blot. 
 
Recipe for separating gel  Recipe for stacking gel 
 (4 pieces) 5% 7% 10% 13% 4% 



















2.7ml 3.7ml 5.4ml 6.9ml  0.67ml 




10% APS 50μl 
TEMED 16μl 10μl 
 
 
2.4.16 Western blot 
 
Western Blot involves a technique were the separated proteins from a polyacrylamide gel are 
transferred to a PVDF membrane which is subsequently stained with antibodies for the 
detection of target proteins. The transfer is performed using a Bio-Rad Mini Trans-Blot cell. 
To remove the hydrophobic propriety of the PVDF membrane, it is first incubated for 30 
seconds in 99.8% Methanol and then washed thoroughly with dH2O. The gel is subsequently 
placed on the activated membrane and enclosed in two squares of filter paper and two 




facing the negative side of the rack so that the transfer of the protein occurs in direction 
membrane. The rack was placed in the BioRad apparatus. A stirrer and a cool pack was 
subsequently added and finally the machine filled with transfer buffer. The transfer was 
adjusted according to the size of the protein of interest at 100V for 1 h. Subsequently, the 
membrane was removed and incubated in 10% milk in TBST for 1 h to block. Next, the 
membrane is probed with the primary and secondary antibody. First, a washing step was 
performed on the membrane by shaking 4 times for 20 min in TBST. Then, the primary 
antibody was diluted in a TBST solution with 5% milk and subsequently added to the 
membrane in a tray for over-night incubation at 4°C. On the next day, another washing step 
in TBST is performed, and then the membrane was probed with a HRP conjugated secondary 
antibody diluted a TBST solution with 5% milk for 1h at R.T.  A last washing step in TBST 
was performed before the membrane is treated with a Biorad Clarity ECL kit. 
After treatment with BM kit, the membrane was either brought to a Biorad Chemidoc XL 
system or exposed to SuperRX Fuji Medical X-Ray Film. 
 
2.4.17 E.coli transformation with plasmid DNA 
 
E.coli preparation and transformation with plasmid DNA was performed using a standard 
transformation protocol. 
E coli JM109competent cells stored at -80°C were thawed on ice and 50µl samples were 
aliquoted in pre-chilled 1.5ml Eppendorf tubes. Next, 50ng of plasmid DNA was added to the 
50µl cell samples gently mixed and then left on ice for 30 min. A heat-shock step was 
induced on the samples, consisting of a brief incubation of the sample at 42°C for 50 seconds 
followed by rapid cooling on ice for 2 min. Cold SOC medium (450 µl) was then added to the 
samples and incubated at 37°C for 1 h in a shaker at 200 rpm. The transformation mixture 
was ultimately plated on LB agar antibiotic selective plates and incubated overnight at 37°C 
until positive transformed colonies appeared. 
 
2.4.18 Small-and medium scale purification of plasmid DNA 
  
For the preparation of plasmid DNA in small (or medium) scale a Wizard® Miniprep Plus SV 
DNA purification system (Promega) was used. First, 5-10ml (or 100ml) of overnight culture 




for 5 min at room temperature to pellet cells. The pellet was re-suspended in 250µl (or 3ml) 
cell resuspension solution (50mM Tris-HCl pH7.5, 10mM EDTA pH8.0, 100g/ml 
Ribonuclease A). Next,  250µl (3ml) of cell lysis solution (0.2M NaOH, 1% SDS) were 
added to each sample and subsequently mixed by inverting the tubes four times and incubated 
at room temperature for 5 min. Then 350µl (3ml) of neutralization solution (760mM (x2) 
potassium acetate, 2.12M glacial acetic acid) was added to the cell lysate, mixed and then 
centrifuged at 13,000 rpm for 15 min at room temperature. The supernatant clear lysate was 
transferred into a spin column (or Midi column mixed with 10ml resin by swirling). The 
Column was then spun at 13,000 rpm for 1 min to let supernatant pass through the resin layer 
(or a vacuum was used to pellet the resin in the Midi column). Washes are then performed 
with 750µl (or 15ml) Column Wash Buffer (60% ethanol, 60mM potassium acetate, 8.3mM 
Tris-HCl, 0.04mM EDTA) and then the plasmid DNA was eluted with 100µl (300 µl) of 
nuclease-free ddH2O (preheated to 70°C and centrifugation at 13,000 rpm for 1min and then 
transferred in a 1.5ml Eppendorf tube at 10,000×g for 2min to remove extra liquid. The 
purified plasmid DNA was stored at -20°C or below. 
 
 
2.4.19 Restriction digestion and agarose electrophoresis 
 
Digestion of Plasmid DNA was performed via restriction endonucleases at 37°C for 2 h in an 
appropriate enzyme buffer. The resulting digestion product was analyzed by agarose gel 
electrophoresis. Agarose gels were prepared by dissolving agarose in 1×TAE and addition of 
ethidium bromide at 0.5µg/ml concentration. The DNA samples of interest were mixed with 
6×Blue/Orange loading dye and subsequently loaded in the agarose gel wells together with 
DNA ladder. Electrophoresis was then performed using the Bio-Rad mini-sub cell GT or wide 
mini-sub cell GT system at a voltage of 5V/cm in running buffer (1×TAE, diluted from 
50×TAE stock solution (2M Tris base, 5% (v/v) glacial acetic acid, and 0.05 M ETDA pH 









2.4.20 Validation of siRNA knockdown by qPCR 
 
UCL93 and IMCD3 cells were cultured in 12 well plates to 75% confluency. Isoform-specific 
siRNA to mouse inpp5e (IMCD3) and human Inversin (UCL93) was chemically synthesized 
by Dharmacon or MWG Biotech respectively. A scrambled negative control siRNA was 
obtained from Dharmacon. Transfection of 10 and 50 nM siRNA into cells was achieved 
using RNAiMax reagent (Life Technologies). Knockdown was confirmed by Taqman qPCR 
72 h post-transfection according to the manufacturer’s protocol (Life Technologies). 
Following RNA extraction, cDNA was synthesised using a high capacity RNA to cDNA kit 
(Life Technologies). Real time PCR was carried out on an ABI7900 qPCR machine. 
Normalisation of expression was carried out using specific taqman probes to mouse or human 
GAPDH. Results presented are representative of 3 replicate experiments. Analysis of gene 
expression was carried out using DataAssist v3.01 (Applied Biosystems) to calculate 1/ΔCt 
normalised expression values for each cell line. Data was plotted in Graphpad Prism and p-
values >0.05 (adjusted for Benjamini-Hochberg False Discovery Rate) were defined as 
significant. Relative quantification was also carried out using the comparative Ct (ΔΔCt) 
method to calculate fold changes in expression between control and siRNA samples. 
 
Cycling conditions for qPCR: 
50°C 2 min 




          1 min     x40 
 
qPCR reaction mix: 
Component Volume (µl) per reaction 
Taqman Universal PCR master mix 
(2x) 
10 
Taqman gene expression assay 
(20x) 
1 







2.4.21 Special equipment 
 
Super-resolution microscopy also known as structured Illumination Microscopy or (SIM) is a 
fluorescence light microscopy method which I used in our study for detailed actin structure 
detection. This microscopy method is designed to record images with a resolution below that 
of the Abbe diffraction limit, thus removing the limitations imposed by the diffraction of light 
during the observation of normally not resolvable biological structures via conventional 
microscopy. The functional basis of the SIM is based on the use of structured spot 
illumination, which replaces standard uniform illumination. These allows for the generation 
of multiple different patterns of the same area, which remain within the diffraction limit  and 
can subsequently be reconstructed and merged via programmed software with precise 
knowledge of pattern location into a final super resolution image. The reconstructed image 
results in an approximate two-fold improvement compared to diffraction limited imaging 
(Dempsey et al, 2011). Samples were prepared on high precision coverslips and mounted one 
per slide to allow placement in the centre of the microscope sample holder due to the super 
microscope limited travel.  
 
2.4.22 Mycoplasma test 
 
Mycoplasma test were performed by laboratory managers. The test was executed by 
providing cell culture supernatant into a 2ml centrifugation tube, which was subsequently 
analyzed with an EZ-PCR Mycoplasma Test Kit from BIOLOGICAL INDUSTRIES (BI) 
according to the provided protocol. Tests were performed routinely on a monthly basis for all 
laboratory cell lines. 
 
2.4.23 Ethic section 
 
The research project was approved by the relevant university ethics committee and/or meets 
the ethical guidelines issued by such and such a learned society. 
 
Where applicable, the origin of cell lines and tissues used this study are protected by 





The studies in this dissertation were performed in an independent and impartial manner. No 
conflicts of interest to declare. 
 
2.4.24 Statistic section 
 
Statistical analysis was performed with Graph-pad Prism software. 
Statistical test used in this thesis were: 
t-test or Student's t-distribution under the null hypothesis which determines if two sets of 
data are significantly different from each other and in our study was used for direct 
comparison experiments. 
two-way-Anova or two-way analysis of variance (ANOVA) which analyzes the influence 
of two different categorical independent variables on one continuous dependent variable and 
in our study was used to test for experiments involving multiple comparisons/treatments. 
The significance of the p value in each graph was displayed in symbols described below. 
 
Symbol    Meaning 
Ns      P > 0.05 
*      P ≤ 0.05 
**      P ≤ 0.01 
***      P ≤ 0.001 



























The first studies linking the pathogenesis of ADPKD to primary cilia were based on the 
ciliary localisation of polycystin-1 (PC1) and polycystin-2 (PC2) (Yoder 2002; Pazour et al, 
2002). It was suggested that polycystin-1 and polycystin-2 could transduce a 
mechanosensitive or ligand activated receptor complex, functionally defective in disease 
(Ong, 2005). Unlike mutations in other ciliary proteins e.g. Tg737/polaris, cilia were assumed 
to be structurally normal indicating a functional defect. Recently, data from another 
ciliopathy i.e. mutations in Inpp5e, indicated that cilia could be structurally normal yet 
disassemble faster than their normal controls (Jacoby et al, 2009). 
 
The main hypothesis of this project is to test the role of primary cilium stability in the 
pathogenesis of ADPKD. First, a robust assay for primary cilium assembly and disassembly 
was established. Secondly, the role of key signalling pathways known to be altered in disease 
especially cAMP and Ca
2+
 on this process was examined.  
 
3.2 Primary cilia formation in baseline models 
 
It is well known that many cells can be induced to exit the cell cycle after short periods of 
growth factor starvation (Larsson et al, 1985). Several cell lines were initially tested for their 
ability to exit and enter the cell cycle according to serum stimulation and starvation, a critical 
precondition for the formation of primary cilia (Plotnikova et al, 2009). These baseline 
models included a mouse embryonic fibroblast cell line (NIH-3T3), a murine inner medullary 
collecting duct cell line (IMCD3) and a human retinal pigment epithelial cell line (hTERT-
RPE1). The cell cycle profile of these lines was studied during serum stimulation and serum 
removal. As expected, a significant decrease in G2 phase cells and an increase in G1 phase 
cells was observed in all three cell lines after serum starvation of 48 h (Figure 3.1 a, b, c). 
Reintroduction of serum after the starvation step induced a decrease in G1 phase cells and 






Figure 3.1 Cell Cycle analysis in IMCD, hTERTRPE and NIH 3T3. Flow cytometric analysis of 
serum starved (a) IMCD3, (b) NIH-3T3, (c) hTERT-RPE1 baseline models results in an increase in 
G1 phase cells, and a decrease in G2 phase cells. (n=3, Statistical test:paired t- test) (* = p≤ 0.05, 









Primary cilium assembly and disassembly is associated with different phases of the cell cycle 
(Plotnikova et al, 2009). Cilium formation occurs post-cytokinesis during the G1/G0 phase of 
the cell cycle and cilium disassembly during the G2–M transition. Optimization experiments 
were carried out on each cell line to ensure optimal primary cilium detection as described in 
methods (chapter 2.2.4). 
 
A low percentage of cilia were detected in pre-starved cycling cells: 21% ± SEM in hTERT 
RPE1, 18% ±SEM in IMCD3, 17.5% ± SEM in NIH 3T3. A significant increase in the 
number of ciliated cells could be clearly measured in IMCD3, NIH-3T3 and hTERT-RPE1 
following a 48 h period in serum free medium (Figure 3.2). This was quantified as a 50% 
increase in IMCD3 and NIH-3T3 (b, c) and a 43% increase in hTERT-RPE1 (a) for a total 
ciliation level of 71% ±SEM, in IMCD3, 73% ±SEM in NIH 3T3 and 64%± SEM in hTERT-
RPE1. Following the reintroduction of serum, resorption of cilia between each cell line was 
variable during the first hours after serum reintroduction. Primary cilium disassembly could 
be detected as early as 2 h after serum reintroduction and was complete by 24 h. A moderate 
rate of cilium disassembly ranging from 10 to 20% was measured in hTERT-RPE1 and 
IMCD3 (a, c) cells, while disassembly was more extensive in NIH-3T3 cells with a 36% 
decrease in ciliated cells (b). Cilium disassembly did not progress in the hTERT-RPE1 and 
IMCD3 cells at 6 h serum reintroduction but then significantly increased after this period in 
prolonged periods ranging from 6 to 24 h following serum reintroduction. In the NIH-3T3 
cell line, cilium disassembly declined in a slower manner reaching baseline pre-starvation 
levels at 24 h. This data confirms previous reports that the assembly and disassembly of 








Figure 3.2  Primary cilium assembly and disassembly before, during and after serum removal. Pre-
starvation.  A low percentage of cilia were detected in pre-starved cells. After 48 starvation, number of ciliated 
cells significantly increases in (a) IMCD3, (b) NIH 3T3 and (c) hTERT RPE1cells. Re-introduction of serum 
results in a significant gradual primary cilium disassembly over a period of 24 h in all tested cell lines, 
comparable to initial pre-starved levels can be detected in all tested cell lines 24 h after serum reintroduction. 
(n=3, Statistical test:paired  t- test) (* = p≤ 0.05, Error bars indicate mean ± S.E.M). Representative images of 
ciliated cells IMCD3, RPE1 and NIH-3T3 at 48h starvation time-point. Magnifications 40X. Cell nuclei (DAPI: 






3.3 Primary cilia length regulation 
 
Previous reports had suggested that agents acutely increasing cAMP and Ca
2+
 could also alter 
cilia length (Besschetnova et al, 2010). The effect of increasing cAMP and Ca
2+
 was 
therefore tested in these baseline models. For cAMP, an increase in intracellular basal cAMP 
from 1 μM to 10 μM is required to reach the activation threshold for protein kinase A (PKA) 
(Houslay and Milligan 1997).  
 
Following treatment with compounds that increased the intracellular level of cAMP, a 
comparable response could be detected in all tested cell lines resulting in a significant 
increase in primary cilia length (Figure 3.3). Comparison of the effect of dibutyryl cAMP 
(dbcAMP) and forskolin resulted in a similar dose dependent increase in average cilia length, 
reaching a maximum at 500 µM dbcAMP and 500 µM forskolin, while treatment with 
Thapsigargin, a compound which release intracellular calcium stores resulted in in a modest 












IMCD3 2.0 ± 0.1 3.4 ± 0.2 3.7 ± 0.2 0.7 ± 0.2 
NIH-3T3 2.15 ± 0.1 3.1 ± 0.1 3.9 ± 0.2 0.5 ± 0.2 
hTERT RPE1 2.6 ± 0.2 3.9 ± 0.1 4.2 ± 0.2 0.6 ± 0.2 
 
This data confirms that modulation of intracellular Ca
2+
 and cyclic AMP is able to alter 








Figure 3.3  Primary cilium length can be modulated by cAMP and Ca
2+
 elevation in baseline models. 
a) Increase in intracellular cAMP via dbcAMP or b) Forskolin treatment for a treatment period of 3h post-
starvation results in a dose dependent primary cilium elongation in all tested baseline models. c) Conversely, 
treatment with Thapsigargin, which releases intracellular Ca
2+
 results in primary cilium shortening at high 









3.4  Primary cilia formation in ADPKD models 
 
For the study of primary cilia dynamics in ADPKD models, a number of conditionally 
immortalised human kidney cell lines normal or deficient in polycystin-1 were studied. Two 
paired models were mainly studied: UCL93-6-2 (normal human), OX161 (8+13) (PKD1 
mutant) and PTEC-DSRED (control shRNA), PTEC-PC1 KD (shRNA PKD1 kd). For 
uncertain reasons, the expression of polycystin-1 in the PTEC-PC1 KD cells showed partial 
recovery at later passages (Figure 3.4 e). These cells were therefore studied at early passages 
(up to P4) where shRNA kd was maintained. 
Serum starvation and temperature switching from 33C° to 37C° induced cell cycle exit 
similarly in ADPKD cells (Figure 3.4 b,d) and normal controls (Figure 3.4 a,c). This was 
marked by a significant increase in G1 cells and a decrease in S/G2 phase cells. These 
conditions were therefore used to study primary cilium formation in normal and ADPKD 
models in subsequent studies. 
 
Similar to the baseline models, both normal and ADPKD models showed a similar pattern of 
ciliary assembly and disassembly in response to serum removal and reintroduction. (Figure 
3.5 a, b). Comparable results were obtained for PTEC PC1+PC2 KD cells (Figure 3.5 d). 
However, the percentage of ciliated cells (Figure 3.6 a, b) and the average primary cilium 
length (Figure 3.6 c ,d) was significantly decreased in the polycystin-1 deficient models 
relative to their normal controls.  






Figure 3.4 Cell cycle profile of cystic and normal human cell lines via serum modulation for 48h and 
temperature switching from 33C° to 37C°. (n=3, Statistical test:paired  t -test (* = p≤ 0.05), Error bars 
indicate mean ± S.E.M) (e) Blot of polycystin-1 in control DSRED and polycystin-1 deficient PTEC Cell lines 
at early and late passages. Knock down of polycystin-1 is confirmed at passage 2 but returning expression is 






Figure 3.5 (a-b, d) Primary cilium assembly (+) and disassembly (*) assay in normal and ADPKD models. 
In ADPKD cells and relative control cell lines primary cilia assemble and disassemble according to the cell 
cycle. Number of primary cilia formed after growth arrest and differentiation is significantly reduced in ADPKD 
cells, however ratio of cilium disassembly upon cell cycle re-entry is similar in both lines (n=4, Statistical 
test:paired  t- test (* = p≤ 0.05), Error bars indicate mean ± S.E.M) (c) Representative images of primary 
cilium staining in normal (UCL93) and ADPKD (OX161): Magnification 60X. Immunofluorescence 
micrographs of cultured cells stained with antibodies.  Cell nuclei are stained in Blue with DAPI and primary 







Figure 3.5 f. DMSO treatments at different concentrations. All compound used were either diluted in dH2O 
or DMSO. Control treatment with DMSO at different concentrations in all tested cell lines did not affect ciliary 












Figure 3.6 (a) (b) Number of ciliated cells comparison Normal v.s ADPKD Number of ciliated 
cells is decreased in tested ADPKD cells compared to normal control (n=6, 100 cells/N. Statistical 
test:paired  t test (* = p≤ 0.05), Error bars indicate mean ± S.E.M) (c) (d) Length of Primary 
cilia comparison Normal vs ADPKD. Length of primary is decreased in tested ADPKD cells 
compared to normal control (n=6, 100 cells/N. Statistical test:paired  t -test (* = p≤ 0.05), Error 










3.5  Primary cilia regulation in ADPKD Models 
 
To test whether polycystin-1 deficiency altered the ciliary response to cAMP and Ca
2+
, 
normal and ADPKD cells were studied as described for the baseline models in results 
chapter 3.3. 
Treatment with Thapsigargin induced significant cilium shortening in the PC1 KD model 
Figure 3.7(a) and cystic cell line (OX161) (e). Comparison of the % change showed no 
significant differences between normal and ADPKD models (b, f).  
Treatment with A23187, a Calcium Ionophore, which facilitates the transport of Ca
2+
 ions 
across the plasma membrane (Dedkova et al, 2000), also led to significant primary cilia 
shortening effect in PC1 KD model (c) and cystic cell line (g). No significant differences 
could be detected in % length decrease (d, h). 
Treatment with the cAMP analogue dbcAMP increased cilia length in both normal and 
ADPKD cells Figure 3.8 (a, c). There was a smaller response to dbcAMP in the ADPKD 
cells, although this did not reach statistical significance (b, d). The reduction in baseline clila 
length and a reduced response to dbcAMP was consistent in multiple other ADPKD lines (e, 














Figure 3.7 Effect of calcium increase in ADPKD models Treatment with agents which result in increase of 
intracellular Calcium levels result in Significant cilium length reduction in normal and ADPKD models, 
although there is no statistical difference in length reduction between normal and ADPKD models after 
normalization, a trend towards ADPKD cells being less responsive is observed. n=3, 100 cells/N. Statistical 





Figure 3.8   Effect of cAMP modulation in ADPKD Models (1, 2 a) Treatment with agents which result in 
increase of intracellular cAMP levels (dbcAMP) results in significant cilium length elongation in normal and 
ADPKD models. (1 and 2 b) Although there is no statistical difference in the length increase between normal 
and ADPKD models after normalization, again a trend towards ADPKD cells being less responsive is observed, 
n=6, 100 cells/N. Statistical test:paired  t test (* = p≤ 0.05), Error bars indicate mean ± S.E.M). (3a and 3b) 
Primary cilia in untreated ADPKD models are significantly shorter compared with normal UCL93-6-2 the cell 
line. Treatment with dbcAMP at 500µM results in a significant increase in ciliary length in normal and ADPKD 
models, the latter reaching approximately the length of untreated normal cells. Primary cilia of ADPKD cells 
treated with cAMP are significantly shorter than primary cilia of cAMP treated normal cells.N=300 cells. 





3.6  PKA controls cAMP dependent cilia elongation 
 
It is well known that the principal intracellular target for cAMP is PKA (Besschetnova et al, 
2011). Using two different compounds to inhibit PKA activation, the ability of cAMP to 
induce ciliary length increase in our models was investigated using H89 (50 µM) and 14-22 
Amide (20µM) (Farrow et al, 2003).  
 
As shown, both PKA inhibitors completely abolished the increase in cilia length following 
incubation with dbcAMP in both normal Figure 3.9 (a, c) and ADPKD cells (b, e). This data 
suggests that the cAMP dependent cilium elongation is acting in a PKA dependent manner 








Figure 3.9 cAMP/PKA elongation is not defective in ADPKD models when modulated directly within the 
cell Treatment for 1 h with H89 or 14-22 amide, two potent PKA inhibitors at 50 µM or at 25 µM respectively, 
prior to dbcAMP treatment at 500 µM + inhibitors, prevented cAMP dependent primary cilium elongation in 
both healthy and ADPKD models. (n=3, 100 cells/N. Statistical test:paired  t- test (* = p≤ 0.05), Error bars 









3.7  dbcAMP treatment induces cilia formation in cycling cells 
 
To assess how db-cAMP treatment would affect ciliary regulation in regards to formation and 
length in non-starved cycling cells, both models were treated with db-cAMP for 4 h and cilia 
length and number was measured.  The overall number of ciliated cells was very low in 
cycling cells, thus a high number of cells (>500) was counted to collect sufficient data for 
analysis, which converged in approximately 80 to 100 measurable primary cilia per 
experiment. 
Our data showed that db-cAMP treatment significantly increased the number of primary cilia 
in normal cells while the increase was marginal in ADPKD cells (Figure 3.10). Also, formed 
primary cilia were significantly longer in the normal cell lines. These results suggest that in 
normal cycling cells, cAMP is able to arrest proliferation and therefore induce cilium 
formation and lengthening or conversely induce ciliogenesis which then leads to cell cycle 





Figure 3.10  Effect of cAMP in non-starved cycling cells. Treatment with 500 µM dbcAMP in cycling cells 
for 3h results in significant primary cilium elongation in (a) normal UCL93 and cystic OX161 and (c) in normal 
PTEC DSRED. (b) & (d) The same treatment significantly increased the number of ciliated cells in all normal 
control lines while no change was detected in ADPKD cells. (n=6, 100 cells/N. Statistical test:paired  t- test (* = 






3.8 Effects of cAMP on the cell cycle 
 
To investigate whether cAMP could directly modulate the cell cycle, the cell cycle profile 
was analysed using different markers of proliferation under the same experimental settings 
used to study primary cilium elongation. Two markers, Ki67 and phospho-H3 were utilised. 
The Ki67 protein is present in all interphase phases (G1, S, and G2) of the cell cycle and in 
mitosis but is absent in quiescent or resting cells in G0 (Gerdes et al, 1992). It has a short 
half-life of 1 h (Heidebrecht et al, 1996). Phospho-histone H3 (PH3) on the other hand is a 
marker for cells undergoing mitosis, a step which is critically important in chromatin 
remodelling and chromosome segregation and condensation before cell division (James et al, 
2012). 
Treatment with db-cAMP in normal cells resulted in a significant decrease of Ki67 and PH3 
positive cells, suggesting that intracellular cAMP increase induces cell cycle exit in G1/G0 in 
normal cells Figure 3.11 (a, c). In the ADPKD models, this effect could not be detected (b, 
d), suggesting an impairment of this function. The Ki67 results were confirmed in additional 
normal (RFH) and ADPKD models (SKI001, OX938 and SKI002), showing impaired decline 









Figure 3.11 Assessment of proliferation profile of cAMP treated cycling cells. (a-e) Treatment with 
dbcAMP in normal cells results in a reduction of proliferation as shown by the significant decrease of 
proliferation markers KI67 and PH3. In ADPKD models no significant reduction of proliferation markers after 
cAMP treatment are detected suggesting that the cAMP effect on anti-proliferation in ADPKD cells is disturbed. 
(n=3, 100 cells/N. Statistical test:paired  t- test (* = p≤ 0.05), Error bars indicate mean ± S.E.M) (Bottom). 






3.9 Role of AKAPs in primary cilia regulation 
 
3.9.1 AKAP350 localizes to the basal bodies at the base of the cilium 
Our laboratory was interested in AKAP350 after it was isolated from one of our mass 
spectrometry screen as a potential binding partner of the polycystin-1 PLAT domain (Streets 
et al, unpublished). AKAP350 is known under different aliases (e.g. AKAP9, AKAP450) and 
is reported in the literature as a typical PKA associated adaptor protein which can also 
associate with other kinases such as Protein Kinase C (PKC) and the Rho-activated protein 
kinase N (PKN) (Homasany et al, 2005). Co-immunoprecipitation experiments confirmed 
that PC1-PLAT is able to bind to AKAP 350 and simultaneous localization studies using 
different fluorescent tagged AKAP 350 constructs in HEK293 cells, revealed partially 
overlapping co-staining pattern of AKAP 350 with PC1-PLAT (Figure 3.12a). Thus 









Figure 3.12  AKAP350 localizes at the base of the primary cilia (a) Co-localization: Fluorescent tagged 
AKAP 350 cherry (Red) constructs with the polycyctin-1 PLAT GFP constructs (Green) shows co-expressed 
areas in HEK293 cells suggesting co-localization of this proteins. Co-immunoprecipitation: GST-tagged PLAT 
proteins co-immunoprecipitate GFP tagged AKAP F3 adaptor protein. (b) Localization studies of AKAP 350 
(Red) in different cell lines shows localization of the adaptor protein to the basal bodies labelled with γ-tub 
(Green) at the base of the primary cilium (green α-tub). Right Panel; basal bodies labelled with γ-tub (Red) and 




In HEK293 cells overexpressing PC1-PLAT and AKAP350 GFP constructs, AKAP350 
staining was co-localised to basal bodies Figure 3.12 (a). Using a specific antibody to 
endogenous AKAP350, co-localization with γ-tubulin was confirmed at the basal bodies in a 
number of different growth arrested cell lines (b). Localization in cycling cells was diffuse 
and not detectable. Co-staining with α-tubulin as a ciliary marker showed that AKAP350 
accumulates at the basal bodies in ciliated cells. This suggested a possible role of this 
complex during primary cilium formation and that AKAP350 might act as an adaptor protein 
to localize the cAMP signalling involved in primary cilium elongation to the base of the 
cilium (b). AKAP350 localization to the basal bodies was not prevented in our ADPKD 
model (OX161) suggesting that AKAP350 localisation was not altered by loss of polycystin-
1; however the normal functioning of this complex could still be defective through incorrect 
or incomplete interaction with other proteins, including polycystin-1. 
 
3.9.2 AKAP inhibition prevents cAMP/PKA cilium elongation 
Next, the role of AKAP adaptor proteins in cAMP dependent primary cilium regulation was 
investigated using a well-recognised pan inhibitor of AKAP binding (InCellect AKAP St-
Ht31 inhibitor peptide from Promega). Treatment with ST-Ht31 (50 µM) inhibited cAMP 
dependent cilium elongation (Figure 3.13). This confirmed that AKAPs are involved in 
PKA/cAMP dependent cilium elongation, thus suggesting that AKAP inhibition prevents the 







Figure 3.13 AKAP inhibitor ST-Ht31. cAMP dependent cilium regulation is regulated at the base of the 
primary cilium, a regulation which is confined through AKAP proteins. Pre-treatment with AKAP inhibitor ST-
Ht31 at 50 µM concentration in normal (a) UCL93, (c) PTEC DSRED and ADPKD (b) OX161, (d) PC1KD 
cells prior to treatment with 500 µM cAMP prevents cAMP dependent primary cilium elongation suggesting 
that AKAP proteins are required to confine the cAMP signalling involved in primary cilium elongation at the 








3.10 The role PGE2 in primary cilia formation 
Previous studies have shown that cAMP dependent cysts expansion in kidney epithelial cells 
can be stimulated by prostaglandin E2 (PGE2), potentially by binding to EP2 receptors 
(Elberg et al, 2007). The role of PGE2 on cilia length and its action via different receptor 
subtypes was therefore investigated.  
 
3.10.1 PGE2 induces primary cilia elongation 
Incubation of normal and ADPKD models with PGE2 for 3 h resulted in primary cilium 
elongation at rates similar to that seen with dbcAMP Figure 3.14 (a-d). Thus, PGE2 could 
represent an endogenous ligand that activates cAMP/PKA regulation of cilia length. Although 
the maximum extension of cilia length was not reached in the cystic cell line after 3 h 
treatment, a subsequent test experiment showed similar levels to normal control after 
prolonged 24 h incubation (e-f), suggesting a delayed maximal response to PGE2 treatment. 
 
3.10.2 PGE2 dependent cilia elongation acts via EP2 and 4 receptors  
To identify the receptor subtypes involved in the cilia response to PGE2, selective EP 
agonists were tested in the same assay. These experiments revealed that activation of EP2 and 
EP4 receptors increased primary cilium length while EP1 or EP3 agonists did not play a 








Figure 3.14 PGE2 induces primary cilium elongation. PGE2 stimulation for 3h post-starvation at 100 µM 
induces significant primary cilium elongation in normal a) UCL93, c) PTEC DSRED and ADPKD b) OX161, 
d) PTEC PC1KD models. PGE2 stimulation for 24 h post-starvation at 100 µM showed similar primary cilium 
elongation in normal and PKD cells (n=3, 100 cells/N. Statistical test:paired  t -test (* = p≤ 0.05), Error bars 







Figure 3.15 (a) EP receptor agonist in normal and ADPKD cells. Treatment with EP2 and EP4 agonists 
causes significant cilia elongation in normal and ADPKD cells while EP1 and EP3 have no effect, suggesting 
that EP2 and EP4 receptors are responsible for ciliary length regulation. (b) % change of various treatments. (c) 
EP2 and 4 antagonists in PGE2 treated cells. Pre-treatment with EP2 and EP4 antagonists for 1 h prior to 
treatment with 100µM PGE2, prevents PGE2 dependent cilium elongation in normal and ADPKD cells (n=3, 







Figure 3.16 PGE2-EP2/4 effect is PKA dependent (a) Pre-treatment with PKA inhibitor at 50 µM, prior to 
treatment with 10 µM, EP2 or EP4 agonists, prevents EP2/EP4 dependent cilium elongation in UCL93 and 
OX161 cells. (n=3, 100 cells/N. Statistical test:paired  t- test (* = p ≤ 0.0001), Error bars indicate mean ± 








As shown with dbcAMP, pretreatment with PKA inhibitors prior to the addition of EP2 or 
EP4 agonists prevented cAMP dependent cilium elongation (Figure 3.16). To confirm that 
the EP receptors were actually responsible for PGE2 induced cilium elongation, specific EP2 
and EP4 antagonists (Steinwall et al, 2004; Forselles et al, 2011; Xu et al, 2014) were also 
used. These results show that blocking either EP2 or EP4 was able to fully antagonize the 
effect of PGE2 on cilium regulation (Figure 3.15c). Blockade of EP2 appeared to have a 
stronger inhibitory effect than EP4 though blocking either subtype was sufficient suggesting 
possible redundancy in this response. It can be concluded that PGE2 acts through EP2/EP4 
receptors to activate PKA/cAMP signalling and increase cilia length. Similar to db-cAMP, the 
percentage increase in primary cilium length regulation is comparable between normal and 
ADPKD cells (Figure 3.15b). 
 
 
3.11  Abnormal cilia structure in PKD1 transgenic cells 
 
To study whether the level of polycystin-1 correlates with cilia length, this study examined 
PKD1 transgenic cells (M7) previously generated from a PKD1 transgenic mouse and 
compared to cells (M8) derived from a non-transgenic littermate (Newby et al, 2002). 
 
Analysis of primary cilium number and length revealed no significant difference between 
both lines. However more structurally altered or deformed primary cilia could be detected in 
the M7 cells (Figure 3.17). The deformed cilia were characterized by either double forked 
ciliary shafts at different heights ranging from the stem to the proximity of the ciliary tip and 










Figure 3.17  Primary cilium comparison of normal and Transgenic ADPKD models  
a) Representative images of transgenic ADPKD model (M7) primary cilia in comparison to normal (M8) cilia. 
b) Representative images of M7 actin organization in comparison to M8 actin organization. 
c) M7 v.s M8 comparison of number of formed primary cilia, primary cilium length and number of deformed 
primary cilia (n=3, 100 cells/N. Statistical test:paired  t- test (* = p≤ 0.05), Error bars indicate mean ± S.E.M). 







3.12 Primary cilia number and length in human normal and ADPKD 
tissue 
 
To confirm that the changes in primary cilium detected in vitro were not related to culture or 
immortalisation, cilia number in available human and mouse control and ADPKD kidney 
tissues was measured. Primary cilia were found almost exclusively on the apical surface of 
tubular epithelial cells. 
 
Initial analysis was performed on fixed kidney sections available from two ADPKD patients 
(SKI-001 and OX161) from whom cell lines had been derived and stored from our Group and 
compared to non-cystic human kidney sections. As shown, a significant reduction in cilia 
length in both SKI001 and OX161 (Figure 3.19 a, c) as well as a reduced number of ciliated 
cells compared to normal controls (b, d) was observed. These results suggest that the changes 
observed in vitro represent that seen in vivo. However, since both tissue and cells represent 
the advanced stages of disease, it was not possible to be certain if they are primary or 
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Figure 3.18  Representative image of primary cilia in human normal and ADPKD (SKI001) tissue.  
In normal tissue, primary cilia can be detected exclusively protruding from the inner lining of the epithelial cells 
of the inner lining of renal tubules as seen in parallel and cross section images. In the ADPKD model, renal 
tubules appear extensively deformed and dilated, with increased disorganization of normal cellular 
arrangements. Primary cilia appear stubby and are sparsely distributed along dilated tubules and cystic sections 












Figure 3.19  Primary cilium analysis in human tissue 
a) Number of ciliated cells and b) primary cilium length comparison between ADPKD (SKI001) derived V.S 
normal cells. (Each column represents the result of 3 independent sections (n=3, N=500 to 1000 cells/n) of one 
test subject. Primary cilia on tubular cells were measured. Test subjects are two different normal controls 
(control K1 & K2) V.S sections from an ADPKD patient SKI-001) c) Number of ciliated cells and d) primary 
cilium length comparison between ADPKD OX161 derived V.S normal cells. (Each column represents the 
result of 4 independent sections (n=4, N=2000 to 4000 cells/n) of one test subject. Test subjects are two 
different normal controls (control 1 & 2) V.S sections from an ADPKD patient OX161. (Statistical test: paired  




3.13 Primary cilia number and length in normal and Pkd1 mouse kidneys  
 
 
To address the limitation of human ADPKD tissues, which could represent end-stage disease, 
Pkd1 mouse tissue available from the early stages of disease was studied. Kidney tissue (4 
month age) was available from tamoxifen-inducible Ksp-Cre Pkd1 mice (induced at PN40) 
and their non-induced controls (Happé et al, 2014). 
 
The results reveal that primary cilium length and number was significantly decreased in 
different tamoxifen induced Pkd1 mice (C to G) compared to wild type controls (A to B) 
(Figure 3.20 a-b). The reduction of ciliary length and number although significant, was 
variable between the different Pkd1 mice. These results confirm that Pkd1 kidney mouse 







Figure 3.20  Mouse tissue of w.t and tamoxifen induced ADPKD models. a) Representative images of 
controls (no tamoxifen induction of PKD1 KO): A: EO9-537, B: EO9-538. PKD1 KO (tamoxifen induction of 
PKD1 KO): C: EO9-353, D: EO9-355, E: EO9-356, F: EO9-363. b) Primary cilium length and c) ciliary 
number in controls A, B and tamoxifen induction of PKD1 KO C-G. (N≈1000 Cells, Statistical test:paired  t- 
test (* = p≤ 0.05), Error bars indicate mean ± S.E.M). Antibody used: DAPI-stained nuclei (Blue), ARL13b 






3.14   Polycystin-1 deficient cells and centrosome number 
 
Finally, this study found that ADPKD cells were characterized by an increased frequency of 
cells with extra centrosomes (Figure 3.21 a, b), confirming data from a previous study (Lee 
et al, 2011). Centrosome abnormalities could interfere with mitosis and cilia formation. 
However the frequency of cells with extra centrosomes was low (less than 10%) suggesting 







Figure 3.21 Analysis of cells with duplicated centrosomes. I measure a significant increase in cells expressing 
multiple centrosomes cells in the cystic OX161 a) and the PC1KD b) lines (n=3, 100 cells/N. Statistical test: 










3.15 Cilia length and cell cycle exit 
 
To address whether the shorter cilia in ADPKD observed were caused either by a delayed 
cilia length increase and/or delayed exit from the cell cycle, quiescent cells were studied for 
an extended duration of up to 96 h. Analysis by light microscopy showed that the number of 
attached cells was unchanged up to 72 h but decreased at 96 h probably due to cell 
detachment (Figure 3.22 a, b, c). In the control UCL93 cells, cilia length increased further up 
to 96 h, whereas there was no change for the OX161 ADPKD line. Expression of Ki-67, 
which marks cycling cells was negative by 48 h (Figure 3.22 d) confirming that both cell 
lines had stopped dividing and were growth arrested by this stage. No normalization of cilia 
length in the ADPKD models was measured after prolonged starvation times (Figure 3.22 e).  
These results confirm that reduced cilia length in the cystic line was not related to delayed 






Figure 3.22  a) Cilia length and cell cycle exit Light microscopy images of normal and ADPKD cells over a 
starvation period of 96 h. b) Microscopy images of washed and 4% PFA fixed normal and ADPKD cells at 
maximum starvation point 96h (Magnification 40X). c) Graphic representation of counted cells per field, 
showing a decline of cell numbers at prolonged starvation periods. d) Fluorescent microscopy images with Ki67 
proliferation marker shows proliferation decline with increasing starvation time (Magnification 60X). e) 
Prolonged starvation does not normalize ciliary length suggesting that length and number is not reduced due to a 





3.16   ADPKD primary cilia have orientation defects in wounding assays  
 
The reduction in cilia length in ADPKD cells led to hypothesis that a possible functional 
defect in relation to their normal function could exist. One of the defects could be related to 
directed cell migration and cilia reorientation (Veland et al, 2014). To test this hypothesis, the 
orientation of cilia in migrating control and ADPKD cells after wounding was examined. 
 
Directly after the scratch assay at time point 0 (t), primary cilia orientation is evenly 
distributed throughout the whole 180° spectrum with the overall mean hovering around 90° in 
normal and ADPKD models. After 9 h incubation, a significant reorientation of primary cilia 
pointing towards the wound scratch (close to 0°) could be measured in the normal cells. 
However, no significant changes were detected in the ADPKD models suggesting that 
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Figure 3.23  Primary cilium orientation in migrating normal and ADPKD cells (a) Time course of 
migrating normal and ADPKD models shows an optimal target with still clear border detection 9h after scratch 
assay. (b) The orientation of primary cilia towards the scratch is shown in a representative image of migrating 
normal cells. Measurement was performed by a leading arrow pointing from the cilium tip to the base to the 
cilium from which a horizontal arrow in direction scratch assay marked the °degree orientation towards the 
wound. The increase in °degrees from 0° (oriented towards the wound) to higher numbers marked the increase 
of cilia not oriented towards the wound. Antibody used: DAPI-stained nuclei (Blue), acetylated tubulin stained 







Figure 3.24  Primary cilium angle of deviation from wound in migrating normal and ADPKD cells 
For this analysis a primary cilium oriented towards the wound is set at 0° as a standard. 
a), c) In normal cells primary cilium orientation switches from a random conformation at time point zero (mean 
of all measurement combined = 90°) to a marked reorientation towards the wound at time point 9 h, with a 
significant shift of the 90° mean towards the 0° point (mean 53° UCL93, mean 61° DSRED). In both ADPKD 
lines a similar but not significant trend is observed, with a majority of cilia still scattered on the complete 
spectrum of angle orientations. (N=400-500 Cells, Statistical test:paired  t- test (* = p≤ 0.05), Error bars indicate 










3.17 Summary and discussion 
 
Previous studies have raised concerns about the ability of cells to predictably form primary 
cilia at different passages or directly after storage (Alieva et al, 1999). However, in our cell 
line models, the level of ciliation in each cell line within a limited passage range (20 
passages) and uniform cell density was found to be stable feature in repeated experiments.  
 
3.17.1 Primary cilia regulators 
In this study, no difference in the dynamics of cilia assembly and disassembly ratio were 
found between normal and ADPKD models in response to serum. However, cilia number and 
length were consistently decreased in ADPKD models compared to normal controls. This 
was an unexpected finding.  
Further studies confirmed equivalent responses in both normal and disease models to two 
factors known to affect cilia length i.e. cAMP and Ca
2+
. Many studies have investigated the 
role of cAMP and Ca
2+
 in normal cell behaviour (Besschetnova et al, 2010).  
Cyclic AMP is a diffusible and ubiquitous second messenger produced in response to 
hormone action and is known to be involved in the regulation of many biological processes 
including cell proliferation, differentiation, or growth arrest in different cell types (Dumont et 
al, 1989). In normal renal epithelial cells, cAMP has an anti-mitogenic effect, while in 
ADPKD intracellular increases in cAMP have been shown to have a mitogenic effect 
(Hanaoka et al, 2000). This opposite role of cAMP in ADPKD has been suggested to relate to 
a disturbed crosstalk of the cAMP and Ca
2+
 pathways (Harris & Torres 2014).  
In normal cells, cAMP has been shown to induce PKA dependent inhibition of the MEK/ 
ERK pathway with inhibition of cell proliferation (Wallace 2011). Ca
2+
 signalling also acts to 
prevent the activation of the B-Raf kinase upstream of the MEK/ERK pathway; however, the 
disturbed homeostasis of Ca
2+
 levels in ADPKD, could cause a release of the Akt inhibition 
of B-Raf, thus resulting in cAMP stimulation of B-Raf, ERK and therefore in cilium 
shortening and proliferation (Wallace 2011). Thus increases in Ca
2+
 would lead to opposite 
effects to increases in cAMP (Cooper et al, 1995; Lee et al, 2010). The balance between 
cAMP and Ca
2+




regulation might be critical for fully functional differentiated cells including the maintenance 
of normal cilia length. 
However, the results from this study show that responses in cilia length to increases in 
intracellular Ca
2+ 
or cAMP were no different in normal and ADPKD models, suggesting that 
these pathways are not defective in ADPKD. These results are in agreement with a previous 
study in control and a Polycystin-1 or Polycystin-2 deficient MEK and IMCD3 cell models 
(Besschetnova et al, 2010).  
 
3.17.2 AKAPs localize the cAMP signalling  
The ability of cAMP to modulate ciliary length was shown to depend on PKA activation 
mediated probably through a scaffold and anchoring proteins abbreviated AKAP for A-
kinase-anchoring proteins complex at the cilia base. More than 50 different subsets of these 
AKAP scaffolding proteins have been identified so far, all determined by a common 
structurally conserved protein kinase A (PKA)-binding domain. AKAPs are able localize 
signalling to specific subcellular compartments and membrane microdomains. In addition, 
they have been shown to play an important role in regulating and localizing PKA signalling 
to specific areas of the cell, and particularly interesting in our case, to the centrosomes at the 
base of the cilia (Sillibourne et al, 2002). AKAPs proteins target PKA to a variety of distinct 
subcellular locations, confining enzyme activity at determined cAMP production sites, with 
the result that only a subset of potential substrates can be phosphorylated (Carnegie et al, 
2003). Many localization examples of these large AKAPs complexes to their subcellular 
target are shown to rely entirely on phosphorylation, and or interaction with other proteins 
and phospholipids. A few examples include the interaction of AKAP79/150 with 
PtdIns(4,5)P2 (Dell’Acqua et al, 1998), or the binding of several AKAPs, i.e. AKAP6 
(Dodge et al, 2001), AKAP7 (Stefan et al, 2007) and AKAP9 (Taskén et al, 2001) to the 
(PDE4D3) protein, a member of the family of the Cyclic AMP-dependent phosphodiesterase 
type D proteins which are elevated in response to cAMP. The PDE enzymes are primary 
involved in local degradation of cAMP, playing a crucial role in the spatial control of cAMP 
propagation. In a recent study, the authors investigated the spatial compartmentalization of 






This study focused on the possible role of AKAP350 which was initially identified as a 
possible interacting partner of polycystin-1 in MS pull-down assays (unpublished). Co-
immunoprecipitation confirmed binding of AKAP350 to polycystin-1 PLAT domain. 
AKAP350 was shown to localise to centrosomes as previously shown. It is a centrosomal 
PKA regulator whose activation threshold could be reduced with an increase in auto-
phosphorylation (Terrin et al, 2012). Moreover, the binding of PDE4D3 to the AKAP350 
complex is entirely regulated by phosphorylation and de-phosphorylation (Takahashi et al, 
1999, Tasken et al, 2001). Thus, the close aggregation of PKA and PDE4D3 enzymes via 
AKAP350 may function as a self-regulating negative feedback system (Dodge et al, 2001). 
Another study has also shown that cAMP concentrations localised to a specific centrosomal 
microdomain modulated by PDE4D3 changed during different stages of the cell cycle; 
disruption of this microdomain stopped cell cycle progression with a resultant accumulation 
of cells in prophase. The study provided the first tangible evidence that control of cell cycle 
progression might rely on regulation of centrosomal cAMP/PKA signals (Terrin et al, 2012). 
PDE4D members are not only involved in PKA, MAP kinases and Erk2 phosphorylation 
activities but also found to play key roles in regulatory mechanism like protein-protein 
interactions with cytoskeletal scaffolding proteins at specific targeted locations. In this study 
however, AKAP350 centrosome localisation was not altered in ADPKD cells suggesting that 
polycystin-1 binding is not essential for its centrosomal location. However, AKAP350 
function may still be abnormal in the absence of polycystin-1, leading to cell cycle 
dysregulation in response to cAMP. This possibility needs to be tested in future studies. 
 
Impairment of normal centrosome function has been shown together with cilia defects to be 
involved in both tumorigenesis and ciliopathies (Nigg et al, 2009). The ability of AKAP 
proteins to localize and modulate the timing of cAMP activation, e.g. through the cell-cycle 
dependent binding of specific regulatory subunits of PKA, have been so far not only linked to 
chromatin remodelling during mitosis (Landsverk et al, 2001), but also in more recent 
investigation to direct or indirect modulation of the Hedgehog and/or RAS/ERK signalling 
pathways, both involved in cell cycle progression (Waschek et al, 2006). Interestingly, 
AKAPs have been associated with various cytoskeletal and structural events, including the 
formation of actin stress fibres via AKAP-Lbc derived activation of the Rho pathway, thus 
underlining another critically important potential aspect of these proteins as orchestrators of 





3.17.3 The role of cAMP in cell proliferation 
It is largely accepted that cAMP is associated with regulation of the cell cycle, exerting either 
an inhibitory or stimulatory effect on proliferation depending on the cell type. The role of 
cAMP also varies greatly on the cell type or strength of the stimulus (Luciano et al, 1999). 
This study confirmed two different effects of cAMP. In growth-arrested cells, cAMP 
increased cilia length independent of the cell cycle. This effect was similar in normal and 
ADPKD cells. However, in cycling cells, cAMP inhibited the cell cycle in normal but not 
ADPKD models. Cell cycle exit was confirmed by loss of Ki67 and PH3 expression and 
associated with ciliation. These results are similar to previous findings in mouse mammary 
adenocarcinoma cells (Rodriguez-Collazo et al, 2008), which showed that cAMP was able to 
regulate PH3 by blocking G2 progression as evidenced by mitotic entry inhibition and 
decreased activity of the CyclinB/Cdk1 kinase. These processes were not only highly 
sensitive to variations in intracellular cAMP concentration but also dependent on the 
expression of the catalytic subunit of PKA. The authors conclude that ultimately the loss of 
mitotic H3 phosphorylation could be caused by either a rather global dephosphorylation of 
H3 in mitotic chromosomes or the prevention of phosphorylation through a pre-mitotic block 
to cell cycle progression (Rodriguez-Collazo et al, 2008).  
 
3.17.4 PGE2 regulates primary cilia length 
In this study, PGE2 was identified as a potential ligand activating the cAMP/PKA effect on 
cilia length. A previous study had shown that PGE2 acting via EP2 receptors could increase 
cAMP and stimulate the formation of cysts, possibly by inhibiting apoptosis (Elberg et al, 
2007). For cilia length, PGE2 appears to act not only via EP2 but also via EP4 with some 
evidence of redundancy. One interpretation of these results could be that the PGE2/EP2-
EP4/AC/cAMP signalling cascade, shown to cause primary cilium elongation is potentially 
necessary for optimal normal cilia length. This could be necessary for normal cilia function 
e.g. to arrest proliferation and responsiveness to other extracellular stimuli which in turn may 







Figure 3.25  Model of primary cilium regulation in ADPKD Normal cAMP signalling results in primary 
cilium elongation, which is subsequently reverted by feedback mechanism to basal levels in normal cells. In 
ADPKD cells a prolonged chronic cAMP level might activates alternative pathways e.g lead PKA 
phosphorylation of Beta catenin, and its subsequent local accumulation which activates the Wnt signalling 
which cause proliferation (Hino et al, 2005). It has also been shown that the Shh is also antagonized by Wnt 
activity through the expression of Gli3 (Ulloa et al, 2010), while when the cilium is formed SHH inhibits Ptch1 






In the study by Zhang, it was shown that cAMP and PGE2 can be pro or anti-proliferative 
and that the difference might exclusively rely on the strength and the actual duration of the 
signal. This biphasic effect was related to the amount and time of PGE2 activation. 
Stimulating at low concentration resulted in proliferation, while high concentrations were 
anti-proliferative (Zhang et al, 2014).  
 
3.17.5 Ciliary length and defective orientation in cell migration 
In this study, ciliary length in human PKD1 cystic kidney lines and tissues were consistently 
shorter than normal controls. This was unexpected since the general consensus in the field is 
that cilia are structurally normal but functionally defective in ADPKD. However, few studies 
have addressed this question systematically. A review of published studies have reported no 
differences (Nauli et al, 2003), shorter cilia in PKD1 cyst cells (Xu et al, 2007), curved and 
less ciliated cells in Adipose-derived stem cells (Bodle et al, 2013; Plotnikova et al, 2014), 
longer cilia in Pkd1 transgenic mice (Kurbegovic, et al 2010) and longer, but less frequent 
cilia in dilated collecting ducts tissue of Pkd1 hypomorphic mice (Hopp et al, 2012). These 
studies indicate that cilia length and number may be altered in ADPKD cells and tissues, but 
the mechanism underlying these changes has not been reported. The possibility of delayed 
cell cycle exit was excluded. The presence of multiple centrosomes was found in a low 
percentage (<10%) of ADPKD cells as previously reported but could not account for the 
general reduction in cilia length observed.  
 
The consistent ciliary length defects observed so far led to the hypothesis that a reduction in 
cilia length could lead to defects in directed cell migration and cilia orientation in ADPKD 
cells. Normal oriented migration occurs via polarization in response to positional cues, which 
consist not only of extracellular attractants, but importantly can also be mediated by the 
disruption or alteration of the contact to neighbouring cells (Etienne-Manneville 2012; 
Cordeiro & Jacinto. 2013). In regards to our study it is important to note that the primary 
cilium as a sensory organelle, hosts and coordinates a number of pathways involved in 
controlling cell migration and orientation such as. TGFβ, PDGF, Hh, Wnt, and RTK 
signalling (Goetz  & Anderson, 2010; Christensen et al, 2012); thus defects in primary cilium 






Previous studies on primary cilium dynamics during migration pointed to a 4 step process 
(membrane protrusion and adhesion in the direction of movement, contraction, detachment, 
and retraction of the rear end) which is based on an initial nucleus repositioning followed by 
the actin cytoskeleton reorganization, which allowed frontal reorientation of the cilia–
centrosome axis (Veland et al, 2014). The actual migration process is then subsequently 
initiated as the primary cilium points towards the movement direction and the actin structures 
force the membrane in corresponding direction of the signal (Veland et al, 2014).  
The clear role of primary cilia in directed cell migration has only recently gained attention 
and its mechanisms are still poorly understood. However, some studies suggest that the 
platelet-derived growth factor receptor alpha (PDGFRα), which is localized to the primary 
cilia might be a key element in ciliary migration mechanisms (Christensen et al, 2013). 
Sensing of PDGF from a specific direction through the ciliary sensor might activate specific 
pathways and positional cues that regulate the organization of the cytoskeleton required for 
actin organization and lamellipodium formation and thus all subsequent migration steps 
involved in this process. 
The reduced ability of ADPKD cells to re-orientate the primary cilium towards the wound 
suggests that either defects in actin organization or aberrant signals from primary cilium 
defects in the ADPKD model affect the normal orientation mechanisms of primary cilia 
during migration. 
Recent studies have uncovered a strong link in other ciliopathies, i.e. Nephronophtisis, 
Bardet–Biedl, Joubert, Meckel–Gruber and Orofacial digital 1 syndromes (Valente et al, 
2014) between primary cilia and cell migration in the developing brain.  
 
Normal migration is characterized by microtubules and F-actin organization dependent 
repositioning of the centrosome between the nucleus and the leading edge (Etienne-
Manneville 2013). A seminal study also showed that in confluent 3T3 fibroblasts, orientation 
of primary cilium appeared random, while in sub-confluent migrating cells, the cilia tended to 
point in parallel to the 2D layer and in the direction of migration (Albrecht-Buehler, 1977), 
suggesting that the cilium acted as a sensory organ capable of following or leading the 
direction of the cell migration path. This observation has been confirmed by many studies 
showing this unique reorientation effect of cilia i.e. at the wound sites of migrating cells, 
suggesting that the primary cilium plays a critical role in directed migration and tissue repair 




oriented cilium could function as a point of reference for the navigation of cells, such as a sail 
on a boat, thus steadying a current of environmental synergistic and opposing signals, 
towards the most favourable direction of migration (IbenRønnVeland et al, 2014).  
 
In support of this, cells with stunted cilia in addition to decreased orientation and 
directionality were characterized by reduced PDGF-AA dependent cell migration (Schneider 
et al, 2010; Pedersen et al, 2008). Recent evidence suggesting that primary cilium signalling 
either induces the transport of polarity proteins along microtubules to the leading edge or 
directly affects the allocation of microtubule tracks (IbenRønnVeland et al, 2014), although 
the exact mechanism are still unclear. Other examples for the role of primary cilia in 
migration include the ciliary PDGFRα, which is involved in PI3K-Akt and Erk1/2-Mek1/2 
activation and has been shown to have critical roles in cell polarization of rat kidney 
epithelial cells (Bisel et al, 2008; 2013) and Wnt/PCP signalling which is also regulated 
through the primary cilium. The latter acts as a regulator of polarized migration and cell 
adhesion by regulation of disheveled (Dvl) proteins, which modulate actin and microtubule 
cytoskeletal rearrangements via Ca
2+
 signalling (Gao & Chen 2010; Amin & Vincan 2012; 
Wynshaw-Boris, 2012). The role of Wnt/PCP signalling in directional primary cilium 
dependent migration has implicated Inversin/Nephrocystin-2. The INVS protein is localized 
to a specific compartment at the base of the cilium termed the INVS compartment (Yamaoka 
et al, 2009). INVS has been shown to control the switch between canonical and non-
canonical Wnt signalling by its ability to degrade Dvl proteins, therefore resulting in βcatenin 
turnover and PCP (Simons et al, 2005). Invs–/–MEFs are characterized by a reduced 
polarization and movement ability, marked by dispersed GSK3β-phosphorylated β-catenin 
localization at the base of the primary cilium, elevated canonical Wnt signalling and defective 
activation and localization of RhoGTPases to leading edge (Veland et al, 2013). Invs–/–MEFs 
not only showed defective leading edge and actin targeting and activation of the controller 
NHE1 (Denker & Barber, 2002), but also failed to upregulate PDGFRα transcription during 
growth arrest. This then resulted in reduced ciliary PDGFRα accumulation which in turn was 
characterized by a decreased ability of the cilium to respond to PDGF-AA and thus impaired 












 Primary cilia assembly and disassembly in response to serum was not altered in 
ADPKD models compared to controls. 
 The average length and number of primary cilia was reduced in ADPKD models 
compared to controls both in vitro and in vivo. 
 This difference was unrelated to delays in cell cycle exit or changes in centrosome 
number. 




 The response to db-cAMP in both models was dependent on both PKA activation and 
AKAP binding. 
 AKAP350 co-immunoprecipitated with the polycystin-1 PLAT domain and localised 
to centrosomes. 
 PGE2 could be a physiological ligand for the response to db-cAMP, acting primarily 
through EP2 and EP4 activation 
 ADPKD models showed impaired cell cycle exit in response to db-cAMP compared 
to controls. 
 In wounding assays, re-orientation of cilia towards the wound was defective in 
ADPKD models compared to controls. 
 
 
In the next chapter, the potential role of the cytoskeleton in regulating cilia assembly was 













Results Chapter IV 
The Role of the Cytoskeleton Dynamics on Primary Cilia 



















4.1  Introduction 
 
Actin filaments and microtubule networks represent important cytoskeletal components in 
every cell and their dynamic regulation is crucial for many cellular processes including 
cytokinesis, morphology changes, cell shape and migration. They also exert control over 
channel and receptor transport, localization and function (Rodriguez et al, 2003; Montalbetti 
et al, 2007). In this chapter, the potential role of cytoskeletal changes on the regulation of 




Microtubules are cytoskeletal polymers essential for the maintenance of cell shape, division, 
migration, compartmentalization and ordered intracellular transport powered by motor 
proteins. A microtubule per se is a cylinder with outer diameter 25 nm formed by 13 laterally 
bound protofilaments built by heterodimers of globular α- and β-tubulin subunits arranged in 
a head-to-tail manner (Nogales et al, 1998) (Figure 4.1). They are polar structures with two 
structurally distinct ends, a slow-growing minus end, exposing α-tubulin subunits, and a fast-
growing plus end exposing β-tubulin subunits (Nogales et al, 2006). Within the cells the 
minus ends are stabilized by anchoring in microtubule-organizing centre (MTOCs), whereas 
plus ends are highly dynamic and switch between phases of growth and shrinkage. 
Polymerization and depolymerization of microtubules are driven by hydrolysis of GTP on β-
tubulin monomer. GTP exchange is necessary for the switch between phases of growth and 
shrinkage separated by catastrophe (growth to shrinkage transition) and rescue (from 
shortening to growth). Importantly, this dynamic instability is an essential feature of 
microtubules that allows them to search through the cell for targets like cell cortex or actin 
cytoskeleton (Desai et al, 1997). The dynamics of microtubules can be regulated by 
incorporation of alternative tubulin isotypes (Luduena et al, 2008) or by post-translational 
modifications (PTMs) of tubulin subunits (mainly acetylation, tyrosination/detyrosination, 
polyglutamylation, polyglycylation and phosphorylation), and binding of microtubule 
associated proteins MAPs (Amos et al, 2005; Verhey et al, 2007). Binding of MAPs has been 
suggested to be largely regulated by PTMs (Nogales 2001). 
Microtubule dynamics can be also regulated by a variety of ligands, including microtubule 







Figure 4.1  Microtubules and Actin a) Microtubule dynamics diagram. α and β tubulin dimers 
polymerize on the + end of the growing cone while depolymerisation occurs on the – end. 
Microtubule-associated proteins (MAPs) when not phosphorylated can function as microtubule-
stabilizing factors that protect microtubules against depolymerisation (Song and Brady 2015). 
PTM such as addition of one or more glutamate (polyglutamylation) or glycine residues 
(polyglycylation) to the α and β tubulin heterodimers influence microtubule regulation. 
b) Actin dynamics diagram Polymerization: actin monomers are added to the barbed end causing 
actin filament elongation. De-polymerization: Hydrolysis takes place on the pointed other end causing 






is γ-tubulin (Oakley et al, 1989), a highly conserved minor member of the tubulin family 
concentrated in MTOCs. γ-tubulin interacts with 6 GCPs (γ-tubulin complex proteins) to 
create small (γ-TuSC) and large (γ-TuRC) complexes that participate in microtubule 
nucleation (Teixido et al, 2012). Interestingly, an important role in the regulation of 
microtubule formation and granule translocation might also be played by Ras guanyl 
nucleotide releasing proteins (RasGRPs) that activate RhoA via PI3 kinase (Liu et al, 2007) 
which contributes to a variety of other factors able to regulate the dynamics of microtubule 
formation. However, the primary determinant of whether microtubules grow or shrink is the 
rate of GTP hydrolysis, a factor that is both intrinsic and essential to filament assembly 
(Sharma et al, 2011).  
The cilia axoneme comprises a microtubular core comprised of α- and β-tubulin stabilised or 
destabilized by post-translational modification such as acetylation, glutamylation and 
polyglutamylation, the latter reported to promote MT severing in vivo and in vitro (Lacroix et 
al, 2010, Song and Brady 2015) (Figure 4.1). The centrosomes at the cilia base also form the 
microtubules organizing centre (MTOC). At the start of cell division, the microtubule 
axoneme of the primary cilium must be completely retracted in order to release the 
centrioles/centrosome to form the mitotic spindle. As a consequence, it could be said that 
organization of cilia microtubules is indirectly involved in the regulation of the cell cycle 




Actin is a structural related multi-functional protein that is able to forms microfilaments in 
the cell. It can be present in two forms: G-actin (globular actin) in form of a free monomer or 
F-actin (filamentous actin) in the form of elongated linear polymer microfilaments. 
Nucleotide hydrolysis by F-actin regulates the transition between G- and F-actin. The ATP 
state is more stable than the ADP state.  
The polymerization has been described to occur in sequential phases, characterized by an 
initial lag period where G-actin monomers combine into short, unstable oligomers. A growing 
phase follows were these oligomer form the basis for the addition of new actin monomers 
which assemble on both ends of the filament. The last phase is the equilibrium phase were 
actin monomers are added to the fast-growing barbed end of the elongating filament in the 
ATP state while hydrolysis takes place on the other end of the filament leading to a faster 




mechanism of actin polymerization/depolymerization also known as actin filament 
treadmilling (Wegner and Isenberg 1983) with an equilibrium in actin filament structure were 
no net change in the total mass of filaments can be measured (Uzman et al, 2000). 
Ultimately, the form in which actin is organised determines its roles. These include 
cytokinesis, vesicle and organelle movement, the establishment and maintenance of cell 
junctions as well as cell shape, mobility and contraction of cells during cell division.  
Treadmilling alone does not account for the high dynamic regulatory mechanisms of actin 
filament formation observed in different in cells. Studies have uncovered a wide variety of 
different proteins involved in the regulation of actin cytoskeleton dynamics, such as actin 
monomer sequestering or filament severing and cross-linking proteins (Pollard and Borisy 
2003). Interestingly, many promising candidates for the mediation of structural interactions 
between microtubules and actin filament have been identified in mammalian cells (Mandato 
et al, 2003). 
 
Recent studies have also suggested a link to primary cilia assembly although the mechanisms 
underlying these observations have not been clarified (Bershteyn et al, 2010; Sharma et al, 
2011).  
 
4.2 Cytoskeletal abnormalities affect normal cilia formation 
 
4.2.1 Introduction  
 
In the previous chapter, it was confirmed that the cAMP/PKA pathway could increase cilia 
length. However, recent studies have pointed to additional clues, particularly changes in 
cytoskeletal dynamics which could alter ciliary length. Most of these studies pointed 
exclusively to cytoskeletal changes and dynamics of tubulin and possibly actin as a main 
cause for cilia or flagella length (Sharma et al, 2011). 
 
Primary cilia consist of a microtubule core arising from a basal body or mother centriole. The 
cilia base could be stabilised by polymerised actin filaments. Although microtubule or actin 
dynamics are shown to be involved in primary cilia regulation in other cells (see chapter 4.2), 
this effect has not been studied specifically in ADPKD. The following analysis was therefore 
performed to investigate their potential involvement in primary cilium regulation and in the 





4.2.2 Actin organisation in normal and ADPKD cells 
 
The organisation of F-actin was first compared in normal and cystic cell lines after 48h 
growth arrest using labelled phalloidin (Figure 4.2). Overall F-actin labelling appeared to be 
more disorganized in both ADPKD models compared to normal controls. Actin fibres 
appeared generally increased, specifically at the perinuclear regions, the orientation of stress 
fibers appeared more randomly distributed throughout the cell and a proportion of stress 
fibers appeared thicker. 
 
                                    Normal                                                    PKD 
 
Figure 4.2 Actin organization.  Representative image of Actin organization and 3D surface intensity Plot (Fiji) 
phalloidin labelled F-actin actin structures and stress fibres can be detected in normal and ADPKD models. 
Subtle differences can be observed in the organization of the cytoskeletal actin structures in the ADPKD model. 
In particular, actin structure seems less organized and characterized by overlapping structures or bundles of 
various intensity and thicker non parallel stress fibers. Magnification 60X, Scale bar 10 µm. Antibody used: 





4.2.3 Modulation of Actin polymerisation alters primary cilia length 
 
In view of the structural defects in actin organisation observed, it was hypothesised that 
modulating actin polymerisation could restore cilia length. 
 
Different compounds are known to affect actin polymerization. Cytochalasin D is a cell-
permeable and potent inhibitor of actin polymerization. It disrupts actin microfilaments 
causing arrest of the cell cycle at the G1-S transition. Although the full mechanism of this 
compound are not clear, the common understanding is that it binds to the plus ends of F-actin 
polymers blocking further polymerization though actin monomers addition, while 
simultaneously natural de-polymerization mechanism at the (-) gradually cause loss of the 
filament (May et al, 1998). 
 
As shown, cytochalasin D treatment induced an increase in cilia length in both normal and 
ADPKD models. Ciliary length in the ADPKD cells reached the same maximum extension as 
the normal cells at 1μM concentration (Figure 4.3  a, c). Comparison of the percentage cilia 
length increase between normal in ADPKD models revealed a significantly greater ciliary 
length increase in the disease models (Figure 4.3  b, d). 
 
The orientation of F-actin fibres was measured by focusing on actin arrangements positioned 
over the nucleus and measurement of the stress fiber angle relative to a horizontal line. As 
shown in (Figure 4.4), there was a wider spread of actin fibre orientation in the ADPKD cells 






Figure 4.3 Effect of Actin depolymerization on primary cilia.  Inhibition of actin polymerization via 
cytochalasin D results in significant primary cilium elongation in a) normal and c) ADPKD models. Primary 
cilium elongation in ADPKD models is significantly increased to the normal control after normalization b), d) 
suggesting that ADPKD cells are more sensible to actin destabilizing agent cytochalasin D (n=3, Statistical 
test:paired  t -test (* = p≤ 0.05), Error bars indicate mean ± S.E.M) e) Representative image of cytochalasin D 
treated/untreated normal and ADPKD cells marked with ARL13b (green) cilia, KI67 proliferation marker (red) 





        
 
Figure 4.4 Actin organization analysis. Comparison between normal and ADPKD a) measurement 
of stress fiber angle orientation. The amount of parallel running stress fibers is significantly decreased 
in ADPKD models. b) Measurement of stress fiber length shows a significant decrease in the average 
stress fiber length in ADPKD cells. (N=60 cells, Statistical test:paired  t -test (* = p≤ 0.05), Error bars 







4.2.4       Structural 3D actin analysis in primary cilia vicinity 
 
To investigate overall 3D actin arrangements in the whole cell especially around the ciliary 
base, confocal microscopy was performed. F-actin was excluded from the cilia shaft as 
reported in the literature (Ishikawa et al, 2012; Washburn et al, 2001).  
Z-stack fluorescent images showed that in normal cells, most of the detected primary cilia 
were situated well above the actin stress fiber plane while in ADPKD cells, more actin fibres 
appeared to be clustered around the cilia base (Figure 4.5).  
 
To obtain a more detailed analysis of actin structures and its organisation around the primary 
cilium, super-resolution light microscopy by SIM (Structured Illumination Microscopy) was 
performed. This allowed the visualization of images with a resolution below that of the Abbe 
diffraction limit. 
 
Using super-resolution imaging, most of F-actin in normal cells was localised to the 
basolateral membrane with little detected in the apical region or membrane (Figure 4.6 a-c). 
In contrast the ADPKD model, F-actin was more randomly distributed within the cell (Figure  
4.6 b, d) and an increase in small actin structures (granules) could be detected around the 







Normal                                       ADPKD 
 
 
Figure 4.5   Representative Z-Stack images of normal and ADPKD actin and primary cilia. 
Representative image of Actin structures (Yellow) and primary cilium (Green) from Z-Stack images 
were used to form a three dimensional representation of structural arrangements in normal and 
ADPKD cells. Two images of each cell line are provided, which move from one side view to the other 
over a 180° degree spectrum with sample images. Primary cilia (ARL13b: Green) can be observed 








Figure  4.6. SIM 3D images of primary cilia and actin structures. Representative 3 dimensional images of 
high-resolution light microscope SIM (Structured Illumination Microscopy) of normal and ADPKD cells.  
a, b) primary cilia (ARL13b: Green) and actin structures (Phalloidin: Yellow) are shown in two representative 
images from two angles of a three dimensional surpass image. c, d) Left: Increased magnification of a region 
located above the bottom actin plane near the primary cilium and on the edge of the nucleus, (Arrow represents 
actin structures distance from the bottom)  Right: corresponding aerial view of the cut section for the 
investigation of micro actin structures near the originating primary cilium. e, f) Representative images of micro 






4.3.1 Introduction  
 
The evidence of crosstalk between microtubules and the actin cytoskeleton which is emerging 
in recent studies in migration of cells, points to closely interconnected regulatory mechanism 
for these two structural proteins (Akhshi et al, 2014; Etienne-Manneville et al, 2004). 
 
4.3.2 Microtubule stability affects primary cilia formation  
 
To investigate the potential role of microtubule organization in cilia formation, nocodazole 
was used as a tubulin depolymerizing agent and taxol as a tubulin stabilizing agent. 
Nocodazole is an antineoplastic agent which exerts its effect in cells by interfering with the 
polymerization of microtubules and is commonly used to synchronise the cell cycle. The 
mechanism of nocodazole in regulating microtubule stabilization are not fully understood, but 
is thought to promote the formation of nocodazole-tubulin dimers and induce tubulin GTPase 
activity thus leading to microtubule depolymerisation (Vasquez et al, 1997).  
 
After treatment with nocodazole, an increase in ciliary length in the normal cells was 
observed, confirming a previous report (Yoder et al, 2011). Conversely in ADPKD cells, only 






               
Figure 4.7 Effect of Microtubule depolymerisation. Treatment with nocodazole induced MT 
depolymerisation and induces a significant ciliary length increase in normal a) and only marginal in b) PKD 
cells. Comparison of % change after treatment shows a significant impaired/reduced cilium elongation effect in 
ADPKD models b), d) suggesting that the latter are more resistant to nocodazole induced cilium elongation. 
(n=3, Statistical test:paired  t -test (* = p≤ 0.05), Error bars indicate mean ± S.E.M). Antibody used: DAPI-





4.3.3 ADPKD cells have increased microtubule stability 
 
The reduced response of ADPKD cells to nocodazole suggested that they might have 
increased microtubule polymerisation. The reversed experiment i.e. the effect of tubulin 
stabilisation on primary cilium formation was next studied using taxol.  
 
Stabilization of microtubules via taxol had little effect on cilia length in formed primary cilia 
of normal and ADPKD cells Figure 4.8 (a-d). As expected, taxol completely prevented 
nocodazole induced cilium elongation in normal cells while in the ADPKD models this effect 
was marginal. Taxol did not prevent cAMP dependent cilium elongation in normal and 
ADPKD cells suggesting that both effects were independent. Strikingly, nocodazole had an 
additive effect to db-cAMP in normal cells but not in ADPKD cells. 
 
The minor effect of nocodazole on cilia length in ADPKD cells implied an increase in 
microtubule stability. To quantify this more accurately, a nocodazole resistance assay was 
performed. Comparison of the normal PTEC DS RED cell line and the PTEC PC1 KD 
showed that a significant increased amount of cells with persistent acetylated a-tubulin 
structures after nocodazole in the ADPKD model compared to controls (e, f). Some of the 
nocodazole-resistant microtubules could be found in the region between the nucleus and the 
leading edge, confirming the polarized formation of stabilized microtubules reported by 
(Gundersen & Bulinski et al, 1988). Unfortunately it was not possible to perform the same 
analysis in patient derived cystic lines due to inability of these cells to remain adherent after 
the intensive 1% Triton washes required for the nocodazole resistance assay. 
 
Analysis of microtubules posttranslational modifications showed no obvious differences in 










Figure 4.8   Microtubule stabilization affects cilium elongation. In all tested cells, db-cAMP 
induced cilium elongation is independent of the effect of nocodazole (amount of free tubulin) in all 
tested cell lines. cAMP elongation was additive to nocodazole treatment in tested cell lines (a, b). 
Stabilization of tubulin via taxol had no significant effect on cytochalasin-D induced cilium 
elongation in normal cells. In the ADPKD model, a significant reduction of the cytochalasin-D effect 
was detected. Stabilization of tubulin via taxol in the nocodazole treatment has as expected a reducing 
effect in the normal cell lines, while in the ADPKD model there is almost no effect, (n=3, Statistical 
test:two way anova + multiple comparison test  (* = p≤ 0.05), Error bars indicate mean ± S.E.M).  
e) Nocodazole resistance assay graph showing amount of cells with α-tubulin left in %. f) 
Representative image of normal and ADPKD cells after nocodazole resistance assay. g) 








4.3.4 Microtubule/Actin organization controls cilia independently of 
cAMP/PKA 
 
cAMP/PKA has been reported to have effects on actin filaments in other cell types, especially 
in the field of cell migration (McKenzie et al, 2011). The striking effects of cytochalasin D 
and nocodazole on cilia length described above led to the analysis, whether they were 
independent of cAMP/PKA regulation. As shown, PKA inhibition did not prevent the 
elongation of the primary cilium in response to either agent, while it was able to fully block 
db-cAMP dependent cilium elongation (Figure 4.9). These results indicated that the changes 













Figure 4.9  PKA inhibition and microtubule/actin modulation on cilia length  
Inhibition of PKA prior to db-cAMP treatment prevents cilium elongation in a) normal and b) 
ADPKD cells. Neither cytochalasin D nor nocodazole prevented db-cAMP induced cilium elongation 
in a) normal and b) ADPKD cells (n=3, Statistical test:two way anova + multiple comparison test  (* 

















4.4    PI3K is important in ciliogenesis 
 
Next, the potential role of the PI3K pathway in regulating cilia length through actin and 
microtubule stability was tested. The PI3K inhibitor LY294002 reduced primary cilia 
disassembly in response to serum reintroduction in serum starved normal and ADPKD cells 
(Figure 4.10 b). There were no significant differences between normal and cystic models at 6 
and 24 h, suggesting that the effect of PI3K on the cilia disassembly or the cell cycle is not 
defective in PKD (Figure 4.10 c).  
 
The next step was to investigate whether inhibition of PI3K could influence actin 
depolymerisation and induce ciliary length increase. As seen in (Figure 4.11 e), PI3K 
inhibition led to actin filament shortening and increased stress fibres in normal cells. In the 
ADPKD models, no further changes could be seen in the already disorganized actin 
structures. PI3K inhibition resulted in significant cilium elongation in normal cells but had 
little effect in ADPKD cells (Figure 4.11 a-d). Treatment with LY294002 and db-cAMP 
resulted in an additive cilium elongation effect only in normal cells. Likewise, the 
combination of LY294002 with nocodazole was additive only in normal cells. In normal 
cells, LY294002 had no additive effect to cytochalasin-D suggesting that they could both be 









Figure 4.10 PI3K in ciliogenesis  a) Representative signalling model of PI3K activation, influncing 
proliferation and cytoskeletal organization. b) After starvation, serum was reintroduced in untreated 
and PI3K inhibited normal and ADPKD cells and the percentage decrease is shown in the graph. PI3K 
inhibition significantly prevents serum reintroduction dependent decrease in percentage of ciliated 
cells. c) Percentange change comparison between the normal (UCL93) and ADPKD model (OX161). 











Figure 4.11  PI3K is involved in primary cilia length regulation a, c) PI3K inhibitor LY at 50 µM induces 
primary cilium elongation in normal cells. dbcAMP treatment in combination with LY induces an additive 
primary cilium elongation in normal cells. Nocodazole and Cytochalasin D treatment in combination with LY 
does not have an additive effect on primary cilium elongation in normal cells. PI3K inhibitor LY at 50 µM does 
not induce primary cilium elongation in ADPKD models; also the effect of Cytochalasin D is reduced in 
OX161. e) PI3K inhibitor LY at 50 µM induces Actin filaments depolymerisation and shortening in normal 
cells. Antibody used: Actin (Phalloidin: Red), nuclei (DAPI: Blue). n=3, Statistical test: Two Way Anova + 




To exclude the possibility that reduced effect of PI3K inhibition on primary cilium regulation 
in ADPKD cells was related to dose, higher doses up to 500 μM were also tested. An increase 
in cilia length was observed in ADPKD cells at 250μM (Figure 4.12 a). However, there was 
evidence of cell toxicity at this concentration and the effect on other kinases cannot be ruled 
out. It has been reported that LY-294002 used at maximum of 50 μM is sufficient to abolish 
PI3 kinase activity (IC50=0.43 μg/ml; 1.40 μM) without affecting other lipid or protein 
kinases such as PI4 kinase, PKC, MAP kinase or c-Src (Vlahos et al, 1994), thus suggesting a 
specific defect in normal PI3K inhibition mechanism in ADPKD models.  
 
Taken together, these results show that PI3K inhibition induces actin filament 
depolymerisation and shortening in normal cells leading to significant primary cilium 
elongation. No effect was however observed in ADPKD models suggesting that it is unable to 
overcome the pre-existing increase in actin polymerisation, unlike the effect of cytochalasin 
D. Finally, it was also observed that the PI3K inhibition had an additive effect to cAMP/PKA 
dependent primary cilium elongation in normal cells, (Figure 4.12 b) confirming that PI3K 









Figure 4.12 a) ADPKD cells are more resistant to PI3K inhibition induced cilia elongation  
The PI3K inhibitor LY294002 resulted in a comparable cilium elongation level in OX161 cells to the UCL93 
cell line at 250μM. b) PI3K inhibitor and EP receptors agonists PI3K inhibition has an additive effect on the 
EP2, EP4 receptor agonist dependent cilium elongation. Statistical test: Two Way Anova + Multiple comparison 









The ability of cytochalasin D to normalise cilia length in disease cells suggested a primary 
defect in actin organisation. The Rho family of GTPases (classically RhoA, Rac and cdc42) 
are known to primarily regulate actin organisation (Nobes et al, 1995). To assess the 
contribution of these 3 regulators in actin and primary cilium dynamics, selective Rho kinase 
inhibitors were tested for their ability to influence ciliary length in normal and ADPKD 
models.  
 
4.5.2 Rac-1 inhibition causes increased cilia elongation in ADPKD models 
 
The well characterized inhibitor NSC23766 was used to block Rac-1 activation (Gao et al, 
2004). Although blocking Rac-1 had no significant effect on the number of formed cilia 
compared to untreated controls (Figure 4.19), a significant increase in ciliary length was 
observed in both normal and ADPKD models, with a more pronounced percentage increase in 
the ADPKD model (Figure 4.13 a, c).  
 
These results indicate the potential role of increased Rac-1 activation in ADPKD cells. As 
with the other two Rho family members of interest, Rac-1 signalling is involved in a variety 
of signalling cascades (Figure 4.13 e), any of which could be defective in ADPKD leading to 







              
 
Figure 4.13 Rac-1 and cilia regulation  Treatment with Rac-1 inhibitor nsc23766 for 4 h induces a significant 
ciliary length increase in normal and ADPKD cells a, c). Comparison of percentage change shows a significant 
increased cilium elongation effect in ADPKD models b), d). (n=6, 100 cells/N. Statistical test:paired  t- test (* = 





4.5.3   ROCK inhibition normalizes ciliary length in ADPKD models 
 
The effect of the Rho kinase (ROCK) inhibitor Y-27632 on primary cilium formation was 
next tested. In contrast to Rac-1, ROCK 1/2 inhibition led to the restoration of normal ciliary 
length in ADPKD cells to that of normal cells. Surprisingly, there was little cilium elongation 
effect in normal cells Figure 4.14 (a, c). The effect of the ROCK inhibitor seemed to be 
limited almost exclusively to ADPKD cells, with a significant fold change increase in ciliary 
length (b, d). 
 
Taxol did not prevent ROCK inhibition-dependent primary cilium elongation in ADPKD 
cells indicating a microtubule–independent effect (Figure 4.14 f, g). Treatment with 
phalloidin to stabilize actin prior to ROCK inhibition to prevent actin depolymerisation had a 
lethal effect. On the other hand, phalloidin treatment itself was not toxic in either normal or 
ADPKD cells and did not alter cilia length except in one line (PTEC-DSRED). 
 
740 Y-P, a PI3K activator had a cilia shortening effect in normal but not ADPKD cells, the 
exact opposite effect to that observed with LY294002 (Figure 4.11). However it reduced the 
increase in cilia length in ADPKD cells after ROCK inhibition (Figure 4.14 f, g,) possibly by 
inducing actin polymerization and antagonising the actin depolymerisation induced by ROCK 





                            





Figure 4.14  ROCK and cilia regulation.  a, c) Treatment with ROCK inhibitor Y-27632 for 4h 
normalizes primary cilium length of ADPKD models to basal levels, and has no significant effect on 
normal cells b), d). Comparison of percentage change shows a significant increased cilium elongation 
effect in ADPKD models. (n=4, 100 cells/N. Statistical test:paired  t- test (* = p≤ 0.05), Error bars 
indicate mean ± S.E.M). e) Pathway model of ROCK inhibition: The influence of hormones, growth 
factors or extracellular stimuli could induce defective signalling in form of an aberrant hyper-
activation of ROCK1/2, thus increase in downstream activation of LIMK and mDia resulting in 
increased stress fiber formation and actin polymerization f-g) Pre-treatment with taxol had no 
significant effect on ROCK inhibition effect. Pre-treatment with PI3K activator Y-P had no effect on 
ADPKD cells while ciliary length was decreased in normal cells. (n=4, 100 cells/N. Statistical 






4.5.4 Cdc42 inhibition causes increased cilia elongation in ADPKD models 
 
 
Using the same protocol, growth arrested cells following Cdc42 inhibition using ML141 were 
analysed. Surprisingly in non-disease models, Cdc42 inhibition had no effect on primary 
cilium regulation in the PTEC while in the UCL93 cell line, a significant increase in cilia 
length was observed. In comparison, Cdc42 inhibition in the ADPKD models resulted in a 
greater increase in cilia length (Figure 4.15).  
Similar to the results of Rac-1 inhibition, the percentage increase analysis revealed that there 
was significant increase responsiveness to the cilia elongation compound in the ADPKD 
models (b, d). This could be due to the known effects of Cdc42 and Rac-1 on both the 
microtubule and actin cytoskeleton, unlike Rho which acts only on actin (Figure. 4.13 e and 













Figure 4.15  CDC42 inhibition and cilia length Treatment with Cdc42 inhibitor ML141 for 4 h 
normalizes primary cilium length of ADPKD models to basal levels, and has no significant effect in 
one normal cell line a), but increased ciliary length in the other c). Comparison of percentage change 
shows a significant increased cilium elongation effect in ADPKD models b) d). (n=6, 100 cells/N. 
Statistical test:paired  t- test (* = p≤ 0.05), Error bars indicate mean ± S.E.M).  
e) Pathway model of Cdc42 inhibition f-g) Treatment with phalloidin alone decreased ciliary length in 








Figure 4.16. Effect of Rho GTPases inhibition on actin structures in normal and ADPKD models. 
In untreated cells, stress fibers can clearly been seen extending throughout the cytoplasm while other actin 
structures are arranged in dense bands around the cell periphery. In the ADPKD model stress fibers appear 
enlarged or entangled in some areas and actin staining appears also increased compared with the normal long 
parallel and defined filaments in the normal model. Upon inhibition of any of the Rho GTPases, actin structures 
and filaments are broken down to different degrees depending on the compound used. The effect on normal and 
ADPKD cells after treatment appears very similar with minimal differences in the ADPKD models in form of 
irregular structures. The Rac-1 effect on actin structures seems to be concomitant with cell contraction and 
concentrated filaments while in the Cdc42 cells and filaments retain a normal appearance after filament 
fragmentation. The effect of ROCK kinase inhibition also results in a decrease of actin structures and fibers 







Next, the effect of microtubule or actin polymerisation on Cdc42 dependent cilium 
elongation effect was studied. In ADPKD cells, Cdc42 inhibition resulted in a significant 
increase in cilia length which was reduced by either tubulin (taxol) or actin (phalloidin) 
stabilization. This suggests that Cdc42 regulation of cilia length depends on both tubulin and 
actin depolymerisation (Figure 4.15 f, g).  
 
In summary, these results show that all three actin modulators were able to rescue ciliary 
length in ADPKD cells. Their effect in normal cells was much more varied but usually less or 
absent compared to the ADPKD lines. 
 
Different Rho GTPases are known to have distinct effectors: in fibroblasts, Cdc42 is reported 
to affect filopodia, Rac-1 affect lamellipodia while RhoA preferably affect stress fibres 
formation (Dubois et al, 2005). Our results show that inhibition of Cdc42, Rac-1 or ROCK 
kinase results to different degrees in actin depolymerization and that the effect of these 
compounds on normal and ADPKD cells is comparable in regards to actin reduction and 





4.5.5 Influence of cytoskeleton agents on primary cilia number 
 
Finally, the effect of these agents on the number of ciliated cells was studied. A short 
treatment (3 h) with these compounds did not alter the percentage of ciliated cells in normal 
controls (Figure 4.17. a, b). In ADPKD models however, there was a consistent increase in 
ciliated cell number observed with cytochalasin D and the ROCK inhibitor. Cdc42 inhibition 






Figure 4.17    Effect of Rho GTPases in ciliogenesis a, b) No significant change in numbers ciliated cells 
could be detected in normal growth arrested cells after treatment with different compounds of interest. c) In 
ADPKD cystic model, significant increase in numbers ciliated cells could be detected with the Cdc42 or ROCK 
inhibitors and cytochalasin D and to the same degree in the PC1KD model d) but without the Cdc42 effect. 












4.6 Sphingolipids affect ciliary length 
 
Sphingolipids, or glycosylceramides belong to a class of lipids containing a backbone of 
sphingoid bases characterized by an eighteen carbon amino-alcohol complex which is 
synthesized in the ER from nonsphingolipid precursors (Gault et al, 2010).  
The multitude of the different sphingolipid family variants is ultimately based on the 
modifications to this simple basic structure, which confers distinct roles in membrane biology 
and cell regulation. Despite their diversity of function and structure, the regulatory 
mechanism involved in the synthetization and breaking down of sphingolipids follows a 
common synthetic and catabolic pathways. The molecules defined as ceramides are produced 
by the action of ceramide synthases, which induce sphingosine acylation with one of several 
possible acyl CoA molecules. Depending on the produced acyl chain, different variants with 
again specialized functions of ceramides can be synthetized (Kitatani et al, 2008; Gault et al, 
2010). 
 
A pathogenic link between sphingolipid metabolism and ADPKD was recently described 
(Natoli et al, 2010). In particular, glycosphingolipids membrane levels were found to be 
abnormally enriched in cystic cells and increased synthesis of glucosylceramide correlated 
with increased cell proliferation and apoptosis. An important study showed that reduction of 
glucosylceramide by treatment with the SK1 inhibitor Genz-123346 inhibited cystogenesis in 
several mouse PKD models (Natoli et al, 2010). 
Sphingosine kinases (SphK) are conserved lipid kinases and the functional role of the 
cytosolic Sphingosine kinase 1 (SphK1 or SK1) involves its ability to phosphorylate 
sphingosine to sphingosine-1-phosphates (S1P). It has been shown that accumulation of 
intracellular ceramide could be prevented with sphingosine kinase 1 (SK1) by promoting its 
metabolism into S1P (Figure 4.18) (Bruce et al, 2012). Previous studies also showed that 
SK1 activators were associated with increased proliferation and activation of the PI3K/AKT 
pathway (Song et al, 2011), while SK1 inhibition was conversely associated with decreased 
proliferation and PI3K/AKT activation (Kapitonov et al, 2009). Interestingly, a recent study 
hints to a possible role of TORC2 upstream of sphingolipid biosynthesis, on top of its ability 









Figure 4.18   Ceramide-sphingosines    a) Ceramide-sphingosine-sphingosine 1- model. Sphingolipids and 
ceramides are situated in a balance with sphingosine 1-phosphates (S1P) responsible for tissue homeostasis. The 
balance regulates basic cellular functions, aiding to proliferation and cell survival in the presence of abundant 
S1P levels or shifting to proliferation arrest and apoptosis with increasing sphingolipid and ceramide levels. b) 
deNovo synthesis of ceramide occurs in the ER, and represents the metabolic precursor of complex 







To study the role of sphingolipid ceramides in primary cilium development in normal and 
ADPKD models, a range of different Sphingosine kinase 1 (SK) inhibitors (Genz-123346, 
RB005, PF543) and an activator (Compound 5) were tested in our cellular models. PF-543 is 
a SK1 selective inhibitor and RB-005 is a SK1/ceramide synthase inhibitor (MacRitchie et al, 
2016). By blocking both SK1 and ceramide synthase, RB-005 may prevent back-conversion 
of sphingosines to ceramide in the presence of SKI inhibition alone (MacRitchie et al, 2016). 
 
Treatment with SK1 inhibitors lead to an increase in cilia length in normal cells but this effect 
was impaired or absent in the ADPKD models Figure 4.19 (a, b). The strongest effect was 
detected with RB005. Treatment with a SK1 activator (compound 5) slightly decreased cilia 
length in one normal cell line (DSRED), but had no significant effect in the other lines. The 
effect of RB005 was not altered in the presence of taxol or phalloidin suggesting that this was 





Figure 4.19 SK1 inhibitors or activators in normal and PKD primary cilium formation 
a) Effect on primary cilium elongation of SK1 activator: Compound 5. SK1 inhibitors: GENZ, PF-543, RB005 
b) Percentage change in ciliary length between treatments and comparison between normal and PKD models 
c) Representative image and comparison of ciliary length appearance after treatment with SK1 inhibitors/activators in 
normal and PKD cells d) Ceramide cilium regulation and actin/microtubules organization. Stabilizing actin or tubulin 
prior and during ceramide inhibition does not prevent cilium elongation, suggesting an actin and tubulin independent 






4.7     Summary and Discussion  
 
The apparent defect in cilia reorientation in wounding assays (Result Chapter 3.16) 
stimulated further study into the role of the actin cytoskeleton in cilia assembly. Further clues 
came from a study showing that cell spatial confinement appeared to regulate primary cilium 
formation, possibly through cytoskeletal alterations which influenced changes in cell 
geometry, polarity and basal body positioning in human retinal pigment epithelial (RPE1) 
cells (Pitaval et al, 2010). 
 
4.7.1 Actin organisation in normal and ADPKD cells 
 
The main finding of this chapter was that actin depolymerisation using cytochalasin D could 
restore cilia length in ADPKD models. Although the primary cilium does not contain actin, 
there is a sub-apical actin network and a specialised compartment around the cilia base which 
appears essential for normal cilia assembly (Keeling et al, 2016).  
 
A recent siRNA screen to identify proteins that could regulate cilia length identified several 
proteins involved in actin organization such as Gelsolin family proteins gelsolin (GSN) and 
Advillin (AVIL), which regulate cytoskeletal actin organization by severing actin filaments. 
They further showed that inhibition of actin polymerization, via cytochalasin-D treatment 
resulted in cilia elongation and an increased accumulation of a vesicular structure called the 
pre-ciliary compartment (PCC) at the basal body (Kim et al, 2010). The link between 
perturbation of the actin cytoskeleton and cilia length control (Bershteyn et al, 2010; Sharma 
et al, 2011) has been confirmed in several other cell types including hTERT-RPE1, IMCD 
and mouse embryonic fibroblasts (MEFs). These findings suggest that an organised and 
dynamic actin network is essential for accurate basal body docking at the cilia base and for 
correct trafficking of ciliary vesicles for cilia formation (Bershteyn et al, 2010; Hernandez et 
al, 2013; Kim et al, 2010, 2015; Rao et al, 2014; Yan et al, 2013). These structures are likely 
to be transient and highly dynamic as suggested by findings that less than 10% population of 
normal cells had detectable actin near the base of an originating primary cilium (Quarmby et 






In ADPKD cells, the actin network was highly disorganised and showed increased 
polymerisation. These findings suggest that polycystin-1 may function to inhibit actin 
polymerisation or stimulate actin depolymerisation in normal cells. ADPKD cells may 
become more ‘stiff’ or rigid as suggested by studies in RPE-1 cells (Pivatal et al, 2010). A 
recent paper has reported associations between polycystin-1 and actin stabilization through a 
novel polycystin-1-Pacsin 2-N-Wasp complex (Yao et al, 2014). Moreover, the ability of 
polycystin-1 to regulate the actin cytoskeleton, cell migration and microtubule stability has 
been reported with polycystin-1 overexpression in MDCK cells resulting in dynamic actin 
protrusion (Castelli et al, 2007 & 2015). Notably, the effect of cytochalasin D on cilia length 
was independent of cAMP/PKA activation (Chapter 4.3.4), but not of PI3K inhibition. It has 
also been reported that other cystoproteins including polycystin-2/TRPP2 can interact with 
cytoskeletal proteins which may regulate its function (Chen et al, 2008). The exact 
mechanism linking cytoskeletal actin remodelling in controlling ciliogenesis are still not 
clear. However, new studies are uncovering interesting candidates such as actin remodelling 
factors LIMK2 and TESK1 which are part of the YAP/TAZ and directional vesicle trafficking 
mechanism, which on its own have shown to modulate primary cilia dynamics (Kim et al, 
2015). Interesting, in the context of actin organization is the finding that the activity of 
YAP/TAZ was shown to require Rho GTPase and tension of the actin cytoskeleton to 
transduce mechanical signals exerted by ECM rigidity and cell shape, thus suggesting that 
defects in actin organization would result in defective YAP/TAZ function or vice-versa 
(Dupont et al, 2011). 
 
 
4.7.2 The role of microtubules in primary cilium regulation 
 
In this study, microtubule depolymerisation using nocodazole had differential effects on cilia 
length in normal and ADPKD cells. Current models suggest that GTPase activity is induced 
by nocodazole followed by nocodazole-tubulin dimer formation, which prevents addition and 
growth of the tubulin chain (Mejillano, 1996).  
The lack of effect in ADPKD suggested increased microtubule stability or polymerisation 
which was confirmed using a nocodazole resistance assay. The effect of nocodazole was 
completely blocked by taxol confirming the importance of microtubule dynamics for normal 




induced cilia elongation indicating that cAMP effect is independent of microtubule stability. 
Likewise, the nocodazole effect was independent of that of cAMP in normal cells. 
Previous studies have reported short or stunned cilia when katanin, a microtubule-severing 
protein was disrupted in Tetrahymena (Sharma et al, 2007) or defects in cilia formation when 
the activity of CrKinesin-13-a microtubule depolymerizing kinesin was decreased (Piao et al, 
2009). These observations confirm that the ability of microtubules to depolymerize into free 
soluble tubulin is critical for cilia formation. Consequently, in addition to IFT regulation, the 
cell may be able to indirectly influence the ability of primary cilia to elongate or retract by 
controlling the levels of soluble tubulin ultimately needed to build the cilia axoneme. The 
first examples of microtubule and flagella dynamics in the model organism Chlamydomonas 
showed that tubulin levels increased in response to deflagellation or amputation (Silflow et al, 
1981). The increase in microtubule stability in ADPKD cells suggests that similar to actin, 
polycystin-1 may inhibit microtubule polymerisation or stimulate its depolymerisation in 
normal cells. Labelling of polycystin-1 on β-tubulin positive microtubules has been reported 
(Beaulieu et al, 2010) and interestingly, one group has reported that polycystin-1 can decrease 
the stability of microtubules, as well as regulate the organization of the actin cytoskeleton 
(Castelli et al, 2015). Although not examined, it is of interest to note that Ca
2+
 promotes the 
disassembly of microtubules by specifically promoting the catastrophe reaction (O'Brien et 
al, 1997) and directly destabilizing growing microtubule ends without any significant change 
in the detected concentration of free tubulin. Potentially, a lowering of intracellular Ca
2+
 at 
the growing ends could lead to more stable microtubules in ADPKD (O'Brien et al, 1997). 
 
4.7.3    The link between actin and microtubules  
Studies of other ciliopathy proteins have suggested regulation of actin and microtubules as 
critical factors influencing ciliogenesis, For instance, BBS4 localizes to the centriolar 
satellites and basal bodies of primary cilia and is crucial for targeting cargo to the 
pericentriolar region, microtubule anchoring and cell cycle progression (Kim et al, 2004). In 
this study, BBS4 acted as an adaptor of p150 dynactin which then recruited the pericentriolar 
material protein 1 (PCM1) to the centriolar satellites. In mutant cells, PCM1 was 
mislocalized resulting in microtubule disorganization and longer cilia. The Meckel-Gruber 
syndrome (MKS) proteins MKS1 and Meckelin (MKS3) have been showed to regulate 




(Dawe et al, 2009). Reduction of meckelin directly correlated with the ability to reorganize 
actin resulting in defects of centriole/basal body migration and/or docking at the cell 
membrane prior to ciliogenesis (Dawe et al, 2009).  
 
A clear hierarchical regulation of microtubules and actin interaction has proved difficult to 
define although many studies have tried to identify which of these two factors is in control. In 
migration, the actin cytoskeleton is thought to provide the major driving force with protrusion 
of actin structures at the leading edge and by the arrangement and contraction of actin stress 
fibers in the cell body and trailing edge (Etienne-Manneville 2004). Other studies however 
suggest that even in the case of migration, microtubules could be the primary regulators of 
actin dynamics, acting as generators for the protrusion activity at the leading edge. This is 
supported by data showing that the growing plus ends of microtubules can generate enough 
force to deform the cell wall lipid bilayer (Howard & Hyman 2003). In other studies such as 
during intrinsic cell polarization, microtubules and not actin appear to be the key elements 
(Palazzo & Gundersen 2002). In most systems however, the organization of microtubule and 
actin appears to be similarly polarized, and studies suggest that these two polymers must be 
able to interact through some still unknown intermediate proteins or signalling molecules, as 
shown by studies where microtubules were able to participate in actin rearrangements 
(Etienne-Manneville 2004). In addition, RhoGTPases whose main assigned role are as 
regulators of the actin cytoskeleton, are also able to regulate microtubule organization thus 
promoting a coordinated mechanism of these structural elements (Wojnacki et al, 2014). 
Conversely, microtubule modulation has been reported to alter the ratio of Rho GTPase 
activity (Togawa et al, 1999; Etienne-Manneville 2004). 
 
Potential candidates linking actin and microtubules are formins, shown to move within the 
growing ends of actin filaments and which are then able to stabilize microtubules as a means 
of assisting directed steering in cell migration (Chesarone et al, 2010). Another potential 
candidate is tau, a neuronal microtubule-associated protein, which has been shown to bind to 
actin and microtubules simultaneously, resulting in a coordinated extension of both networks. 
Specifically, this coupled mechanism showed actin filaments which polymerised along pre-
established microtubule tracks and single microtubules which grew along actin filament 
bundles (Elie et al, 2015). Alternatively, if we consider the plain mechanical and physical 




microtubules networks limit actin polymerization while actin-rich regions barely contain any 
microtubules during cell migration. Microtubules would then simply be excluded from actin-
rich networks, by a physical steric obstruction of microtubule elongation, and studies 
supporting this show that depolymerisation of actin resulted in elongation of microtubules 
towards the leading edge in migrating cells (Pierini et al, 2002).  
 
In this study, depolymerisation of actin (but not microtubules) was able to normalise cilia 
length in ADPKD cells suggesting that this is likely to be the primary abnormality. However,  
in ADPKD cells taxol partially inhibited the effect of cytochalasin D suggesting that its effect 
in disease may be two-fold i.e. to increase the levels of free tubulin as well as depolymerise 
actin. A previous study in htRPE and IMCD3 cells found that cytochalasin D resulted in an 
increase in the levels of free tubulin which was prevented by taxol pre-treatment (Sharma et 
al, 2011). In our study however, taxol did not prevent cytochalasin D induced cilium 
elongation in normal cells suggesting that the level of free tubulin was not a rate-limiting 
factor under normal conditions. However, since a dense microtubule network could prevent 
normal actin organization (Etienne-Manneville 2004), it seems likely that there is a functional 
interaction between both actin and microtubules in regulating cilia length.  
 
 
4.7.4    Polycystin-1 is involved in cytoskeletal organization 
 
In cell adhesion and migration it was shown that over-expression of polycystin-1 induced 
actin protrusion (Boca et al, 2007; Castelli et al, 2013), while polycystin-1 silenced models 
had less actin and microtubule-based protrusions at the leading edge in wounding assays, 
bigger and more randomly localized focal adhesions and a reduced ability of adherence. The 
authors suggest that focal adhesion kinase (FAK) is a potential target regulated by polycystin-
1 with focal adhesion disassembly positively regulated by polycystin-1 and that the latter also 
regulated microtubule elongation and stabilization (Castelli et al, 2015).  
 
In polycystin-1 over-expressing cells, actin rearrangements were also mediated by the PI-3 
kinase cascade (Castelli et al, 2015) suggesting a critical role of PI3K in polycystin-1 
mediated actin regulation. Other studies have also shown that polycystin-1 is able to interact 
with different GTPases and GTPase-activating proteins, a family of proteins which have been 




including the regulation of the Actin Cytoskeleton via an Arf GTPase-activating protein of 
the centaurin β family named ASAP1 (Randazzo et al, 2000).  
 
 
4.7.5    PI3K is a ciliary length regulator 
 
Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3Ks) are a large family of enzymes 
subcategorized in different classes and involved in a variety of different cellular functions 
(Liu et al, 2009). These enzymes have been shown to have multiple roles in cell behaviour, 
especially in cell migration, cell survival and cell division but also in differentiation, motility, 
and intracellular trafficking (Liu et al, 2009; Franco et al, 2014).  
 
PI3K is activated in response to a variety of growth factors and has long been known to be 
involved in cell migration through regulating the actin cytoskeleton e.g. PDGF-induced 
lamellipodium formation (Wennström et al, 1994). Phosphorylated Akt, which is activated 
downstream of PI3K after PDGF stimulation, can be localized to the leading edge in 
migrating cells, thus providing one of the many hints which seem to highlight the importance 
of this pathway in cell migration (Higuchi et al, 2001). Other studies have shown that that the 
PI3K-Akt signalling pathway is involved in the stabilization of microtubules oriented toward 
the leading edge of wound-edge cells. In addition the PI3K-Akt pathway was suggested to 
stabilize microtubules in migrating fibroblasts which acted as tracks for the transfer of 







Figure 4.20   PI3K pathway  Key function of PI3K is the regulation of a membrane lipid called 
phosphatidylinositol-3,4,5-trisphosphate (PIP3) from its Phosphatidylinositol 4,5-bisphosphate 
precursor (PIP2). PI3K signalling can be activated via different means, such as G protein–coupled 
receptors (GPCRs) or receptor tyrosine kinases (RTKs). The levels of PIP3 are regulated by several 
lipid phosphatases such as Phosphatase and tensin homolog (PTEN). PIP3 is involved in the 
activation of different pathways, most importantly the serine/ threonine kinase Akt (or protein kinase 
B) which results in a variety of PI3K/Akt downstream signalling activation, such as the well-known 






The PI3K pathway is also involved in microtubule dependent membrane transport for 
neuronal growth cone guidance, downstream of Ca
2+ 
which locally acted as axon turning 
potentials in oriented cone growth. Interestingly, PI3K inhibition attenuated microtubule 
advance, while exogenous phosphatidylinositol 3,4,5-trisphosphate (PIP3) had the opposite 
effect in promoting microtubule advance (Akiyama &, Kamiguchi 2010). These studies 
implicate PI3K in directional cell migration and demonstrate the potential importance of 
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 in activating downstream signalling components, 
including Rac-1 GTPases. This in turn activates the polymerization of F-actin and membrane 
protrusion at the leading edge and further activation of PI3K through Rac-1 as a positive 
feedback loop to enhance cell polarity and oriented cell migration (Qing et al, 2012; Kölsch, 
et al, 2008). The link between actin dynamics, the PI3K signalling pathway and migration 
offers an important clue to the specific cell mechanics involved in cell movement and 
orientation.  
 
To our knowledge a detailed role of PI3K in cilia assembly had not been previously examined 
in ADPKD. PI3K inhibition via LY-294002 induced primary cilium elongation in normal 
cells. This effect on cilium elongation was independent of cAMP/PKA and microtubule 
stability but was dependent on actin polymerisation (Figure 4.11-12).  
 
Surprisingly, PI3K inhibition had no effect in ADPKD models. The effect of the latter in 
normal cells is therefore likely to be via actin depolymerisation whereas the effect of 
PGE2/cAMP may be via stimulating anterograde IFT velocity (Jin et al, 2014). While cAMP 
had similar effects in control and ADPKD cells, the lack of effect of PI3K inhibition in the 
latter was surprising given that PI3K inhibition could inhibit cilia disassembly in response to 
serum similarly in starved control and disease cells (Figure 4.10). One explanation could be 
that there is mislocalisation of a distinct PI3K isoform (PI3K Class II α) from the basal body 
or pre-cilia compartment in disease that specifically regulates cilia assembly (Franco et al, 
2014). Alternatively, there could be a disconnection between PI3K and its downstream 
effectors acting on actin to stabilise cilia formation. These possibilities need to be tested in 















Figure 4.21  Rho GTPase regulation The activation cycle of Rho-GTPases at the plasma membrane, 
is regulated by GEFs that promote GTP loading resulting in activation of Rho-GTPases as an active 
effector involved in the activation of different downstream effectors. The inactivation of Rho-
GTPases is mediated by GAPs by GTP hydrolysis to GDP. Rho-GTPases are deactivated via Rho-
GDP dissociation inhibitors (Rho-GDIs) which transport and seclude inactive GDP-bound Rho-










The downstream effect of cytochalasin D was studied using selective Rho GTPase inhibitors. 
Although inhibition of all three major effectors (Rac-1, ROCK, Cdc42) resulted in increased 
cilia length, the most selective effect for ADPKD cells was seen with ROCK inhibition which 
restored cilia length (Figure 4.14). The link between Rho GTPase expression or activation in 
vivo with renal cyst formation and reduced cilia length or number is supported by previous 
reports from mouse mutants. 
 
First, a mouse Rho GDIα mutant was found to develop various degrees of cystic distal and 
collecting renal tubular dilatation (Togawa et al, 1999). Rho GDIs bind to and interact with 
variety of Rho family members, including RhoA, Rac-1 and cdc42 (Tapon et al, 1997) 
keeping them in the GDP-bound inactive state; thus mutation would result in Rho activation. 
In this model, cilia were not examined. 
 
A second study reported that a mouse mutant p190A RhoGAP (Arhgap35) developed 
glomerular cysts, accompanied by a drastic reduction of ciliated cells and average ciliary 
length in the proximal tubules. Loss of this GAP led to persistent activation of Rac-1 and 
ROCK. Of relevance, ciliogenesis in Rho GTPase Activating Protein 35 (Arhgap35) mutant 
cells could be rescued by inhibition of Rac1 or ROCK1/2 suggesting a direct pathogenic link 
between ciliogenesis and Rho activation (Stewart
 
et al, 2016).  
 
Finally, kidney-specific inactivation of Cdc42 in mice using a specific Cre recombinase 
(Ksp-Cre) resulted in the development of cysts in distal tubules and collecting ducts with 
associated ciliary defects, increased tubular cell proliferation and apoptosis (Choi et al, 2013). 
Here, the loss of Cdc42 rather than its increased activation resulted in structural cilia 
abnormalities and cyst formation. Although cilia were described as ‘disordered’ in cyst areas, 
surprisingly changes in length were not detected. Conversely, it has been shown that pre-
cystic kidneys have high up-regulation of Cdc42 protein levels, suggesting that it is 










4.7.7  Sphingolipids (ceramides) and primary cilium formation 
 
A possible role in lipid signaling in the pathogenesis of ADPKD was first reported several 
decades ago, linking ceramide lipids with altered signalling role in PKD epithelial cells 
(Deshmukh et al, 1994). 
 
Ceramides are molecules present in the lipid cell membrane of cells and are a mixed 
composite of sphingosine and fatty acids. A ceramide synthesis and deriving complex 
sphingolipid model is shown in the diagram (Figure 4.18 b) Pioneering studies on 
sphingolipids showed that they could be divided into two main categories, the family of 
ceramide sphingoid bases, which are involved in modulation of protein kinases and 
phosphatases, ion transporters, and signal transduction processes and the family of complex 
sphingolipids defined by an carbohydrate or phosphor-choline head group which interact with 
the extracellular matrix and growth factor receptors (Spiegel et al, 1996). Recent studies 
suggest that glycosphingolipids levels are abnormally enriched in cystic cell membranes and 
that increased synthesis of glucosylceramide correlated with increased cell proliferation and 
apoptosis (Natoli et al, 2010). Glucosylceramide and ganglioside GM3 levels were markedly 
increased in PKD tissues from human and several mouse models independent of the causative 
mutation. Importantly, the authors showed that treatment with the SK1 inhibitor Genz-
123346 inhibited cystogenesis in Pkd1, jck and pcy mice (Natoli et al, 2010). The effects on 
primary cilia were not examined in this study. 
In this study, a striking difference between normal and disease cells on cilia length following 
inhibition of Sphingosine-1-phosphate synthesis using SK1 inhibitors was observed. In 
normal cells, the effect on cilia length was independent of actin and microtubule 
polymerization (Figure 4.19). A previous study reported that ceramide is required for 
ciliogenesis and was co-localized to centrosomes with Cdc42 and atypical protein kinase 
Cζ/λ (aPKC) (Wang et al, 2009; He et al, 2012). The increased effect of RB-005 that we 
observed in normal cells may imply that apart from ceramide, sphingosines could be 
important mediators of cilia length. The lack of effect with the SK1 inhibitors on cilia length 
in disease cells was unexpected but is similar to the lack of effect of PI3K inhibitors observed 
in the same assay. These negative results could indicate that the pericentriolar recycling 







 There was significant disorganisation of the actin cytoskeleton in ADPKD models. 
 Actin depolymerisation (cytochalasin D) restored cilia length in ADPKD models to 
control levels. 
 Microtubule polymerisation and stability was increased in ADPKD models compared 
to control cells. 
 Microtubule modulation depolymerisation (nocodazole) increased ciliary length only 
in normal, but not ADPKD models. 
 Microtubule/actin depolymerisation dependent cilium elongation was independent of 
cAMP or PKA activation. 
 PI3K inhibition reduced cilia disassembly in response to serum reintroduction 
similarly in serum starved control and ADPKD models 
 PI3K inhibition increased cilia length in control but not ADPKD cells. This effect was 
independent of cAMP and microtubule depolymerisation. 
 Rac-1, ROCK and Cdc42 inhibition causes primary cilium elongation in normal and 
ADPKD cells to different degrees. 
 The effect of ROCK inhibition in ADPKD cells was independent of microtubule 
polymerisation but not of PI3K activation. 
 The effect of cdc42 inhibition was dependent on both microtubule and actin 
depolymerisation. 
 There was an increase in the number of ciliated cells in the ADPKD models with 
cytochalasin D and ROCK inhibitors. 
 Inhibition of sphingosine kinase 1 increased cilia length in normal but not ADPKD 
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5.1  Introduction 
 
In this chapter, the potential role of two ciliary proteins in primary cilium regulation was 
studied. Preliminary studies in our laboratory (unpublished) had identified INPP5E and 
NPHP3 as potential binding partners of polycystin-1 and polycystin-2 respectively. Both 
these proteins have been identified as playing roles in regulating primary cilia structure and 
function (Jacoby et al,  2009; Zhou et al, 2010). 
 
5.1.1  Inositol-polyphosphate 5-phosphatase (INPP5E) 
 
The first part of the study was concentrated on the interacting partners of the polycystin-1 
protein. Because of the difficulties associated with the study of full-length polycystin-1 in 
biochemical assays, the study was concentrated on the intracellular domain of polycystin-1 
called PLAT (polycystin lipoxygenase α-toxin). Previously, the PLAT domain has been 
shown in our laboratory to be able to bind lipids (Xu et al, 2015). 
 
PLAT is the abbreviation for an evolutionary conserved polycystin/lipoxygenase/α-toxin 
domain found in all Polycystin-1 family members and in some lipid-associated proteins. It is 
suggested that this domain, which is located in the first cytoplasmic loop between TM1 and 
TM2 of PC-1, is involved in protein or membrane protein interactions (Bateman and 
Sandford 1999) and that its primary role might be as an evolutionary conserved mediator of 




A potential interacting candidate of the PLAT domain based on its ability to bind lipids (Xu, 
et al, 2015), is the lipid phosphatase, inositol polyphosphate 5-phosphatase, INPP5E. 
Preliminary work in our laboratory showed that the Polycystin-1 was able to bind to 
phosphoinositol (PI-4P) and the lipid kinase PI-4P-5Kinase via PLAT domain possibly acting 
as a protein scaffold involved in the regulation of PIP2 and PIP3 synthesis. INPP5E has been 
localized to the primary cilium and plays a critical role in the conversion of phosphatidyl-
inositol-4,5-bisphosphate [PI(4,5)P2] to PI4P regulating PIP2 and PIP3 levels. A potential 




signalling pathway had been shown to be involved in primary cilium stability and cell 
proliferation in recent studies (Jacoby et al, 2009; Garcia-Gonzalo et al,  2015). The INPP5E 
gene on human chromosome 9q34.3 encodes for a 72kDa protein (Jacoby et al, 2009). Inpp5e 
mutant mice developed several ciliopathy phenotypes such as renal cysts, defects in neural 
tube closure and developmental problems including absence of eyes and polydactyly (Jacoby 
et al, 2009).   
 
5.1.2  NPHPs, Gatekeepers of the ciliary compartment 
 
The contribution of polycystin-2 to ADPKD is obvious but another important function of this 
protein is in left-right axis determination (Pennekamp et al, 2002). Polycystin-2 and a number 
of other cystoproteins are associated both with the formation of kidney cysts and laterality 
defects when disrupted in the mouse models. Two examples of these proteins are the 
nephrocystins (NPHP), NPHP2 or Inversin (INVS) (Otto et al, 2003) and NPHP3 (Olbrich et 
al, 2003). 
 
The nephrocystins are mutated in Nephronophthisis (NPHP), an autosomal recessive kidney 
disease and one of the most frequent genetic causes of end-stage renal disease up to the third 
decade of life. Today more than 20 genes have been identified (Wolf 2015), which are 
involved in a wide variety of cellular processes. Recent studies have suggested that most of 
the nephrocystins localize to the primary cilium or centrosomes. These observations have lent 
support to a common ciliary hypothesis of cyst formation (Wolf et al, 2005; Jauregui et al, 
2008). The current view is that many of the NPHP proteins act as gatekeepers of the ciliary 
compartment and as such are able to control the influx or aid the transition of proteins from 
the cellular compartment to the primary cilium.  
 
In the case of NPHP2 (INVS), NPHP3 and NPHP9 (NEK8), it has been demonstrated that 
these proteins localized to the proximal cilia shaft in ciliated cells – the so-called ‘Invs 
compartment’ (Wolf et al, 2010). Recently, another cystoprotein named ANKS6 has been 
shown to interact with NPHP3, INVS and NPHP9 and co-localize to this region (Hoff et al, 
2013). This localization is determined specifically by INVS, which may function to anchor 
the complex to this compartment (Shiba et al, 2010). Interestingly, another paper has linked 




decreased expression of polycystin-1 and 2 in cultured fibroblasts (Frank et al, 2013), 
suggesting that NPHP9 could be important for normal polycystin function or localization. In 
this context, nphp9 mutations were shown to cause juvenile cystic kidney (jck) disease in a 
mouse model (Liu et al, 2002). Another study pointed out, that the appearance of renal cysts, 
laterality defects and the defective response to fluid shear and reduced calcium response to 
flow in the Nek8-null phenotype strongly resembled that of the polycystin-2-null mice, 
suggesting a strong functional link between these two proteins. Interestingly, this study found 
aberrant phosphorylation of polycystin-2 in jck mice beside the ability of polycystin-2 to co-
immunoprecipitate both w.t. and disease Nphp9 (Sohara et al, 2008). In the same study, 
ciliogenesis was reported to be normal in nphp9-null kidney cells, suggesting that a loss of 
polycystin-2 cilia localization might be the primary defect (Manning et al, 2013). 
 
A MS analysis of the polycystin-2 interactome in our laboratory using a stable MDCK cell 
line expressing epitope-tagged polycystin-2 identified NPHP3 as a potential interacting 
partner. This study tested the hypothesis that NPHP3 interacts with polycystin-2 and in a 





5.2.1 INPP5E binds to polycystin-1 PLAT domain 
 
To investigate a possible interaction between these two proteins, HA-tagged INPP5E and 
YFP-tagged PLAT domain were co-expressed in HEK cells followed by co-
immunoprecipitation with specific HA and YFP epitope tag antibodies. Controls in this study 
were a positive control GFP and a negative control empty vector PCDNA3.  
The epitope-tagged INPP5E and PLAT proteins were pulled down and detected by 
immunoblotting with rat HA and mouse GFP antibody respectively. The pull down 
experiment showed that HA-INPP5E (78kDa) was able to co-immunoprecipitate with YFP-
PLAT (42kDa) in both directions (Figure 5.1A). 
 
Next, a FLAG tagged polycystin-1 construct (PC1-FLAG) was used to confirm the 




length polycystin-1 (460kDa) and INPP5E (78kDa) were shown to co-immunoprecipitate.  
 
The interaction capability of INPP5E with several PLAT mutants was next tested. These 
mutations included a PKD1 patient mutation YFP-PLAT (R3162C) and two mutants created 
in our laboratory. The YFP-PLAT (S3164A) phosphodefective mutant prevents 
phosphorylation by endogenous PKA at serine 3164 and a phosphomimetic YFP-PLAT 
(S3164D) mutant. This residue at Ser3164 has been shown to be phosphorylated by PKA, a 
cAMP activated protein kinase (Xu et al, 2015). The consensus binding domain for PKA at 
S3164 includes the residue R3162 which has been shown to be a pathogenic mutation 
(R3162>C) giving rise to ADPKD, highlighting the functional significance of 
phosphorylation at this site. Work in our laboratory showed that this phosphorylation site 
might be important in regulating trafficking of PLAT to the plasma membrane. YFP-PLAT 
was able to localize to the plasma membrane, while the S3164D mutation was characterized 
by a complete loss of surface localization. However, none of these mutations affected the 
interaction between these two proteins in vitro (Figure 5.2). 
 
In conclusion, the study showed that INPP5E was able to interact with polycystin-1, 
specifically through the PLAT intracellular domain, suggesting that this interaction might 










Figure 5.1  PLAT/INPP5E interaction: A) I.P GFP: Blot HA shows co-immunoprecipitation of 
INPP5E-HA protein which can be detected as a band at 78 KDa (Predicted Molecular Weight of 
INPP5E 72 kDa). I.P HA: Blot HA shows direct pull down of INPP5E-HA appearing at 80 KDa. 
Controls (INPP5E-HA + PCDNA3), (GFP + INPP5E-HA). I.P GFP: Blot GFP shows direct pull 
down of YFP-PLAT appearing at 42KDa. I.P HA: Blot Mouse GFP shows coimmunoprecipitation of 
YFP-PLAT which can be detected at 44 KDa. B) PC1 I.P: Blot FLAG shows direct pull down of 
PC1-FLAG. Blot HA shows co-immunoprecipitation of INPP5E-HA protein which can be detected as 
a band at 78 KDa (Predicted Molecular Weight of INPP5E 72 kDa).C) Generation and verification of 







Figure 5.2  PLAT Mutants/INPP5E interaction: a) I.P with rabbit GFP isolates YFP-PLAT protein 
complexes, blot with Rat HA shows INPP5E-HA Co-Immunoprecipitation in YFP-PLAT and YFP-PLAT 
(S3164A, S3164D, R3162C) mutants. b) Direct I.P with Rabbit HA and blot with Rat HA shows pull down of 
INPP5E. c) I was able to directly I.P with rabbit GFP and detect YFP-PLAT and YFP-PLAT Mutants via Mouse 
GFP blot. d) I.P via Rabbit HA isolates INPP5E-HA protein complexes, blot with mouse GFP shows YFP-PLAT 









5.2.2 INPP5E localization in normal and ADPKD cells  
 
In view of the interaction between INPP5E and polycystin-1, the hypothesis that INPP5E 
cilia localization was altered in polycystin-1 deficient cells was next tested. 
 
The INPP5E antibody used in this study was an anti-mouse Inpp5e antibody (Jacoby et al, 
2009). Sequence alignment showed that this antibody was able to detect INPP5E specifically 
in mouse kidney cells and probably canine kidney cells.  
 
INPP5E was shown to localize to the primary cilium of different normal mouse cell lines and 
MDCKII, as shown in (Figure 5.3). INPP5E was detected along the cilia of IMCD3 and 
polycystin-1 knocked down IMCD3 (Figure 5.3 a) which showed significant reduction of 
expressed polycystin-1 (Figure 5.3 b). INPP5E appeared to localize uniquely to the primary 
cilium in growth arrested IMCD3, and this localization was not impaired in polycystin-1 
knock down cells. Similar results were confirmed in the MEK PC1 null cells and the WT 
control lines, with uniform co-localization of INPP5E staining with the α-acetylated tubulin 
at the primary cilia (Figure 5.3 c). An interesting observation showed that a distinct small 
percentage around 10% of primary cilia was characterized by a non-uniform Inpp5e 
localization to the primary cilium in different models, which concentrated predominantly at 
the ciliary base or was not able to fully extent to the ciliary tip. In addition in extensive 
elongated cilia such as in MDCKII, some degree of INPP5E localization extends towards the 








Figure 5.3  INPP5E localization in different cell lines. INPP5E staining (green) localize to primary cilia 
stained with α-Tub (Red) a) w.t and PC1 KD IMCD3. b) Blot showing expression of PC1 in KD IMCD3 cells. 
INPP5E (Green), α-Tub (Red). c) w.t and PC1 null MEK cells and MDCKII cells. 
d) Localization of Inpp5e to the cilium is limited to the proximal region in a reduced number of cells.  





5.2.3 INPP5E siRNA reduces ciliary length 
 
In the previous chapters, it was shown that polycystin-1 deficiency appeared to be associated 
with a defect in primary cilium formation rather than cilium stability. For this purpose, a 
specific siRNA against mouse INPP5E was used to analyse the effect of INPP5E knock 
down in two baseline mouse models, IMCD3 and NIH3T3. 
 
Treatment with INPP5E siRNA at 10 and 50 µM concentrations significantly decreased 
INPP5E expression in mouse IMCD3 cells by qPCR with a fold change in INPP5E mRNA of 
0.5 (Figure 5.4 a, b). Interestingly, INPP5E knockdown was associated with a significant 













Figure 5.4 INPP5E siRNA treatment and ciliary length. a) INPP5E expression in CT and fold change after 
siRNA treatment at different concentrations. b) Representative image of INPP5E reduction after siRNA 
treatment under fluorescent microscopy analysis. c) Length of primary cilia after treatment with INPP5E siRNA 
at different concentrations in IMCD3 and NIH3T3 and scrambled control. Antibody used: primary cilia 




5.3 Polycystin-2 interacts with NPHPs 
 
5.3.1  Polycystin-2 interacts with NPHP3 and NPHP9 
 
Since NPHP3 and NPHP9 are known to interact (Frank et al, 2013), this was confirmed first 
by co-expression in HEK293 cells followed by co-immunoprecipitation (Figure 5.5 A). 
Interestingly, the NPHP3 protein appeared to have a stronger ability to co-immunoprecipitate 
the NPHP9 than the reverse.  
 
Next, the ability of polycystin-2 to interact with both NPHP proteins was tested. For these 
experiments, the FLAG tagged NPHP proteins were used and tested for their co-
immunoprecipitation ability of PKTAG tagged polycystin-2 (PC2-PKTAG) (Figure 5.5 B). 
Blotting for PKTAG or a polycystin-2 antibody (G20) showed a possible interaction although 
binding was weak in this direction. A reverse IP using a HA tagged polycystin-2 construct 
however showed a stronger interaction (Figure 5.6).  
 
 
5.3.2 NPHP2/INVS binds to the polycystin-2/nephrocystins complex 
 
To study a potential interaction between inversin and polycystin-2, co-immunoprecipitation 
of GFP tagged INVS and HA tagged polycystin-2 constructs were used. Pull-down of HA-
PC2 using HA affinity beads or HA antibody showed that INVS-GFP could be detected. 
(Figure 5.7 a, b). The reverse pull down with INVS-GFP protein resulted in co-







Figure 5.5 A) NPHP3/NPHP9 interaction FLAG tagged NPHP3 and NPHP9, PKTAG Tagged NPHP3 and 
NPHP9, NPHP3 (148 KDa), NPHP9 (74.9 kDa). NPHP3 pulls down NPHP9 and reversely NPHP9 pulls down 
NPHP3, suggesting that this two proteins interact B) NPHP3/NPHP9 and PC2 interaction. NPHPs pulls down 
Polycystin-2. NPHP3 and NPHP9 were able to immune-precipitate PC2 and be detected with two different 





Figure 5.6 Polycystin 2 pulls down both NPHP3 and NPHP9. Polycystin-2 immuno-precipitates NPHP3 and 
NPHP9 at comparable levels. Representative experiments of 3 repeats. 
 
 
Figure 5.7   INVS/PC2 interaction A) HA Beads affinity beads were used to pull down INVS-GFP which was 
detected as a co-immunoprecipitate band at the correct molecular weight via GFP blot. B) Standard 
immunoprecipitation was used to confirm that INVS-GFP co-immunoprecipitated with polycystin-2 protein. C) 
In reverse, pull down of INVS results in co-immunoprecipitation of polycystin-2 detected at the correct 
molecular weight marker via HA blot. PC2 (HA) = 110 kDa, INVS (GFP) = 117 kDa. Representative 








5.3.3 Localization of cystoproteins to the primary cilium 
 
 
Of the NPHP proteins in our study, NPHP2/Inversin retains the most important role of the 
entire complex, by possibly overseeing and localizing various parts of the complex to the 
correct cellular compartment (Shiba et al, 2010). Thus, the requirement of NPHP2 for the 
correct localization of endogenous polycystin-2 to the primary cilium was tested. Preliminary 
experiments showed that polycystin-2 could be detected at the primary cilium (Figure 5.8 A). 
Next, all our cell lines were tested for polycystin-2 localization (G20) in combination with 
the ciliary protein ARL13b. The results show that polycystin-2 can be detected almost 
uniformly along the entire length of the primary cilium in all normal cells as previously 
reported (Pazour et al, 2002). However, no difference was detected in polycystin-1 defective 
cell lines, though ciliary polycystin-2 localization in normal cells appeared to be increased 
towards the ciliary tip (Figure 5.8 A-C). The specificity of these findings was confirmed by 










Figure 5.8 A-D (left) Endogenous polyscytin-2 localization study in primary cilia. Representative images of 
co-localization of polycystin-2 via G20 (Red) antibody with the ciliary antibody ARL13b in (green) growth 
arrested normal and ADPKD cell lines. A (right) G20 on its own stains the primary cilium.  A-D (right) Control 







Figure 5.9   INVS in primary cilia   A) Representative images of INVS localization to primary cilia in normal and ADPKD 
models via transfection of INVS-GFP construct for INVS detection and endogenous G20 antibody for polycystin-2.  
B) Control, INVS GFP detection alone. C) INVS expression CT and fold change after siRNA treatment at different 
concentrations. D) Representative images of polycystin-2 localization to primary cilia after knock down for Inversin via 











Figure 5.10  INVS and primary cilium regulation Primary cilium length measurement in normal 
(UCL93/PTEC DSRED) and ADPKD models (OX161/ PTEC PC1KD) after reduction of INVS via 














Following the identification of an interaction complex between INVS and polycystin-2, the 
importance of this interaction for cilia localization of polycystin-2 was examined. 
 
Over-expression of INVS-GFP in normal and PKD models showed accumulation of INVS 
protein along the entire length of the primary cilium in normal cells, but surprisingly this 
localization was impaired in the ADPKD cells (Figure 5.9 A).  
 
To study the localization of polycystin-2 in Inversin deficient models, expression of INVS 
was reduced using INV-siRNA. Treatment with INVS siRNA at 10 and 50 µM 
concentrations significantly decreased INVS mRNA expression in human UCL93 cells 
(Figure 5.9 C). In normal cells, the cilia localization of polycystin-2 was significantly 
reduced (Figure 5.9 D). A non-significant trend was also observed in ADPKD cells (Figure 
5.9 E). Cilia length was not significantly reduced by INVS knockdown in normal and PKD 








In this study, a number of candidate cystoproteins involved in primary cilium regulation were 
analysed for their ability to interact with polycystin-1 or polycystin-2 and tested for their 
effect on cilia length and polycystin-2 cilia localisation. 
 
5.4.1 INPP5E interacts with the PLAT domain of polycystin-1 
 
In recent years, research has focused on the role of different enzymes involved in lipid 
signalling associated with possible roles in the ciliopathies. INPP5E is one of the most 
investigated and its main pathogenic role has been associated with Joubert syndrome. 
Although rare, it is possible that the function of this enzyme may shed light on ADPKD 
pathogenesis due to a common cilia pathway. Defects in INPP5E have been shown to lead to 
a variety of ciliopathy related features such as polydactyly, retinitis pigmentosa, cerebellar 
changes and renal cysts (Jacoby et al, 2009; Luo et al, 2012). INPP5E is widely expressed in 
the cytosol and accumulates at the perinuclear/TGN via its N-terminal proline rich domain 
(Kong et al, 2000) while in non-proliferating cells, it has been localized to the primary cilium 
possibly via an N-terminal CAAX motif (Jacoby et al, 2009). INPP5E is shown to 
specifically inactivate PI(4,5)P2, (PIP2) and at higher rates PI(3,4,5)P3 (PIP3) by hydrolysis, 
showing no activity towards soluble inositol phosphates compared with other phospoinositide 
5 -phosphatase family members (Kisseleva et al, 2000;  Kong et al, 2000). These two types of 
membrane phospholipids play a crucial role in a variety of key cellular processes including 
primary and second messenger signalling, membrane trafficking and regulation of proteins 
involved in phospholipid metabolism. Growth factor stimulation directly activates the 
PI3K/AKT/mTOR pathway via PIP3 synthesis generated by phosphorylation of PIP2 
(Lieberthal and Levine 2009). PI3K/AKT/mTOR pathway starts at the plasma membrane via 
external growth factor stimulation. Usually, the binding of the growth factor causes 
phosphorylation of the intracellular region of the receptor which will now be able to bind 
PI3K. Subsequently PI3K shifts to the PIP2 protein on the membrane which is 
phosphorylated to generate the second messenger PIP3. PIP3 will then activate Akt which 




growth or apoptosis. Both PIP2 and PIP3 are most likely connected to pathways that inhibit 
PI3K activation (Lieberthal and Levine 2009) and so responses to growth factor stimulation. 
It is suggested that INPP5E inactivation of PIP cause inhibition of Akt phosphorylation by 
platelet-derived growth factor (PDGF) and insulin-like growth factor-1 (IGF-1) stimulation 
resulting in the sensitization of cells to Fas induced apoptosis (Kisseleva et al, 2002). 
 
Previous studies have shown an involvement of the INPP5E protein in primary cilium 
regulation, but this study shows for the first time a potential link to polycystin-1 through the 
intracellular PLAT domain. A cilia localisation for INPP5E was confirmed but showed that it 
does not change in the absence of polycystin-1. INPP5E knockdown however resulted in 
shorter cilia in both normal and ADPKD cells. In the original study by Jacoby et al, INPP5E 
inactivation did not prevent the formation of normal primary cilia, but rather affected the rate 
of cilium disassembly after serum reintroduction. Ciliary stability was restored by either 
PI3K or PDGF-R alpha blockade suggesting a clear involvement of INPP5E as a controller of 
the PDGF/PDGF-R/ PI3K kinase signalling pathway, primary cilium stability and cell 
proliferation (Jacoby et al, 2009). However, a recent study challenges these results, showing 
that INPP5E was also associated with shortened and decreased cilia formation in zebrafish 
(Luo et al, 2012).  
 
 
5.4.2 NPHP2, 3 and 9 form a complex with polycystin-2  
 
In this study, it was shown that NPHP3 and NPHP9 are able to interact with each other and 
that both interact with polycystin-2 to different degrees. NPHP3 appeared to bind more 
strongly to polycystin-2 than NPHP9 suggesting a possible direct interaction. To my 
knowledge, an interaction between INVS and polycystin-2 was also shown for the first time. 
Other groups have shown that INVS has a controlling role over many nephrocystins (Fukui et 
al, 2012) and may act as a molecular anchor for the NPHP3/ NPHP9 complex and possibly 
others at the cilium base (Dai Shiba et al, 2010). Together, the nephrocystins are thought to 
act as gatekeepers for different ciliary proteins (Omran et al, 2010). Results from this suggest 
that the function/or trafficking of polycystin-2 in or out of the cilium could be influenced by 






Although some studies had suggested that the nphp9 mouse mutant (Nek8 Null) had a more 
similar phenotype to polycystin-2 than Inversin Null phenotypes, it was also shown that Nek8 
reduction did not correlate to a failed expression or localization and Ca
2+
 channel function of 
polycystin-2 in tissues and cells (Manning et al, 2013). Thus NPHP9 might be involved 
indirectly in regulating polycystin-2 function through other proteins such as the 
transcriptional regulator TAZ which binds to NPHP9 and has shown to promote the stability 
of the polycystin-2 protein via direct binding to its C-terminal domain (Habbig et al, 2012; 








Figure 5.11  Polycystin-2/NPHP complex.  Schematic representation of the theorized arrangement of the 
polycystin-2/NPHP complex at the base of the cilium. Polycystin-2 in the primary cilium is involved in different 
functions including cell cycle regulation and homeostasis. The trafficking in and out of the cilium is regulated at 
the INVS compartment at the base of the cilium, where the INVS protein forms anchors different cystoproteins 







5.4.3 INVS siRNA influences polycystin-2 localization 
 
Treatment of normal cells with INVS siRNA resulted in a reduction in ciliary polycystin-2 
localization, suggesting that INVS could be regulating its cilia localization, one of the 
hypotheses of this study. Further studies will have to be performed in additional cell lines to 
confirm this finding. There was also a trend towards ciliary length reduction in reduced INVS 
samples, which did not however reach statistical significance except in one line. Variability in 
the efficiency of knockdown could have led to the biological variability. Of interest, a 
previous report showed that Inversin was able to modulate the cortical actin network during 
mitosis (Werner et al, 2013). In this study, Inversin was required for proper spindle 
positioning and resulted in an increase of multinucleated cells; notably, Inversin knockdown 
also resulted in extensive filopodia (actin-based) formation in human HeLa or HEK-293 cells 
(Werner et al, 2013). An effect on the cortical actin network could imply a role for INVS in 









 INPP5E was able to bind to the polycystin-1 PLAT domain. 
 INPP5E was localized to the primary cilium in both normal and ADPKD cells. 
 Knockdown of INPP5E reduced ciliary length. 
 Polycystin-2 interacts with NPHP3, NPHP9 and NPHP2/INV. 
 NPHP2/INVS knockdown reduced polycystin-2 cilia localization without a consistent 



























The pathogenesis of ADPKD is associated with germ line mutations in PKD1 or PKD2. 
However, the molecular basis that leads to cyst formation remains elusive. The localisation of 
polycystin-1 and polycystin-2 to primary cilia and their putative role as a flow-activated 
mechanosensory receptor-cilia channel complex has been the dominant hypothesis over the 
past decade, although recent results have cast doubt on this idea. In this study, the potential 
role of the polycystins in regulating the dynamics of primary cilia assembly were examined. 
Two consistent characteristics were identified in ADPKD cells when compared to normal 
cells. First, defects in primary cilia formation with a lower number of ciliated cells and a 
shorter average primary cilium length and secondly, structural alterations in actin 
polymerisation and organization. Treatment with actin depolymerizing compounds was able 
to rescue cilia length, suggesting that the changes in actin prevent normal cilium development 
in ADPKD cells. Previous studies have shown that polycystin-1 may play a key role in actin 
remodelling, a conclusion confirmed by these results.  
The incomplete or defective primary cilium formation in ADPKD models tested in this study 
was remarkable discovery. The development of functional primary cilia seems to be a 
conserved and essential feature of many cells and accordingly, partial or even complete loss 
of primary cilia development is shown to ultimately facilitate the growth of hyperplastic 
epithelia in various organs, including liver, kidney and pancreas as a result of failure to detect 
flow through the tubules of these organs (Moyer, et al 1994). This leads to a diverse spectrum 
of clinical phenotypes characterized by cystic dilatation of renal tubules as found in ADPKD 
(Zalli, et al 2012).  
A fully formed functional primary cilium could be a needed requirement for both, 
proliferation control and maintenance of planar cell polarity, which are important in the 
regulation of tubular diameter in the nephron. Studies on a PKD mouse model support this, 
showing that wound healing following acute kidney injury modulated cilia length and 
modulated cell cycle processes. Conversely, the removal of normal cilium surveillance 
mechanisms promoted the uncontrolled proliferation of cells and ultimately increased the 
overall cystogenic potential and expansion of cysts (Happe, et al 2009; Patel, et al 2009; 
Verghese, et al 2008 & 2009). The primary cilium in kidney epithelial cells might be required 




enduring tissue homeostasis, while alterations of this balance would gradually shift this 
homeostasis in an inability to inhibit growth.  
The original cilia hypothesis suggested that the ciliary polycystin-1/2 complex acted to 
regulate flow-activated Ca
2+
 entry upon primary cilium bending in the apical lumen of renal 
epithelial cells (Nauli et al, 2003). However, this model has recently been challenged by 
evidence that cilia bending did not elicit a rapid Ca
2+
 response (Delling et al, 2016). These 
new insights indicate that the function of the cilia polycystin-1/2 complex remains 
unresolved. It is possible that the polycystins might have other mechanosensitive polycystin-2 
independent roles in cilia or even mechanosensory roles in other cell substructures, including 
cell junctions with relevant roles in cytoskeletal organization (Bhoonderowa et al, 2016). Our 
study showed that deficiency in polycystin-1 affected the organization of actin structures and 
the primary cilium orientation capability during migration, supporting a primary role in 
directing cytoskeletal organization and cellular morphology and resulting functions such as 
directional migration, orientated cell division and proper cilia formation.  
This study supports that the two major elements of the cytoskeleton, actin and tubulin are 
able to influence primary cilium formation. Normal actin and microtubule organization 
ability could represent the basic matrix upon which a smooth dynamic regulation of primary 
cilium and its signals is possible.  
Disorganization or stabilization of one of these two processes is then likely to result in a 
defected or impaired extension or maintenance of the primary cilium as supported by studies 
which suggested that the elongation of cilia caused by actin depolymerisation excreted its 
effect on vesicular structures around a vesicle docking site named PCC which functions as a 
temporary reservoir for ciliary membrane and associated proteins, and that destabilization of 
this site resulted in an increased membrane transport into the cilium (Kim et al, 2004 2010).  
So far not only cystoproteins have been found to interact with several cytoskeletal 
components (Chen, et al 2008) but also many promising candidates for the mediation of 
structural interactions between microtubules and actin filament have been identified in 
mammalian cells (Mandato et al 2003). Although further investigation is needed to elucidate 
all the mechanisms and effectors of these interactions, it is reasonable to assume that any of 
the cystoproteins involved in ADPKD or its effectors might directly or directly be involved in 
tubulin/actin interaction, thus worth a detailed investigation in future work. 
A large genomic screen strongly supports a coupling between the actin cytoskeleton and cilia 




ADPKD cells of actin depolymerizing agents. It is possible that increased actin 
polymerization or simple disorganization in ADPKD cells could affect normal primary cilia 
development, with nodes and lumps of entangled actin filaments preventing normal 
organization of the cytoskeletal matrix. Drastic treatments with acting depolymerizing agents, 
which aim to release these entangled structures and restore normal cytostructural mechanism, 
could be responsible for restoring maximum primary cilia elongation to levels seen in the 
normal cells. Actin structural analysis performed in this study showed that the primary cilia 
itself are actin free organelle, suggests that the actin modulatory effects on primary cilium 
length modulation are indirectly governed from within the cell, probably in structures near 
the primary cilia like the basal bodies. The growing number of reports underlining the 
influence of filamentous versus soluble actin in ciliogenesis plus the ability of the actin 
cytoskeleton as some studies suggest to directly regulate and promote the correct docking of 
the basal bodies at the base of the cilium, enabling in the first place the normal trafficking of 
ciliary vesicles, offers a valuable target for a more precise cellular localization of possible 
defective actin organization in ADPKD cells (Bershteyn , et al 2010; Hernandez, et al 2013; 
Kim, et al 2010, 2015; Rao, et al 2014; Yan, et al 2013). In our study, high resolution analysis 
of actin structures near the basal body area, revealed an increase or accumulation of what 
appeared as partially unpolymerized actin residues or structured in ADPKD cells compared to 
normal cells. One hypothesis could be that this debris at the basal body area of ADPKD cells 
could represent leftovers of partially unpolymerized actin structures, which in turn could 
sterically hinder normal ciliation processes or pathways involved in this regulation. This 
hypothesis would also assume that polycystin-1 is required to organize and prevent the 
uncompleted depolymerisation of these structures. In support of this, it was shown that 
overexpression of polycystin-1 in MDCK cells induced actin reorganization and cell 
scattering which was directly proportional to an increase in migratory ability and decrease in 
cell-cell adhesion (Boca et al, 2007). I have shown that in polycystin-1 deficient cells, there is 
increased disorganisation and polymerisation of actin leading to shortened cilia and impaired 
cilia reorientation in response to wound healing. A primary role for polycystin-1 in regulating 
the actin cytoskeleton, either in the cortical apical membrane or at the cilia base seems highly 
likely.  
 
Previous studies have shown localization of polycystin-1 to tight junctions and adherens 




filaments, assembling in a complex containing α -, β - γ –catenins and E-cadherin (Huan  and 
Adelsberg 1999). Interestingly, the latter has been shown to be abnormally secluded in 
intracellular pools in ADPKD models (Charron et al, 2000). Furthermore, polycystin-1 is 
found in a complex with α2β1 integrin, tropomyosin, troponin 1, vinculin, α-actinin and other 
cytoskeletal proteins, reinforcing a cytoskeletal organizing role of polycystin-1 (Wilson 
2001). Polycystin-1 may also sense mechanosensory stimuli between cells via its 
extracellular domains through homophilic interactions (Streets et al, 2009) and transduce 
these signals through its cytoskeletal connections such as actin and intermediate filaments to 
regulate cellular shape, adhesion, movement and cytoskeletal organization. 
 
Similarly, some studies have shown that polycystin-2 localizes at intercellular contacts, 
together with polycystin-1 (Newby et al, 2002; Scheffers et al, 2002; Bhoonderowa 2016). 
Specifically, a link between α –actinin, which binds F-actin, and polycystin-2 has been shown 
with data suggesting that α –actinin regulates polycystin-2 channel function (Li et al, 2005). 
Recent studies even suggested that the primary role of polycystin-2 in mechanotransduction 
was in cytoskeleton recruitment independent of its channel function (Bhoonderowa et al, 
2016). Interestingly in mitotic spindles of dividing cells, polycystin-2 was shown to interact 
with mDia1, a Rho GTPase effector protein, which accelerates actin nucleation and 
elongation by interacting with its barbed ends (Rundle et al, 2004). The binding of several 
actin-binding proteins to polycystin-2 could imply potential reciprocal functional regulation 
between F-actin and polycystin-2. To support this is data suggesting a link between 
polycystin-2 and the actin cytoskeleton, with polycystin-2 directly interacting with Hax-1 
(Gallagher et al, 2000). 
This study found that the inhibition of different actin effectors i.e. Rho GTPases were able to 
restore primary cilium length to different degrees. Thus polycystin-1 could specifically 
regulate the activation of Rho GTPases including RhoA, Rac1 and Cdc42, which are 
important factors enabling the cell to dynamically organize the actin and microtubule 
cytoskeleton. Changes in the cytoskeletal organization in disease also negatively influenced 
primary cilium reorientation towards the leading edge during migration following wound 
healing. These results suggest that polycystin-1 is an important regulator of cytoskeletal 
organization and that deficiency in this protein affect other mechanisms requiring dynamic 
and flexible changes in cell morphology including migration, division or primary cilium 




of cytoskeletal organization through targeting of specific pathways involved in these 
processes such as ROCK could be tested.  
 
Finally, data showing that the nephrocystins (NPHP 2, 3, 9) can interact with polycystin-2 
and may regulate its cilia localisation supports a functional interaction between two different 
cystic kidney diseases, nephronopthisis (NPHP) and ADPKD. This finding suggests that 
polycystin-2 may be the common link in both diseases and therefore further studies of its role 
in cilia is indicated. 
 
In Figure 6, the main findings from this study are summarised. Is is shown that the formation 
and organisation of the primary cilium is complex. Trafficking of different ciliary proteins 
including GPCRs and RTK receptors and calcium channels such as polycystin-2 is regulated 
at the ciliary base at the transition zone, where key proteins such as INVS exert a gatekeeping 
role. The mother centriole which develops into the basal body as well as the MTOC plays a 
key role in cilia formation and could be influenced by different signalling pathways such as 
Ca
2+
 and cAMP/PKA; PKA also has an effect on intraflagellar transport (IFT). The core of 
the cilium comprises microtubules and their polymerisation and stabilisation is an important 
determinant of cilia assembly and disassembly. Finally, the organisation of actin in the 
cortical membrane and at the cilia base seem to be key in maintaining normal cilia length. 
Changes in actin and microtubule polymerisation appear to be processes dependent on normal 
















Figure 6. Role of cystoproteins in primary cilia/cytoskeletal regulation.  
Left: The regulation of primary cilia is dependent on different specialized sections, each of which 
when disturbed affect normal ciliogenesis. The polycystin-1/2 complex and other cystoproteins are 
able to modulate cytoskeletal organization and different RhoGTPases. This in turn creates permissible 
conditions for normal primary cilium development and cellular functions. Right: In ADPKD, 
polycystin-1 deficiency results in an increase in RhoGTPase signalling, actin disorganization and a 












Implications and Further Research 
 
ADPKD has long been categorized as a class of incurable diseases, which from the 
categorization itself is a high burden for patients newly diagnosed with this disease.  
In every disease, hope and a mind-set oriented towards a positive outcome plays important 
psychological role in the disease development of the afflicted patient. Providing a therapeutic 
approach in ADPKD, which is not only aimed at managing the symptomatic journey towards 
kidney replacement and instead influences or greatly reduces disease progression, is a 
critically important step in the fight against this disease. Recently a promising potential 
treatment based on the vasopressin-2 receptor antagonist Tovalptan has emerged. Clinical 
trials showed some success of this drug at slowing down ADPKD progression (Torres, et al 
2012). Tovalptan or OTSUKA'S JINARC® has been approved by the European Commission 
for treatment of ADPKD patients in February 2015 and can be prescribed to patients with 
advanced chronic kidney disease (stages 4-5). Another potential treatment is a synthetic 
somatostatin analogue named octreotide, which in recent clinical trials has shown an 
encouraging effect on decreasing kidney volume in ADPKD patients, however these results 
are limited by a short one year follow up and need more validation in the long term (Caroli, et 
al 2013). In this study we have identified an underlying defect in normal ciliogenesis in 
ADPKD cell models and tissue samples, suggesting that the regulation of normal primary 
cilia structure and potentially its normal function is disrupted during ADPKD pathogenesis. 
Primary cilia are key regulators of many important signalling pathways, thus abnormal 
regulation and formation is likely to result in disease development such as cyst formation, 
which is associated with most ciliopathies. Future therapeutic treatments aimed at rescuing 
normal ciliogenesis e.g. ROCK inhibitors, hence allowing the normal transduction of 
ciliogenic signals, or treatments replacing the underlining intact signalling pathways will be 
promising novel approaches, with the potential to add to or improve the current limited 
number of ADPKD therapeutic treatments. 
Critical future work deriving from my work, will be to test the hypothesis that an abnormal 




and cytoskeletal defects described in this thesis. Detailed localisation and activation studies 
of Rho kinases in the cell, i.e. at the cilia are warranted. This idea is supported by findings in 
another ciliopathy, in which RhoA-GTPs were found to modulate ciliary length through 
regulation of actin polymerization in Bardet–Biedl syndrome. In addition RhoA-GTP levels 
were found to be highly upregulated in the absence of Bbs protein (Hernandez et al, 2013).  
Deriving from this, RhoGTPase inhibitors could be tested to rescue the primary cilia 
formation, length and orientation defects additional ADPKD model cell lines as well as other 
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